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This thesis aims to understand how helminth co-infection affects the susceptibility of wild 
wood mice to wood mouse herpes virus (WMHV) infection and disease progression, and 
whether the mechanism behind these within-host parasite interactions is via the host 
immune response. Co-infection with more than one parasite species is the norm rather than 
the exception in animal and some human populations, importantly infection with one 
parasite species has the potential to affect how a host deals with another co-infecting 
parasite. This is particularly important for helminth-viral co-infections, as they initiate 
mutually exclusive arms of the host immune system and helminths are well known for 
modulating the host immune response, hence they are important in co-infection 
interactions. Here I use a wild wood mouse population (Apodemus sylvaticus) which is 
naturally infected with the helminth, Heligmosomoides polygyrus, and WMHV to determine 
the causes and consequences of H. polygyrus – WMHV co-infections in their natural host. 
First, I investigated if co-infection with H. polygyrus can make individuals more susceptible 
to WMHV infections using samples from wild wood mice which were naturally infected with 
both WMHV and/or H. polygyrus. These results suggest that animals with higher previous H. 
polygyrus burdens (~3 weeks prior) had an increased probability of having a subsequent 
WMHV infection, but only in wood mice given prior deworming treatments. This is most 
likely due to the short-lived effects of ivermectin treatment, with previous studies showing 
that worm burdens quickly return to pre-treatment levels. Overall, these results show 
potentially counter-intuitive interactions between H. polygyrus burden and deworming 
treatment, suggesting that there may be complex, dynamic interactions between worm 
infection and reinfection, and host susceptibility to WMHV, which are sensitive to the 
timescales of infection and treatment. 
Since WMHV infections typically begin with a lytic (active) phase of infection, which is then 
followed by latent and lifelong infection, I next investigated if infection with H. polygyrus 
increases susceptibility to WMHV infection or increases the probability of having a lytic 
WMHV infection. I used samples taken from wild wood mice, some of which had received 
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deworming treatments, to carry out RT-qPCR analysis for open reading frame 73 (ORF73) 
which is one of the few viral genes expressed during viral latency as a marker of latent 
infection, and PCR for open reading frame 50 (ORF50) which encodes the viral gene rta 
(replication and transcription activator) and plays a central role in re-activating the virus 
from latency. This data was used alongside data already collected on the individuals H. 
polygyrus infection status to determine whether H. polygyrus co-infection affected the 
likelihood that WMHV infections were in the lytic or latent phase of infection. I found that 
effective deworming treatments can reduce the probability of having a WMHV co-infection. 
However, there was no suggestion that H. polygyrus co-infection or deworming treatments 
had any effect on the probability of having a lytic WMHV infection in this wild wood mouse 
system. 
To further explore the underlying mechanisms of helminth-viral co-infection interactions in 
this wild wood mouse system, I used RT-qPCR for some Th1 (anti-viral) and Th2 (induced by 
helminth infection) cytokine genes, to determine if co-infection with H. polygyrus results in 
the downregulation of the anti-viral Th1 arm of the immune system. I found that in this wild 
wood mouse population, mice with current or previous H. polygyrus co-infections had 
reduced Th1 cytokine gene expression (TNF-α and IL-6) compared to those with only WMHV 
infections. Additionally, there was no evidence of Th2/immunoregulatory cytokines being 
upregulated in response to H. polygyrus infection, indeed the immunoregulatory cytokine 
TGF-β was upregulated in mice with WMHV-only infections. Overall, these results suggest 
that there could be a lag between upregulation of Th2 cytokines and the downregulation of 
Th1 cytokines which our trapping time scales were not able to capture.   
Finally, I used controlled infection/co-infection experiments, with an outbred wild-derived, 
but now laboratory reared colony of wood mice, to further investigate these within-host 
interactions under both high- and low-quality nutritional provisioning. Overall, these results 
show that Heligmosomoides bakeri co-infection reduces the ability of the host to control 
WMHV in mice on lower quality diets, but not in mice on higher quality diets. Additionally, I 
found that being co-infected with H. bakeri was associated with mice on both diets having a 
longer period of lytic infection in the lungs, however during the early stages of WMHV 
infection, co-infection seems to enable to host to suppress lytic virus in the lungs to lower 
levels. Furthermore, there was some evidence of co-infected mice having higher Th2 (IL-5) 
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expression, however I found the Th1 response to co-infection was very mixed. Overall, H. 
bakeri co-infection had a negative impact on the host ability to deal with WMHV co-
infections, and this was particularly apparent in mice on lower quality diets. Despite this 
there was no apparent reduction in Th1 cytokine responses, suggesting there could be other 
immune factors at play which contributed to the increased susceptibility to WMHV infection 
seen this in wood mouse system. 
Taken together, these results show how complex within-host co-infection interactions can 
be and why it is particularly important to study these interactions in the natural host. They 
also highlight that whilst the host immune response can play a critical role in determining 
the outcomes of co-infections, other factors such as host nutritional status can also play an 
important role. This also provides additional support to moving away from artificially clean 
SPF laboratory studies, and instead using wild or ‘dirty’ lab animals, whose immune systems 
are challenged by co-infections and/or poor nutrition, and who are the natural hosts for the 
parasites. Thus, providing a more natural model of infection, with the hope that these 




1. General Introduction 
1.1 Introduction 
Co-infection of hosts by multiple parasite species is extremely common in nature (Cox 
2001). Many animals and humans harbour infections of both macroparasites such as 
helminths, and microparasites which include viruses, bacteria, and protozoa. Helminths are 
frequently found co-infecting individuals infected with microparasites such as malaria, 
tuberculosis (TB) and HIV (Brown et al. 2006, Hartgers and Yazdanbakhsh 2006, Griffiths et 
al. 2015). Furthermore, parasitic helminths can have powerful effects on the host’s immune 
system, potentially altering the host’s ability to fight microparasitic infections (Spiegel et al. 
2003, Ezenwa et al. 2010). Unsurprisingly, this can lead to within-host interactions between 
the co-infecting parasites, potentially resulting in the host having increased susceptibility to, 
or morbidity from, microparasitic infections. For instance, infection with one parasite can 
alter a host’s ability to respond to co-infection with another parasite (Salgame et al. 2013, 
Guivier et al. 2014).  
Given this, there is a great scientific and applied interest in understanding, whether, and 
how, co-infecting macroparasites and microparasites interact simultaneously in each host. 
Many studies on HIV/AIDS sufferers have found evidence suggesting that immunological 
responses to helminth infection may predispose an individual to HIV infection (Fincham et 
al. 2003) or increase HIV viremia levels in an already infected individual (Mulu et al. 2013). 
Hence, making them more susceptible to infection and/or disease progression. Additionally, 
Su et al. (2014) found that mice co-infected with the nematode Heligmosomoides polygyrus 
and the bacterium Salmonella enterica, serovar typhimurium had more severe pathology 
and a higher mortality rate, compared to mice infected with S. typhimurium alone. Similarly, 
Ezenwa et al. (2010) found that gastrointestinal (GI) nematodes in African Buffalo induced 
immune suppression which affected the immune response needed for protection against 
microparasitic infections. This immunosuppression by the nematode resulted in an 
increased probability of an individual becoming infected with TB; in buffalo without GI 
nematode infections TB was predicted to fail to establish an infection (Ezenwa et al. 2010).  
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1.2 Host immunity to macroparasites and microparasite infections, and potential for 
immune mediated interactions between them. 
Helminths are macroparasites that can potentially cause persistent asymptomatic or 
subclinical chronic infections which may be lifelong (Moreau and Chauvin 2010). Helminths 
and other macroparasites in general are dealt with differently by the host immune system 
compared to most microparasitic infections (Figure 1.1). Broadly, microparasites tend to 
induce a pro-inflammatory T-helper cell type 1 (Th1) immune response which is essential for 
the control of viral infections, and results in increased levels of the cytokines IL-2, IL-23, 
tumor necrosis factor (TNF)-α, and interferon (IFN)- γ (Anthony et al. 2007, Alves et al. 2009, 
Moreau and Chauvin 2010). Some Th1 responses have now been split into a ‘new’ T-cell 
subset, called Th17 cells, which are distinct from Th1 cells and are crucial for controlling 
microparasitic infections (Milner et al. 2008, Dienz et al. 2012); in particular they secrete IL-
17 along with pro-inflammatory cytokine TNF-α (Kolls and Lindén 2004, Langrish et al. 2005, 
Anthony et al. 2007). Recently, it has been found that TGF-β1 is important in activating Th17 
cells making it important in the pro-inflammatory response (Eisenstein and Williams 2009). 
These cytokines produced during a Th1 immune response can activate CD8+ cytotoxic T cells 
which kill virus-infected cells, induce neutralising IgG antibodies against virus particles, and 
cause inflammation. In contrast, helminths tend to induce T-helper cell type 2 (Th2) immune 
responses. In mice infected with H. polygyrus group-2 innate lymphoid cells (ILC2s) expand 
in the intestinal lamina propria (LP) during early infection invoking a local Th2 response 
(Pelly et al. 2016). Additionally, ILC2s are important for Th2 cell differentiation, they produce 
significant amounts of IL-4 and IL-2 following H. polygyrus infection which is required for 
optimal Th2 cell differentiation (Pelly et al. 2016). The Th2 immune response is 
characterised by the proliferation and activation of T cells that secrete Interleukin (IL) 4, IL-5, 
IL-9 and IL-13 (Anthony et al. 2007). These Th2 cytokines enable helminth expulsion from 
the gut by inducing eosinophil differentiation, activating B cells (Chan et al. 1992, Anthony 
et al. 2007), and inducing alternatively activated macrophages (Weng et al. 2007). 
Additionally, helminth infections are known to induce T-regulatory cells (Treg) to produce 
TGF-β which has been found to down regulate both Th1 and Th2 immune responses (Su et 
al. 2005, Anthony et al. 2007). IL-6 also plays an important role in the Th2 response by 
promoting naïve T cell to differentiate into Th2 cells via IL-4, additionally IL-6 can inhibit Th1 
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responses by upregulating suppressor of cytokine signalling (SOCS)-1 expression which 
interferes with INF- γ production and differentiation of Th1 cells (Velazquez-Salinas et al. 
2019). 
Importantly, there may be interactions between these different components of the immune 
response (Figure 1.1, red arrows). This means that prior infection with helminths may affect 
the ability of the host to respond to subsequent microparasitic infections. The Th2 
cytokines, as well as immune-regulatory pathways initiated by infection with helminths 
(such as those that activate T-reg cells), have the potential to downregulate the effector 
functions (e.g. Th1 cytokines such as IFN- γ) that induce resistance to microparasites during 
a Th1 immune response (Salgame et al. 2013). Taken together, the downregulation of the 
Th1 immune responses by Th2 cytokines could impair the ability of the host’s immune 
system to cope with microparasite co-infections such as viruses, thus exacerbating the 
impact of those viral infections. Thus, these complex immune interactions between 
helminths and microparasites are thought to be the main drivers of many of the within-host 
parasite interactions seen in laboratory and wild animal models of co-infection. 
 
Helminths are prime candidates for causing immune-mediated within-host interactions 
during co-infection with microparasites such as viruses, bacteria or protozoa, due to their 
well-studied immunomodulatory effect on the host (Maizels et al. 2004, Elliott et al. 2007, 
Maizels et al. 2012a). Studies using laboratory animals have demonstrated that helminths 
can exacerbate disease severity caused by viral infections. For example, Actor et al. (1993) 
infected mice that had previously been infected with Schistosoma mansoni, with a 
recombinant vaccinia virus expressing the HIV-1 protein gp120 and it was found that co-
infected mice could take as much as 3 weeks longer to clear the virus, compared to mice 
only infected with the vaccinia virus. Additionally, when spleen cells taken from mice 
infected with only vaccinia virus were stimulated with gp120 they produced higher INF- γ 
and IL-2, but lower IL-4 responses than the mice infected with the S. mansoni only. 
However, those infected with both the vaccinia virus and S. mansoni produced lower INF- γ 
and IL-2 responses when challenged with gp120 than the vaccinia virus alone, but produced 
no IL-4 response above the non-specific response displayed by S. mansoni only infected 




Figure 1.1.  Th2 immune response produced in response to helminth infection can 
downregulate the Th1 immune response aimed at controlling viral infections.  Broadly, 
parasites are presented to cellular components of the immune system via professional antigen 
presenting cells (APCs), such as dendritic cells in the context of MHC class II molecules to naïve T 
cells (Hivroz et al. 2012). Naïve T cells then become activated into different T cell subsets depending 
on the type of pathogen/immunogen. Generally helminths initiate Th2 immune responses including 
cytokines such as IL-4, 5 and 13 (Anthony et al. 2007).  In contrast, viruses promote a Th1 immune 
responses producing IL-2 and INF- γ (Palm et al. 2012). Moreover, Th2 immune responses can 
downregulate Th1 responses (Salgame et al. 2013). The cytokines produced during a Th2 immune 
response enable helminth expulsion from the gut by stimulating antigen activated B cells to produce 
antibodies and antibody class switching from IgM to IgE (McHeyzer-Williams and McHeyzer-Williams 
2005), recruiting and activating eosinophils to destroy pathogens (Gause et al. 2003).  The Th2 
response  also promotes alternatively activated macrophages (AAMs) (McSorley et al. 2013) which 
are detrimental to helminths (Anthony et al. 2006). The Th1 response also activates CD8+ cytotoxic T 
cells which will detect virus infected cells using the T cell receptor (TLR) and induce cell death by 
apoptosis (Nair et al. 2010), stimulate B cells to produce neutralising IgG antibodies (Nair et al. 
2010). Additionally, alarmin cytokines induced by exposure to helminths activate ILC2s which secrete 
Th2 cytokines support the differentiation of naïve T-cells into Th2 cells, recruit and activate 
eosinophils, and enable dendritic cells to induce Th2 cell differentiation (Gurram et al. 2019). The 
Th1 responses can also promote classically activated macrophages (CAMs) by engaging the IFN- γ 
receptor (IFN- γR) and CD40 ligand (CD40L) which in turn can eliminate intracellular pathogens (via 
nitric oxide (NO)) which are resistant to phagocytosis (Mantovani et al. 2005). Alternatively activated 
macrophages can also have a negative impact on CAM activation (De'Broski et al. 2004). Red arrows 
represent inhibitory interactions of the Th-2 immune response on the Th1 response, and hence a 
potential immune-mediated pathway of interaction between macro- and micro-parasites, facilitating 




Another study using mice co-infected with S. mansoni and lymphocytic choriomeningitis 
virus (LCMV) found that co-infected individuals showed more sever clinical outcomes and 
the liver was more susceptible to virus replication, with increased liver damage in co-
infected mice compared to those with only single infections (Edwards et al. 2005). Another 
example using Rhesus monkeys with stable simian-human immunodeficiency virus (SHIV) 
found that animals with clinically stable infections (no sign of immunodeficiency or 
detectable viral RNA), developed spikes in viral RNA levels when co-infected with S. mansoni 
(Ayash-Rashkovsky et al. 2007). Moreover, Using mRNA expression to determine levels of 
Th1 or Th2 specific cytokines from blood samples they found that levels of the Th2 cytokine 
IL-4 were higher in individuals with concurrent S. mansoni infections compared to virus only 
infected (Ayash-Rashkovsky et al. 2007). However, there were no differences in levels of the 
Th1 cytokines (IL-2 and INF-γ)  between singly and co-infected individuals (Ayash-
Rashkovsky et al. 2007).  
 
The evidence indicates that infection with a Th2 inducing macroparasite has the potential to 
downregulate the pro-inflammatory Th1 arm of the host immune response, with 
consequences for co-infecting microparasites. However, even in these highly controlled 
laboratory experiments results can vary. For example, Scheer et al. (2014) studied the effect 
of murine Schistosomiasis on subsequent infection with influenza A virus or pneumonia 
virus of mice (PVM), they found that mice infected with S. mansoni 12 weeks before viral 
infection survived what would normally be lethal doses of influenza A and PVM. 
Additionally, the authors found a correlation between S. mansoni egg production and TNF-
α-mediated goblet cell hyperplasia and mucus secretion, suggesting that these processes 
may infer protection to viruses of the respiratory system (Scheer et al. 2014). These studies 
show that infection with a parasite that causes a Th2 immune response has the potential to 
alter the Th1 immune response needed to control co-infecting viruses, therefore potentially 
increasing/decreasing viral replication and disease severity in laboratory animals. However, 
we do not know whether or how these findings in the laboratory relate to wild animals in 






1.3 Translating from lab to field 
Most of our understanding of the how co-infecting parasites interact come from laboratory 
models of infection, however laboratory animals have very different immune responses 
compared to wild animals, thus raising the question of whether these interactions, 
measured in laboratory mice, are detectable in their natural host populations. Interestingly, 
laboratory mice raised in SPF conditions have been found to have immune systems more 
closely related to those of neonatal humans than adult humans (Beura et al. 2016a). This 
should not be surprising since animals in their natural environment will typically be infected 
with numerous parasite species throughout their lives. Conversely, laboratory mice have 
relatively naïve immune systems since they have far less experience with infectious disease 
than free-living animals would naturally acquire (Babayan et al. 2011, Pedersen and 
Babayan 2011, Maizels and Nussey 2013, Cadwell 2015, Beura et al. 2016a). Additionally, 
laboratory mice have limited genetic diversity and receive a constant supply of food and 
water (Pedersen and Babayan 2011, Maizels and Nussey 2013, Cadwell 2015), whereas wild 
animals have much more genetic diversity, variable amounts of food and water and diverse 
environmental conditions (Cox 2001, Ezenwa et al. 2010, Telfer et al. 2010). Hence, to fully 
understand the host immune response to infections and how it drives co-infection dynamics 
we may need to move more towards ‘dirty’ or wild mice for immunological studies. 
 
While most of our understanding of co-infections comes from laboratory studies there are 
some studies which have used wild animals. For example, Guivier et al. (2014) used wild 
vole populations and found a positive association between Heligmosomum mixtum and 
Puumala Hantavirus infections (PUUV), whereby those infected with H. mixtum where more 
likely to become infected with PUUV. Similarly, Risco et al. (2014) found that wild boars co-
infected with bovine tuberculosis (bTB) and a nematode species (Metastrongylus spp.) had 
an increased infection severity than those only infected with bTB (Risco et al. 2014). 
Furthermore, there have been studies using human patients with helminth and viral co-
infections. Although the results are somewhat more conflicting, with some finding co-
infection was associated with increased viral loads (Mulu et al. 2013), and decreased virus 
specific immune responses (Farid et al. 2005), and others finding lower viral loads 
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(Modjarrad et al. 2005) or no effect of co-infection on viral disease progression 
(Hosseinipour et al. 2007).  
1.4 Deworming in the context of co-infection interactions 
Unsurprisingly, the growing evidence around helminth infections having an impact on co-
infecting microparasites has brought into question whether the severity of, and 
susceptibility to, infection with microparasites could be altered using anti-helminthic drugs 
(Nacher 2006), and as a result there have been calls for deworming to be incorporated into 
programmes aimed at controlling major diseases caused by microparasitic infections (Gerns 
et al. 2012). Helminth infections are common infections of poor people in the developing 
world and can cause a considerable amount of disease burden in human populations 
(Brooker 2010). Consequently, there have been calls for mass deworming to be introduced 
into control measures against major viral, bacterial or protozoal diseases (Molyneux et al. 
2005, Hotez 2009). For example, some studies show reduced HIV viremia (Mulu et al. 2013), 
and increased CD4+ cell count (Blish et al. 2010) in anthelminthic treated individuals. 
Additionally, Wolday et al. (2002) studied the effect of anthelminthic treatment on HIV viral 
load in individuals co-infected with helminths and HIV in Ethiopia. They found that six weeks 
after treatment there was a significant change in HIV viral loads between treated and non-
treated individuals; treated individuals had lower viral loads. However, the benefits of these 
integrated control programmes are debated, mainly due to conflicting results on the 
outcomes of deworming co-infected individuals since interactions between helminths and 
microparasites can also be negative (Pedersen and Fenton 2007). Furthermore, Modjarrad 
et al. (2005) found that there was no association between the treatment of helminth 
infections and reduced HIV viral load in adults in Zambia. 
These studies show how variable the outcomes of deworming can be. Hence, there is a need 
to better understand how microparasite and macroparasite co-infections affect disease 
outcomes in each host and what targeted therapeutic interventions will provide the best 
protection/resolution in such cases. Studies in wild animal populations can serve as a 
suitable and tractable model to explore, not only how these co-infections in a given host 
may affect the overall immunological fitness by assessing helminth-microparasite 
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interactions- but also determine the effects of different treatment strategies that are 
envisaged will be relevant to co-infections in human populations. 
1.5 Wood mice as a suitable model system to study helminth-microparasite co-
infection dynamics. 
The wood mouse (Apodemus sylvaticus) is a common free-roaming wild mouse species in 
the UK and has proved invaluable to both ecological and immunological studies. In the UK, 
most wood mice naturally harbour both helminth and viral co-infections and they can be 
readily treated using deworming drugs (Knowles et al. 2013). The anthelmintic drugs 
ivermectin (Wahid and Behnke 1993) and pyrantel (Wahid et al. 1989) are widely used to 
clear H. polygyrus infections. Ivermectin targets the larval stages of infection, whereas 
pyrantel targets adult worms (Wahid et al. 1989).   This makes wood mice a suitable model 
to assess the interactions between helminths and viral-pathogens, and explore the effects of 
mass deworming on helminth-viral dynamics (Su et al. 2006, Knowles et al. 2012). Many 
wood mouse  populations in the UK are infected with Wood Mouse Herpes Virus (WMHV) 
and the helminth Heligmosomoides polygyrus (Knowles et al. 2012). Given the ubiquity of 
infection, and co-infection between these parasites, these is considerable potential for 
within-host interactions between them. 
WMHV is a gamma-herpesvirus (γ-HV), belonging to the family Herpesviridae and is most 
commonly found in wood mice and other murid rodents (Telfer et al. 2007). There are over 
70 species of virus in the Herpesvirus family, and eight of these are pathogenic to humans, 
with 30%-90% of the adult population being infected with at least one herpesvirus (Shukla 
and Spear 2001). Importantly for this project, murine herpesvirus 60 (MHV-68 or the 
laboratory strain of WMHV) has been found to be closely related to Human Herpes virus-8 
(HHV-8; also known as Kasposi’s sarcoma-associated herpes virus or KSHV), Epstein-Barr 
virus (EBV) and non-human Saimiriine herpes virus-2 or Herpes Virus Saimiri (HVS-2) 
(Efstathiou et al. 1990, Virgin et al. 1997, Nash et al. 2001). Given the ease with which MHV-
68/WMHV can be cultured in tissue culture grown cells, it is an ideal model to study these 
closely related viral pathogens.  
Although the natural route of WMHV transmission is not entirely clear, WMHV viral antigens 
have been readily detected in upper respiratory tract and lung alveolar epithelial cells in 
18 
 
free roaming wood mice. Therefore, a preferred route of infection of laboratory mice with 
MHV-68 has been the respiratory route (Nash et al. 2001). Gamma-herpes virus infection in 
mice typically begins with a lytic phase which involves productive viral replication in the 
lungs (Sunil-Chandra et al. 1992a). Lytic virus replication in the lungs is usually cleared by 10 
days post infection (Sunil-Chandra et al. 1992a, Usherwood et al. 1996a). From the lungs, 
the virus then spreads to the spleen were a latent and lifelong infection is established, 
mainly in splenic B cells, but also in macrophages and dendritic cells (Flaño et al. 2000, Nash 
et al. 2001, Flaño et al. 2005). During viral latency, very few viral genes are expressed 
therefore allowing it to evade immune control, but also reducing the likelihood of virus 
transmission to other individuals (Nash et al. 2001). However, the latent virus has the 
molecular ability to reactivate into the lytic infection, so re-enabling it to infect new hosts 
(Wu et al. 2000). While very few viral genes are expressed during latent infection, open 
reading frame 73 (ORF73) is critical to establish and maintain viral infection in latently 
infected cells (Fowler et al. 2003, Marques et al. 2003). Additionally, the viral gene rta  
(replication and transcription activator) plays a central role in re-activating the virus from 
latency and is primarily encoded by open reading frame 50 (ORF50) (Liu et al. 2000, Wu et 
al. 2000, Wu et al. 2001). Given the similarities to pathogenic human gamma-herpesviruses 
and the ease with which MHV-68 can be maintained and used for controlled infection 
experiments, MHV-68 has become widely used as a suitable model to understand other 
gamma-herpesviruses and their host-parasite interactions.  
MHV-68 infection in laboratory mice usually starts with a lytic phase of infection (most viral 
genes are expressed, and the virus can replicate) in the lungs before moving to the spleen 
(Sunil-Chandra et al. 1992a, Flaño et al. 2005) (Figure 1.2). Lytic virus replication in the lungs 
can be detected from 1 day post infection (dpi), with peak titres at 7 dpi and is usually 
cleared from the lungs by 10 dpi (Flaño et al. 2005). Furthermore, latent (non-replicating) 
virus has been found in the lungs of mice from as early as 3 dpi with levels of latent virus 
remaining high before declining to low stable levels by 30 dpi (Flaño et al. 2005). From the 
lungs the virus then spreads to the spleen, with infectious virus detectable at low levels 
from 3 dpi, with latent virus detectable from 6 dpi and peak latent infection is reached 
around 14 dpi before declining to low stable levels by day 90 days post infection (Sunil-
Chandra et al. 1992a, Flaño et al. 2005). WMHV then establishes a latent and lifelong 
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infection, mainly in splenic B cells, but also in macrophages and dendritic cells (Flaño et al. 
2000, Nash et al. 2001, Flaño et al. 2005) and lung epithelial cells (Stewart et al. 1998). The 
lifecycle of rodent gammaherpes viruses was investigated in laboratory mice, however 
Hughes et al. (2010b) studied the progression of lytic MHV-68 infection in the lungs and 
latent infection in the spleens of wood mice, and found that progression of MHV-68 in wood 
mice is similar to that in laboratory mice. Noticeably, the main differences were that 
infectious virus in the lungs could not be detected until day 7 and there were lower levels of 
latent virus in the spleen after 20 days post infection (Hughes et al. 2010b).  
Figure 1.2. MHV-68 infection progression in the spleen and lungs of mice. A) Progression in the 
lungs: Lytic virus can be detected from 1 day post infection (dpi) with peak titres at 7 dpi and 
infection cleared from the lungs by 10 dpi, and latent virus can be detected from 3 dpi with levels 
remaining high through the lytic phase and declining to low stable levels from 30 dpi (Flaño et al. 
2005). B) Progression in the spleen: Infectious virus is detectable at low levels from 3 dpi with latent 
virus detectable from 6 dpi, and peak latent infection is reached around 14 dpi before declining to 
low stable levels by 90 dpi (Sunil-Chandra et al. 1992a, Flaño et al. 2005). 
 
Nematodes of the genus Heligmosomoides are very adept at modulating the host immune 
system (Monroy and Enriquez 1992). A member of this genus, H. polygyrus is a murine 
intestinal nematode that naturally occurs in wild mouse populations in the UK and across 
Europe (Maizels et al. 2012b), and typically at relatively high prevalence; approximately half 
of wild wood mice in the UK carry H. polygyrus infections (Knowles et al. 2013). The lifecycle 
of H. polygyrus begins when a mouse ingests infective larvae (L3) which pass through the 
digestive tract to the small intestine (Reynolds et al. 2012). The larvae penetrate though the 
wall of the small intestine to the submucosa, where they undergo two molts and by day 10 
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post ingestion they return to the gut lumen as adult worms, they then mate and the female 
worms release eggs (Reynolds et al. 2012). These eggs are released into the environment in 
the hosts faeces, the larvae then emerge from the eggs and two molts are needed before 
the larvae are at the infective L3 stage and ready to infect a new host (Reynolds et al. 2012). 
Many laboratory studies have been conducted using H. bakeri (formally H. polygyrus bakeri) 
which is a closely-related laboratory species of the wild species, H. polygyrus found in 
European wood mice (Behnke and Harris 2010, Maizels et al. 2012b). H. bakeri is used in 
many laboratory models because most laboratory bred mice are unable to expel primary 
infections, thus providing a stable host-parasite system in which to analyse the immune 
mechanisms of chronic helminth infection (Maizels et al. 2012b). Additionally, H. bakeri is 
well known for its immunosuppressive abilities in laboratory mice, because it can modify a 
wide range of host immune responses (Finney et al. 2007, Segura et al. 2007, Grainger et al. 
2010). Therefore, I aim to use this model system to study the effects of helminth co-
infections on susceptibility to viral infections and disease progression.  
1.6 Co-infection outcomes can affect parasite and host population dynamics. 
As co-infection has the potential to change within-host infection dynamics, this could 
potentially have consequences for between host dynamics and epidemiological dynamics. 
For example, if macroparasite and microparasite co-infection results in more infectious 
particles (microparasite) being released into the environment then co-infection could result 
increased microparasite transmissibility. Fenton (2008) found that in models where the 
presence of a macroparasite favours microparasite transmission, then the microparasite 
was predicted to be able to persist, even when it had no effective transmission without the 
macroparasite co-infection. It was also predicted that if co-infection increases host mortality 
then there was a reduced chance of microparasite persistence (Fenton 2008). Additionally, 
within-host interactions has noticeable consequences for the abundance of both host and 
parasite species, this could potentially result in a reduction of the host population 
abundance (Fenton 2008). These results suggest that if there are co-infections interactions 
in our wood mouse system then there could be consequences for parasite and host 
population dynamics. For example, Reese et al. (2014) found that H. bakeri co-infection re-
activated MHV-68 from latency, this could have consequences for microparasite 
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transmission rates since MHV-68 is only transmissible to others when in the lytic stage of 
infection. 
1.7 Aims and objectives of research project  
Clearly, co-infection can have an impact on the host’s immune system and eventual disease 
outcome. Helminth infection potentially increases susceptibility to infection, disease 
progression, and parasitaemia levels for viruses, bacteria, and protozoa. A suitable system 
assessing helminth-viral interactions in the natural setting, as well as determining the 
effects of different treatment scenarios is needed, and wild rodent models are ideal for this. 
A vast amount of background information and logistics have previously been worked out 
using wild rodent models and in particular wild wood mice, hence this allows helminth-virus 
interactions to be assessed and alternative treatment scenarios explored. 
 
This study aims to test the overarching hypothesis that natural H. polygyrus infections 
reduce a host’s ability to deal with co-infecting WMHV via the host immune system. This will 
be done by addressing the following specific objectives: 
1) Determine if helminth infection increases the likelihood of becoming infected with 
WMHV in the field, using immunofluorescent assays on a substantive set of 
longitudinally collected wood mouse sera samples collected over the period 2009-
2014. 
2) Determine if helminth co-infection and/or deworming influences the likelihood of 
being infected with WMHV, or WMHV-infected individuals having a lytic WMHV 
infection, by carrying out RT-qPCR and PCR analysis on wild wood mouse spleens in 
order to detect expression of viral ORF50 and ORF73 genes.  
3) Determine the mechanism of interaction between H. polygyrus infection and WMHV 
susceptibility, using RT-qPCR to detect expression of key cytokines produced by a 
Th1 and Th2 immune response. These data were used to determine if co-infected 
mice have reduced Th1 and/or elevated Th2 responses compared to those infected 
only with WMHV. 
4) Determine the effect of chronic and cleared (using ivermectin treatment) H. 
polygyrus infections on WMHV infection dynamics, using laboratory raised wood 
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mice experimentally infected with WMHV and H. polygyrus, additionally some mice 
were give a standard diet while others were on a high quality diet. Next, we used RT-
qPCR to understand how expression levels of key Th1 and Th2 cytokines are affected 

























2. The effects of H. polygyrus infection on 
susceptibility to WMHV infection in a 
wild wood mouse population 
 
2.1 Abstract  
Co-infection with more than one parasite species is the norm rather than the exception in 
animal populations, including human populations, particularly those in developing 
countries. Wild animal populations can be excellent model systems for exploring whether 
co-infection drives susceptibility and/or infectiousness of major diseases, since they are 
commonly co-infected by several pathogen species. Parasitic nematodes are often 
considered to have strong immunomodulatory effects on the host, potentially altering host 
susceptibility to other, co-infecting parasite species. Here, using samples from wild wood 
mice which were naturally infected with both wood mouse herpes virus (WMHV) and/or the 
nematode Heligmosomoides polygyrus, I investigated if co-infection with H. polygyrus can 
make individuals more susceptible to WMHV infections. These results suggest that animals 
with higher previous H. polygyrus burdens (~3 weeks prior) was associated with increased 
probability of having a subsequent WMHV infection, but only in wood mice given prior 
deworming treatments. This is most likely due to the short-lived effects of ivermectin 
treatment, with worm burdens quickly returning to pre-treatment levels. There was though 
no evidence of a direct effect between H. polygyrus infection and the likelihood of becoming 
infected with WMHV. Overall these results show potentially counter-intuitive interactions 
between H. polygyrus burden and deworming treatment, suggesting that there may be 
complex, dynamic interactions between worm infection and reinfection, and host 








Historically, disease dynamics were typically studied using the classical one-host-one 
parasite approach (Pedersen and Fenton 2007). However, co-infection with more than one 
parasite species is the norm rather than the exception in animal populations (Petney and 
Andrews 1998), including human populations, particularly those in developing countries 
(Mupfasoni et al. 2009, Griffiths et al. 2011). Co-infection allows for potential within-host 
interactions between parasite species, which can affect disease progression (Modjarrad et 
al. 2005), and disease severity (Su et al. 2014). Additionally, co-infection can shape disease 
epidemiology by altering parasite dynamics, and their rate of replication and transmission 
(Altizer and Pedersen 2008). These interactions can either be direct, such as competition for 
space between species that occupy the same physical location within the host, or indirect 
via resource competition or the immune system (Pedersen and Fenton 2007). Furthermore, 
although some individuals may not be simultaneously co-infected with two parasite species, 
prior infection history may play a role in determining the outcome of current infection, for 
example due to the longer-term impact of changes to the host’s immune system (Walzl et 
al. 2000). Since co-infections can have a considerable impact on the clinical outcomes of 
disease, recent ‘One-Health’ frameworks highlight the importance of multi-parasite systems, 
and suggest they be accounted for in all human and animal disease control plans (Webster 
et al. 2016). In particular, having a better understanding of how co-infecting parasites 
interact, and how they affect key parameters such as parasite transmission and disease 
progression will allow for better model predictions and more efficient treatment 
programmes (Lello and Hussell 2008). 
2.2.1. Helminth-microparasite interactions 
Helminths in particular are prime candidates for causing immune-mediated within-host 
interactions during co-infection with microparasites such as viruses, bacteria or protozoa, 
due to their often-strong immunomodulatory effect on the host (Maizels et al. 2004, Elliott 
et al. 2007, Maizels et al. 2012a). Several laboratory studies using helminth and viral species 
have demonstrated that, in terms of host susceptibility to infection and disease progression, 
helminths can have a negative impact on the outcome of viral infections. For example, mice 
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co-infected with Schistosoma mansoni and lymphocytic choriomeningitis virus (LCMV) 
showed more severe clinical outcomes, increased susceptibility to virus replication, and 
increased liver damage than mice with only single infections (Edwards et al., 2005). 
Additionally, co-infection with helminths has been shown to increase viral RNA levels 
(Ayash-Rashkovsky et al. 2007), increase time taken for hosts to clear virus infections (Actor 
et al. 1993), more serve viral pathology and increased mortality (Edwards et al. 2005), and 
decreased production of the cytokines interferon (INF)- γ and Interleukin (IL) -2 resulting in 
delayed virus clearance (Actor et al. 1993). These studies all show a negative impact of 
helminth co-infection on the outcome of viral infections for the host, however there are 
some studies that show conflicting results. For example, Scheer et al. (2014) studied the 
effect of murine schistosomiasis on subsequent infection with influenza A virus or 
pneumonia virus of mice (PVM). They found that mice infected with S. mansoni 12 weeks 
before viral infection survived what would normally be lethal doses of influenza A and PVM.  
The mechanism of these interactions is thought to be via the host immune system (Salgame 
et al. 2013). Helminths are dealt with differently by the host immune system than 
microparasites. Helminths tend to stimulate a type 2 (Th2) immune response which 
produces messenger molecules (cytokines) which play a role in activating immune effector 
functions aimed at controlling helminth infections (Ezenwa et al. 2010). Whereas, 
microparasites tend to produce a type 1 (Th1) immune response, which produces cytokines 
aimed at controlling microparasitic infections (Ezenwa et al. 2010). These arms of the 
immune system can be mutually inhibitory, meaning the helminth induced Th2 responses 
can potentially increase susceptibility to microparasites by downregulating the Th1 immune 
response (Spiegel et al. 2003, Ezenwa et al. 2010). Consequently, there is a great scientific, 
and applied, interest in understanding, whether, and how, co-infecting macroparasites and 
microparasites interact in each host.  
2.2.2. Wood mice as a suitable model system for studying helminth-viral interactions in 
the wild 
Wild animal populations can be excellent model systems for exploring whether co-infection 
drives susceptibility to, and infectiousness of, major diseases; since they are commonly co-
infected by several pathogen species (Bordes and Morand 2011). The wood mouse 
(Apodemus sylvaticus) is a common free-roaming wild mouse species in the UK and has 
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proved invaluable to both ecological and immunological studies. Most wood mice in the UK 
are naturally co-infected with both helminths and viruses, and they can be readily treated 
using deworming drugs to explore the effects of helminth removal on susceptibility to other 
parasite species (Knowles et al. 2013). Additionally, wood mice are commonly infected with 
wood mouse herpes virus (WMHV) and/or the nematode Heligmosomoides polygyrus. Both 
these species have closely related laboratory species that are often used as standard 
laboratory models of infection, both of herpes viruses and the immunomodulatory effects 
of helminth infections. Wood mouse herpes virus is a gamma-herpesvirus that is commonly 
found in mice and other murid rodents (Telfer et al. 2007), and its closely related laboratory 
species, MHV-68, has been well studied in laboratory mice (Sunil-Chandra et al. 1992b, 
Reese et al. 2014). WMHV, like most herpesviruses, are able to produce persistent latent 
infections in the spleen (Sunil-Chandra et al. 1992b), this latent virus then has the molecular 
ability to reactivate into an active infection (Wu et al. 2000, Wu et al. 2001). Moreover, H. 
polygyrus is known to have suppressive effects on the host immune system (Maizels et al. 
2012a), allowing for potential immune-modulated interactions between WMHV and H. 
polygyrus. Taken together, this makes wild wood mice a suitable model to assess the 
interactions between helminths and viral pathogens in a naturally infected wild animal 
population (Su et al. 2006, Knowles et al. 2012). Here, I use samples from wild wood mice 
which are naturally infected with both WMHV and/or H. polygyrus, to determine if co-
infection with H. polygyrus is associated with increased susceptibility to WMHV infections. 
 
2.3  Methods 
2.3.1. Source of wild rodent samples 
This study examined for evidence of WMHV and helminth infections from previously 
collected blood and faecal samples respectively, from wild mouse sampling conducted every 
3 weeks between May and December in 2009-2012 from three mixed woodlands in the UK 
(Manor Wood, Haddon Wood, and Rode Wood). Woodlands were split into grids, and each 
grid had two traps (H.B. Sherman 2 x 2.5 x 6.5-inch folding trap) placed every 10m in a 70 x 
70m square, and each trap contained grain and bedding. All trapped individuals were tagged 
using subcutaneous passive integrated transponder tags so they could be identified on 
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recapture. For every animal trapped a small blood sample was taken from the tip of the tail 
and a faecal sample collected at each capture. Morphometric details were also taken from 
each animal then placed in one of the following groups: adult (over 16g), sub-adult (12-16g), 
or juvenile (under 12g), the sex of each individual, and reproductive state was also recorded. 
Reproductive status was determined by assessing body shape and by visual examination of 
genitals. Fecal eggs counts (FEC) were obtained prior to this project using the fecal flotation 
procedure. Fecal samples are first weighed and formalin added, before adding sample to a 
fecalyzer and adding a salt solution to separate oocysts from the fecal sample. Next,  
oocycts are removed from the solution using a cover slip and examined under a microscope 
for the presence H. polygyrus eggs.   On some of grids randomly selected individuals were 
treated with the anthelminthic drug Ivermectin to suppress their helminth infections, with 
the remaining animals receiving water as a control. All blood samples and demographic data 
had already been collected prior to the start of this current project.  
 
2.3.2. Immunofluorescent assay to detect antibodies to WMHV 
Immunofluorescent (IFA) assays were carried out to detect antibodies to WMHV from wild 
mouse sera samples. IFA assays had been carried out on samples from 2009, 2010 (Knowles 
et al. 2012), and 2012 (Gallagher 2015) prior to this project; the samples collected in 2011 
were analysed as part of this project. The original IFA assay protocol had issues with 
reproducibility therefore steps were taken to optimise the assay. Firstly, experiments were 
carried out to determine the number of cells needed to create a 70% confluent monolayer 
after 24 hours and different plastics were also trailed to determine which the cell monolayer 
had the best adhesion to. To make the assay more reliable and to reduce any non-specific 
binding we added in steps to lyses cells using Triton x-100 and then added bovine serum 
albumin to act as a blocker against unspecific binding. Assay validation was carried out using 
samples which had previously tested positive for WMHV antibodies, and PBS as a control. 
The assay first requires NIH-3T3 cells, which are cultured in Dulbecco's Modified Eagle's 
medium (D-MEM) supplemented with 10μl/ml penicillin streptomycin (Gibco), 20μl/ml L-
glutamine (Gibco), 10% heat inactivated foetal bovine serum (Gibco). Monolayers of these 
cells were grown in 96-well plates, inoculated with 5 p.f.u of MHV-68 virus, and fixed with 
paraformaldehyde after a 24-hour incubation period before immediately starting the assay. 
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IFAs were carried out by rehydration of the cells in PBS, then adding 0.3% Triton x-100 to 
lyse cells before adding 5% (w/v) bovine serum albumin (BSA)/PBS to act as a blocker. Serial 
dilutions with serum (diluted 1:20 and 1:40) were made, and bound antibodies detected 
using conjugate anti-mouse/anti-rat IgG FITC (Sigma) diluted in 1% BSA/PBS, before 
separating by washing in PBS in preparation for viewing under UV illumination. Positive 
samples were illuminated under UV light (Gallagher 2015).  
2.3.3. Statistical analysis 
All statistical analyses were performed in R, v. 3.6.1 (R development core team 2011).  
My primary aim was to understand the relationship between current or prior helminth 
infections and current or subsequent WMHV infections. Since WMHV infections are lifelong 
(Nash et al. 2001) we can assume that if animals were seropositive for WMHV antibodies 
then they were infected with WMHV. Furthermore, since mice were trapped every 2-3 
weeks, I could examine how helminth infection or treatment at the previous capture 
affected WMHV treatment at the subsequent session (2-3 weeks later). I conducted 2 
analyses, each examining different aspects of how current and previous H. polygyrus 
infection or FEC affected the probability of being infected, or becoming infected, with 
WMHV: 1) is current and/or previous H. polygyrus infection associated with the probability 
of also being infected with WMHV (regardless of when the infection occurred)? 2) Does 
current and/or previous H. polygyrus infection affect the probability of an uninfected animal 
becoming infected with WMHV (i.e., are animals that are WMHV seronegative at one 
capture more likely to become positive by the next successive capture if they also have H. 
polygyrus)? Current and prior H. polygyrus FEC included all individuals regardless of whether 
they had a H. polygyrus infection or not (i.e., zero counts were included in the FEC metric for 
this predictor variable). Here is a description of each analysis in more detail: 
1) Is current and/or previous H. polygyrus infection associated with being infected with 
WMHV? 
First, I analysed whether H. polygyrus infection or FEC was associated with the likelihood of 
being infected with WMHV. This ignores when the animal became infected with either 
parasite and only looks at whether the two infections significantly co-occur in individual 
mice. This is the coarsest level of analysis considered here but maximises the amount of 
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data that could be used because it does not require animals to initially be seronegative for 
WMHV at the first capture, as the other analysis does (see below). Two separate binomial 
GLM’s were created both with WMHV seropositivity at the current session (factor: yes or 
no) as the response variable, and as the main predictors of interest either current and 
previous H. polygyrus (Hp) infection (absence/presence): 
WMHV seropositive ~ Current Hp infection +  Previous Hp infection * prior ivermectin 
treatment + age + reproductive status * weight + year * Session + woodland,  
or current and previous H. polygyrus FEC: 
WMHV seropositive ~ Current Hp FEC +  Previous Hp FEC * prior ivermectin treatment + age 
+ reproductive status * weight + year * Session + woodland.  
In each case I controlled for age (factor: adult or not), reproductive status/sex (factor: 
Descended testes (Male), abdominal testes (Male), scrotal testes (Male), pregnant or 
perforated (female), not pregnant or perforated (female)), weight (continuous), year (4-level 
factor: 2009-2012), session (factor: June-December), woodland (3-level factor: Manor, 
Haddon, Rode) and ivermectin treatment (factor: treated or not). Additionally, interactions 
between these variables were considered and included previous H. polygyrus 
infection*prior ivermectin treatment to determine if the effect of treatment varies 
depending on previous H. polygyrus infection, a reproductive status * weight interaction to 
check for weight specific reproductive status effects (Knowles et al. (2012) found that heavy 
males were more likely to be infected with WMHV), and finally a session*year interaction to 
determine any within year seasonal effects. Ivermectin treatment was not associated with 
either H. polygyrus infection (presence/absence) or FEC, due to the transient impact of 
treatment on these nematodes (Knowles et al. 2013), so could be included in the models. 
Full models were simplified by backwards elimination of non-significant terms (initially 
defined as p<0.07), starting with interactions, until a minimal model was obtained with all 
terms p<0.05.   
2) Does current and/or previous H. polygyrus infection affect the probability of 
becoming infected with WMHV? 
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Next, I analysed whether H. polygyrus infection or FEC was associated with the likelihood of 
WMHV-negative animals subsequently becoming infected with WMHV. Only individuals that 
were seronegative for WMHV antibodies at the previous capture session (2-3 weeks 
previously) were included in the analysis, allowing me to determine individuals that became 
infected between successive captures. Using a binomial GLM with WMHV seropositivity at 
the current session (factor: yes or no), as the response variable separate models were 
created to first determine the effect of current and previous H. polygyrus infection 
(absence/presence): 
WMHV seropositive ~ Current Hp infection +  Previous Hp infection * prior ivermectin 
treatment + age + reproductive status * weight + year * Session + woodland, 
and second current and previous H. polygyrus FEC: 
WMHV seropositive ~ Current Hp FEC +  Previous Hp FEC * prior ivermectin treatment + 
reproductive status * weight + year * Session + woodland, 
on the likelihood of an individual becoming WMHV seropositive (i.e. changing from 
seronegative at the previous session and to seropositive at the current session). Again, I 
controlled for the same covariates and interactions listed above, excluding age from the H. 
polygyrus FEC models (since all animals were adults), and simplified the maximal model by 
backwards elimination to obtain a minimal model with all terms p<0.05. 
 
2.4  Results  
A total of 2,695 samples were screened using IFA from individual mice that had both blood 
and faecal samples taken, 607 of these samples were from 2012, 668 from 2011, 485 from 
2010, and 935 from 2009 (2009 and 2010 data from Knowles et al. (2012), 2012 data from 
Gallagher 2015). In order to carry out the full longitudinal analysis described above (analysis 
1), data from two successive trapping sessions was needed for each individual to determine 
how helminth infection at one session affects the likelihood of that individual being WMHV 
seropositive at the next successive capture, which resulted in sample sizes being reduced 
(n=1065).  Across all years there was a 20.8% WMHV seroprevalence in wood mice and 
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39.7% had H. polygyrus infections. Additionally, between years 2012 had the highest 
proportion of co-infected individuals while 2010 had the highest number of WMHV only 
infections (Figure 2.1).   
Figure 2.1. Prevalence of un-infected, WMHV only, H. polygyrus only and co-infected wild 
wood mice by year. The numbers in each block represent the percentage of samples in that 
category (n=1065). 
 
2.4.1 Is current and/or previous H. polygyrus infection associated with being infected 
with WMHV. 
Overall, no co-infection or treatment factors were found to be associated with WMHV 
infection. I found no significant association between current or previous H. polygyrus 
infection (current session: x21=0.07, p=0.797; previous session: x21=0.507, p=0.48), or prior 
ivermectin treatment (x21=0.67, p=0.41) and the likelihood of an individual being infected 
with WMHV at the current session (Table2a).  The only terms that remained in the model 
were year (x23= 31.76, p<0.001) and a reproductive*weight interaction (x24= 13.63, p= 0.01), 




In the model containing H. polygyrus FEC there was no association between current H. 
polygyrus FEC (x21=0.54, p=0.46) and the likelihood of an individual being infected with 
WMHV at the current session (Table 2.2b). However, there was a significant previous H. 
polygyrus FEC* prior ivermectin interaction (x21=5.55, p=0.02), with higher previous H. 
polygyrus FEC being associated with increased probability of WMHV infection in treated 
mice (Figure 2.3). Other variables and interactions that also remained in the model were 
session (x26= 13.72, p=0.03), year (x23= 30.89, p<0.001), age (x21= 3.96, p=0.05) and weight * 
reproductive/sex (x24= 13.40, p= 0.01) (Table 2b).  
 
Figure 2.2. Probability of wild wood mice being seropositive for WMHV depending on 








Figure 2.3. Probability of wild wood mice being seropositive for WMHV depending on previous H. 
polygyrus FEC and prior ivermectin treatment for abdominal adult males of mean weight from 
October 2010 (n=485).  
Table 2.2. Factors affecting the probability of infection with WMHV in a wild wood mouse 
population. Models were simplified by backwards stepwise elimination. For variables not in the 
minimal model, statistics are those at the point they left the model. 
a) Model containing  H. polygyrus presence/absence  df x2 P 
Weight 1 - - 
Current H. polygyrus infection   1 0.0690 0.7929 
Previous ivermectin treatment   1 0.6720 0.4124 
Previous  H. polygyrus infection   1 0.5040 0.4780 
Woodland    2 4.6040 0.1000 
Age (adult or not)  1 3.5490 0.0596 
Sex/reproductive 4 - - 
Session * Year 18 14.247 0.7129 
Weight (g) *  Sex/reproductive   ¥ 4 13.627 0.0086 
Year   ¥ 3 31.763 <0.001 
Session 6 10.968 0.0893 
Previous  H. polygyrus infection  *  Previous ivermectin treatment   1 1.0440 0.3069 
        b)    Model containing H. polygyrus  FEC    
Weight 1 - - 
Current H. polygyrus  FEC    1 0.3063 0.5800 
Previous ivermectin treatment   1 - - 
Previous  H. polygyrus  FEC    1 - - 
Woodland     2 4.709 0.0950 
Age (adult or not)  1 3.961 0.0466 
Sex/reproductive 4 - - 
Session * Year 18 13.768 0.7441 
Weight (g) *  Sex/reproductive  ¥ 4 13.400 0.0095 
Year  ¥ 3 30.887 <0.001 
Session 6 13.722 0.0329 
Previous  H. polygyrus  FEC   *  Previous ivermectin treatment   1 5.5466 0.0185 
¥ Variables in the minimal model (P < 0.05)    
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2.4.2 Does current and/or previous H. polygyrus infection affect the probability of 
becoming infected with WMHV? 
Since this analysis only included individuals that were seronegative for WMHV at their 
previous capture (in addition to being captured at 2 successive sessions as in analysis 1), the 
sample size was reduced (n=442), with 44 animals becoming positive for WMHV at the next 
capture (current) session. There was no significant effect of current or previous H. polygyrus 
infection (current session: x21=1.01, p=0.32; previous session: x21=0.13, p=0.72), or prior 
ivermectin treatment  (x21=0.91, p=0.34) on the likelihood of an individual becoming WMHV 
seropositive at the current session (Table 2.3a). The only term remaining in the model was 
year (x23=14.31, p<0.01) (Figure 2.4), although these analyses potentially suffer from low 
power due to small sample sizes. 
Additionally, current or previous H. polygyrus FEC (current session: x21=0.30, p=0.58; 
previous session: x21=0.01, p=0.94), or prior ivermectin treatment (x21=0.44, p=0.51) had no 
effect on the likelihood of an individual becoming WMHV seropositive at the current session 
(Table 3b). As above the only term remaining the model is year (x23=14.31, p<0.01). 
 




Table 2.3.  Factors affecting the probability of wild wood mice becoming infected with 
WMHV between concurrent trapping sessions (2-3 weeks apart). Models were simplified by 
backwards stepwise elimination. For variables not in the minimal model, statistics are those  
at the point they left the model. 
 
 
2.5 Discussion  
In this study I used blood samples from a longitudinal study of wild wood mice, plus data on 
their H. polygyrus treatment and, for some individuals, prior anthelminthic treatment to 
determine if; 1) H. polygyrus infection is associated with being seropositive for WMHV and 
2) H. polygyrus infection is associated with becoming seropositive for WMHV (they were 
seronegative for WMHV at the previous capture and have subsequently become 
seropositive at the next successive capture).  I found no association between deworming 
treatment and being seropositive for WMHV. However, I did find a FEC-dependent effect of 
treatment; higher previous H. polygyrus FECs were associated with increased probability of 
WMHV infection in mice that were given ivermectin treatments. This is an interesting but 
counter-intuitive result, as we would expect clearing helminth infections would reduce the 
a) Model containing  H. polygyrus presence/absence  df x2 P 
Weight 1 0.2551 0.6135 
Current H. polygyrus infection   1 1.0098 0.3150 
Previous ivermectin treatment   1 0.9118 0.3396 
Previous  H. polygyrus infection   1 0.1298 0.7186 
Woodland    2 2.2722 0.3211 
Age (adult or not)  1 0.7370 0.3906 
Sex/reproductive 4 4.8036 0.3080 
Session * Year 18 8.1223 0.9188 
Weight (g) * Sex/reproductive    4 5.3770 0.2508 
Year   ¥ 3 14.312 0.0025 
Session 6 6.4563 0.3741 
Previous  H. polygyrus infection* Previous ivermectin treatment   1 0.3425 0.5584 
        b)    Model containing  H. polygyrus  FEC    
Weight 1 0.4316 0.5112 
Current H. polygyrus  FEC    1 0.2985 0.5848 
Previous ivermectin treatment   1 0.4351 0.5095 
Previous  H. polygyrus  FEC    1 0.0054 0.9413 
Woodland     2 2.2722 0.3211 
Sex/reproductive 4 4.7189 0.3174 
Session * Year 18 8.1892 0.9160 
Weight (g) * Sex/reproductive   4 5.0958 0.2776 
Year   ¥ 3 14.312 0.0025 
Session 6 6.4486 0.3749 
Previous  H. polygyrus  FEC * Previous ivermectin treatment   1 0.3405 0.5595 
¥ Variables in the minimal model (P < 0.05)    
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probability of WMHV infection.  Additionally, among those that were initially WMHV 
negative, the probability of becoming infected was not associated with H. polygyrus 
infection or ivermectin treatment. I also found heavy reproductive males had the highest 
probability being infected with WMHV, which Knowles et al. (2012) hypothesised could be 
due to specific interactions that occur between reproductive males, such as territorial scent-
marking or biting. 
Helminth infections are known to have immunosuppressive effects on the host immune 
system, with many studies showing increased susceptibility to co-infecting microparasitic 
infections (Actor et al. 1993, Edwards et al. 2005, Dietze et al. 2016). However, our results 
show no effect of H. polygyrus treatment on being, or becoming infected with, WMHV. One 
reason why we see a different effect of co-infection in our study system compared to other 
studies may be down to the use of naïve laboratory mice with no history of previous 
infection challenge in these studies (Actor et al. 1993, Edwards et al. 2005), whereas natural 
populations will have had previous exposure to other infections which could impact the 
outcomes of current infections (Cox 2001, Ezenwa et al. 2010). Additionally, the outcomes 
of co-infections can vary, even among laboratory studies there is some variation in the 
effect of co-infection on microparasites, for example, a meta-analysis on mouse helminth-
malaria co-infection experiments found that co-infection with helminths exacerbated 
mortality in some studies, but showed protective effects in others by significantly delaying 
death, while some showed no effect of helminth co-infection on malaria (Knowles 2011). 
Another study by Scheer et al. (2014) found that prior infection with murine Schistosomiasis 
had a protective effect against subsequent infection with influenza A virus or pneumonia 
virus of mice (PVM), with these mice surviving what would normally be lethal doses of 
influenza A and PVM. Another possibility could be that the effects of co-infection just are 
not visible over the timescales monitored in this experiment.  
I found a surprising effect of prior H. polygyrus FECs in treated mice; higher FECs were 
associated with increased probability of having WMHV at the next capture. This counter 
intuitive result could be due to less than ideal trapping time scales and the short-lasting 
effects of ivermectin treatment on H. polygyrus infections, meaning mice who were treated 
have become re-infected with H. polygyrus; potentially suggesting that reducing H. 
polygyrus FECs and having them bounce back (as the effect of treatment wears off) can 
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impact susceptibility to WMHV. It has previously been noted that worm FECs of ivermectin 
treated mice quickly return to pre-treatment levels (Knowles et al. 2013, Clerc 2017). These 
results show the effects of co-infection can be varied and unexpected, therefore solidifying 
the importance of co-infection studies in wild populations to aid our understanding of co-
infection dynamics in the wild. 
This study suffers from limitations since serological analyses only detect antibodies to 
WMHV, therefore is no way of knowing if these infections are latent or lytic. WMHV 
infections start with a lytic phase followed by latent and lifelong infection, which has the 
potential to reactivate back into the lytic phase during times of immunosuppression (Wu et 
al. 2000). Since serological assays can only detect if an individual has been infected at some 
points in its life, these analyses miss any potential interaction whereby H. polygyrus causes 
WMHV to reactivate from latency. To fully understand the effects of helminth infections on 
WMHV there would need to be a more in-depth analysis to determine if co-infection is 
associated with lytic WMHV infections. 
 
2.6 Conclusion  
In summary, there was a distinct lack of interaction between H. polygyrus infection and 
becoming infected with WMHV. The only interaction that was found was between 
ivermectin treated mice and prior H. polygyrus FEC; higher H. polygyrus FECs were 
associated with increased probability of WMHV infection in treated mice. However, this 
data potentially suffers from limitations due to only detecting antibodies to WMHV and less 
than ideal trapping timescales, therefore a more detailed analysis of WMHV infection stages 





3. Does helminth co-infection influence 
the likelihood of individuals having a lytic 
WMHV infection? 
 
3.1  Abstract 
Helminth infections are extremely common infections of both humans and wildlife and are 
well known for modulating the host immune response, hence they are important in co-
infection interactions with other parasites within the same host. One group of 
microparasites of global importance, and for which helminth co-infection may play an 
important role in their transmission and disease progression, are the gammaherpes viruses 
(γ-HV). Given the relatively high prevalence of both herpes viruses and helminth infections 
in many populations, it is not surprising that co-infection between them is common, both in 
humans and in wildlife. Gamma herpes virus infections typically begin with a lytic phase, 
which is then followed by a latent and lifelong infection.  Here, I analysed samples from wild 
wood mice, some of which were given deworming treatments, to determine if infection 
with the helminth H. polygyrus increases susceptibility to WMHV infection, or increases the 
probability of having a lytic WMHV infection. I used open reading frame 73 (ORF73) which is 
one of the few viral genes expressed during viral latency as a marker of latent infection, and 
open reading frame 50 (ORF50) which encodes the viral gene rta (replication and 
transcription activator) and plays a central role in re-activating the virus from latency, to 
determine whether H. polygyrus co-infection affected the likelihood that WMHV infections 
were in the lytic or latent phase of infection. I found that effective deworming treatments 
can reduce the probability of an animal also having a WMHV co-infection. However, there 
was no suggestion that H. polygyrus co-infection increases the probability of having a lytic 





3.2  Introduction 
Helminths are ubiquitous throughout nature, infecting many human and most 
wildlife/livestock populations. They typically cause chronic lifelong infections which are 
often acquired at an early age, meaning they are a common and persistent part of the host’s 
environment and consequently that of any co-infecting microparasites. Most macro- and 
microparasites have co-evolved with their hosts over millennia and can influence the host’s 
immune responses and overall fitness. These effects on the host’s immune system can then 
influence susceptibility to, and pathology of, any co-infecting parasites. Such within-host 
interactions between co-infecting parasites may therefore play a major role in shaping the 
spread of infectious diseases in both animals and humans (Hotez et al. 2006, Telfer et al. 
2008). 
3.2.1. Macro-micro parasite interactions via the host immune response 
Interactions between helminths and microparasites are thought to be driven mainly via the 
immune system (Cox 2001, Su et al. 2005, Tetsutani et al. 2009, Su et al. 2014). Helminths 
predominately activate a type 2 (Th2) immune response within the host, promoting the 
production of cytokines which enable the host to fight off infections by inducing eosinophil 
differentiation, activating B cells (Chan et al. 1992, Anthony et al. 2007), and inducing 
alternatively activated macrophages (Weng et al. 2007). However, viruses (and other 
microparasites) predominantly stimulate a type 1 (Th1) immune response, which is essential 
for the control of viral infections via CD8+ cytotoxic T-cells and virus neutralising antibodies 
(Moreau and Chauvin 2010, Palm et al. 2012). These two arms of the immune system are 
known to be mutually inhibitory. Furthermore, the Th2 immune response simulated by 
helminth infections can potentially downregulate the Th1 immune response needed to 
effectively control viral infections resulting in changes in disease susceptibility and 
progression for a number of microparasitic diseases such as HIV, malaria and TB (Spiegel et 
al. 2003, Ezenwa et al. 2010, Mulu et al. 2013). Therefore, prior infection with helminths 
may affect the host’s susceptibility to viral infections, and increase disease progression or 
duration of infection. For example, patients co-infected with both helminths and Hepatitis C 
virus (HCV) had a decreased HCV specific immune response, when compared to patients 
with only HCV infections (Farid et al. 2005). In wildlife, voles infected with Heligmosomum 
40 
 
mixtum have been found to be more likely to also be infected with Puumala Hantavirus 
infections (PUUV) (Guivier et al. 2014). Furthermore, helminth infections may not only affect 
host susceptibility to initial microparasite infection, they can also affect the ability of the 
host to control or clear the infection once it has taken hold. For example, mice infected with 
a recombinant vaccinia virus expressing HIV-1, took three weeks longer to clear the virus 
when co-infected with Schistosoma mansoni, compared to when singularly infected with the 
virus (Actor et al. 1993). Likewise, Edwards et al. (2005) found that the liver of mice co-
infected with S. mansoni and lymphocytic choriomeningitis virus (LCMV) was more 
susceptible to virus replication, compared to those only infected with LCMV. Hence, prior or 
ongoing helminth co-infection can alter many aspects of virus infection, host susceptibility 
and disease progression. 
3.2.2. Deworming to aid in the treatment of major microparasitic infections 
The ubiquity of helminths, coupled with the potentially powerful immune-modulatory effect 
they exert on their hosts, raises the question of whether the severity and susceptibility of 
infection with microparasites could be altered using anthelminthic drugs on co-infected 
individuals (Nacher 2006). However, there are a lot of conflicting results concerning the 
outcome of helminth removal on co-infecting microparasites (Modjarrad et al. 2005, Walson 
et al. 2008, Blish et al. 2010). For example, Blish et al. (2010) found that treatment of Ascaris 
lumbricoides in individuals co-infected with HIV-1, results in increased expression of CD4+ 
cells as well as a trend for decreased HIV-1 RNA levels. Moreover, it was found that in co-
infected hosts IL-10 levels were directly correlated with HIV-1 viral load, and negatively 
correlated with CD4+ cell count, although this was not the case for treated individuals, 
suggesting that deworming of co-infected individuals may reduce immunosuppression (Blish 
et al. 2010). Many have published results that support the findings of increased CD4+ cell 
count, and reduced viral load in treated individuals (Wolday et al. 2002, Kassu et al. 2003, 
Walson et al. 2008, Lankowski et al. 2014). Despite many studies agreeing with the 
hypothesis that deworming reduces viral load, increases CD4+ cell count, and ultimately 
leads to reduced susceptibility and slower disease progression, there are a few that show 
no, or opposite, results (Modjarrad et al. 2005, Hosseinipour et al. 2007). For example, 
Modjarrad et al. (2005) found that there was no association between the treatment of 
helminth infections and reduced HIV viral load in adults in Zambia.  Additionally, a study 
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conducted by Mulu et al. (2013) on HIV-1 infected individuals from Ethiopia with and 
without helminth co-infections, subsets of which were given a treatment of anthelminthic 
drugs, found that treatment reduced the HIV RNA levels found in the plasma, but contrary 
to Blish et al. (2010) there was no reduction in CD4+ cell counts. These studies show that 
results of deworming can vary, and we therefore need a suitable model system in which to 
study the effects of deworming on co-infecting parasites. This would allow us to pick apart 
the interactions between helminths and microparasites and conduct deworming 
experiments that may be difficult to carry out in human populations.  
3.2.3. Wood mice and Gammaherpes viruses 
One group of microparasites of global importance, and for which helminth co-infection may 
play an important role in their transmission and diseases progression, are the gammaherpes 
viruses (γ-HV). Between 30%-90% of the world’s population is infected with at least one 
species of herpes virus (Shukla and Spear 2001), while more than a quarter of humans are 
infected with helminths (Pullan et al. 2014). Given the relatively high prevalence of both 
herpes virus and helminth infections it is not surprising that co-infection between them is 
common, both in humans and in wildlife (Knowles et al. 2012, Knowles et al. 2013). Gamma 
herpes virus infections typically begin with a lytic phase, which is typically followed by a 
latent and lifelong infection (Sunil-Chandra et al. 1992b, Usherwood et al. 1996b, Nash et al. 
2001). During viral latency, very few viral genes are expressed therefore allowing it to evade 
immune control, but also reducing the likelihood of virus transmission to other individuals 
(Nash et al. 2001). While very few viral genes are expressed during latent infection, open 
reading frame 73 (ORF73) is critical to establish and maintain viral infection in latently 
infected cells (Fowler et al. 2003, Marques et al. 2003). However, the latent virus has the 
molecular ability to reactivate into the lytic infection, so re-enabling it to infect new hosts 
(Wu et al. 2000). The viral gene rta  (replication and transcription activator) plays a central 
role in re-activating the virus from latency, and is primarily encoded by open reading frame 
50 (ORF50) (Liu et al. 2000, Wu et al. 2000, Wu et al. 2001). Investigating the pathogenesis 
associated with helminth-Herpes virus co-infections in humans can be difficult, so laboratory 
mouse models are often used to explore these interactions. In the context of helminth co-
infection, previous work has explored possible mechanisms of interaction between the 
nematode Heligmosomoides polygyrus and murine herpes virus (MHV-68) in laboratory 
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mice. Reese et al. (2014) found that infection of laboratory mice with the nematode 
Heligmosomoides bakeri induced expression of the ORF50 gene in MHV-68, which encodes 
expression of the rta viral protein, causing MHV-68 to reactivate from latency.   
Despite these findings in the laboratory setting, questions remain about whether these 
interactions, measured in laboratory mice, are detectable, or drive the dynamics of infection 
of these pathogens in their natural host populations. Animals in laboratory settings may be 
challenged with unnatural combinations of parasite species, or species to whom they are 
not the natural host. Furthermore, hosts in their natural setting will typically be infected 
with numerous parasite species, which naturally reside within the host population. 
Additionally, wild animals will experience other stressors: social interactions, food 
limitation, other infections, adverse weather, and predation risk- all of which may alter how 
the host copes with infections and co-infections. This therefore calls into question if the 
relationship between helminth and microparasite co-infections we see in laboratory animals 
will be applicable in wild animal populations. It is therefore important that we have a 
feasible model system to explore the pathogenesis of the herpes viruses in the context of a 
natural host (Hughes et al. 2010b). 
Wood mouse herpes virus (WMHV) is a gamma-herpesvirus, belonging to the family 
Herpesviridae and is most commonly found in wood mice and other murid rodents (Telfer et 
al. 2007). WMHV is closely related to a number of human herpes viruses (Efstathiou et al. 
1990, Virgin et al. 1997, Nash et al. 2001), and the laboratory strain, MHV-68, which is 
commonly used in laboratory mouse models of infection e.g., (Wu et al. 2000, Wu et al. 
2001, Hughes et al. 2010b, Reese et al. 2014, Rolot et al. 2018); WMHV has a nucleotide 
sequence identity of 85% to MHV-68, and similar pathogenesis (Hughes et al. 2010b). 
Studies using wild wood mouse populations have found that WMHV infections are higher in 
reproductively active, heavy males, indicating that male reproductive behaviours could 
provide an important route of transmission(Knowles et al. 2012). 
3.2.4. Aims and hypotheses  
In this study I investigate the interactions between H. polygyrus (the wild-type strain of H. 
bakeri, the laboratory derived strain used by Reese et al. (2014)), and susceptibility to 
WMHV and its association with a lytic infection in their natural host, the wood mouse 
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(Apodemus sylvaticus), under natural conditions. These wood mice are commonly co-
infected with both H. polygyrus and WMHV and, as part of an ongoing experiment, some 
were given anthelmintic (ivermectin and pyrantel) treatments to remove or suppress H. 
polygyrus infections. I examined wood mouse spleen samples from a wild population to test 
for ORF73 (expressed during both latent and lytic infection) and ORF50 (expressed only 
during lytic infection) gene expression, to determine the presence of latent or lytic WMHV 
infections, and whether these were influenced by the presence or burden/ fecal egg counts 
(FEC) of H. polygyrus infection, or the treatment status of mice, under natural conditions.   
Specifically, I sought to address the following questions:  
1) Does current H. polygyrus infection or burden affect susceptibility to WMHV infection. 
2) Does current H. polygyrus infection or burden affect the probability that WMHV infected 
mice will have latent or lytic infections or affect the quantity of viral ORF73 gene expression 
(used as a proxy measure of viral load). 
3) Is there any association between ivermectin treatment and previous H. polygyrus 
infection or FEC, and susceptibility to WMHV infection.  
4) Does ivermectin treatment and previous H. polygyrus infection or FEC affect the 
probability that WMHV infected mice will have latent or lytic infections or affect viral ORF73 
quantities. 
 
3.3  Methods  
 
3.3.1 Source of samples & data 
Wood mouse spleen samples were collected from wild mouse populations in Falkirk, 
Scotland from 2013-2014 (Clerc et al. 2018, Clerc et al. 2019a) and 2015-2016 (Sweeny et al. 
2019). For the 2013 spleen samples mice were trapped over a 2-month period and sacrificed 
at first capture; hence these are cross-sectional, resulting in contemporary measures of 
WMHV and H. polygyrus treatment at the same time point for each individual. Here, the 
measure of H. polygyrus infection for these samples is the number of worms in the gut on 
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dissection. Additionally, morphometric data of the mice were taken such as weight, length, 
and sex. For the 2014-2016 samples, a longitudinal sampling approach was adopted, 
whereby all trapped mice were tagged using subcutaneous passive integrated transponder 
tags so that they could be identified upon recapture. Individuals were assigned to a 
treatment group on first capture, either deworming treatment (ivermectin and pyrantel) or 
water as a control. They were then captured daily (Tuesday-Thursday) over ~2-3 week 
period and given the same treatment during each capture. Around 2 weeks after first 
capture, animals were sacrificed, and their spleens removed for analysis. Hence, these data 
are longitudinal, potentially allowing insight into how past infection or treatment status 
influences subsequent infection. For every animal trapped a faecal sample was collected, 
along with morphometric details such as weight, length, and sex. Faecal samples from each 
capture were used to quantify H. polygyrus egg count (FEC) by determining the number of 
H. polygyrus eggs in the sample, and number of worms in the gut were counted upon 
dissection to determine worm burden. For methods on worm egg counts refer to section 
2.3.1. Spleen samples were stored in RNA later at -80oC. Eye lens mass was used as a 
measure of age (Rowe et al. 1985, Clerc et al. 2018, Clerc et al. 2019a).  
3.3.2 Sample selection 
All available spleen samples for 2014 (n=15), 2015 (n=11) & 2016 (n=6) were used in RT-
qPCR for WMHV and cytokine gene expression. 
As there were many samples for 2013 (n=85), samples were selected to include an even 
number of male/female mice and H. polygyrus status (positive/negative) from the adult 
population. Any outliers, or those that fell outside the interquartile range in spleen sizes for 
the population were excluded (Figure 3.1), as very large spleens could be the result of 











Figure 3.1.  Spleen mass (g) for 2013 samples, any spleens with a mass outside the interquartile 
range were excluded (n=85). 
 
3.3.3 RNA extraction from spleens 
RNA extraction from spleens (2013) was carried out using RNeasy® PowerLyzer® Tissue & 
cells kit (Qiagen) according to instructions, including on column DNase 1 treatment. RNA 
extraction from spleens from 2014 - 2016 was carried out by first homogenising 30mg of 
spleen sample in lysis buffer (containing mercaptoethanol), before carrying out RNA 
extraction using RNeasy Mini Kit (Qiagen) including on-column DNase 1 treatment. Optical 
density of RNA samples was measured to determine RNA concentration before running an 
agarose gel to ensure there was no DNA contamination. cDNA was reverse transcribed from 
RNA by first heating 2μg total RNA in the presence of random primers, dNTP’s and RNase 
free water (total volume of 13μl) to 65oC, before snap cooling on ice and adding first strand 
synthesis buffer plus 0.1M DTT, then heating to 42oC before adding 1μl RTase (SuperScript 
II) and incubating at room temperature. The mixture was then incubated at 42oC for 2 
hours, then inactivated at 70oC. Samples were stored at -20oC until needed. 
3.3.4 RT-qPCR for active/latent WMHV infection 
WMHV presence was examined in spleen samples from 2013-2016 from wild mouse 
populations in Falkirk, Scotland using PCR and RT-qPCR. cDNA purified from mouse spleen 
samples was used to amplify WMHV genomic ORF50 (encodes the key lytic switch protein, 
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Rta) and ORF73 (latency associated gene) genes. Primers from MHV-68 were first tried on 
WMHV known positive samples, after analysing the melt curve from the RT-qPCR analysis it 
was decided to redesign both ORF50 and ORF73 primers using the WMHV genome. These 
new primers were tested on known WMHV positive samples and the melt curve examined 
to ensure there was one single peak, an agarose gel was then run to ensure a single band 
was visible. I also tried different concentrations of MgCl2 and primers in the PCR master mix, 
and different annealing temperatures for qPCR cycles. However, I was unable to design 
primers for ORF50 that could be used for RT-qPCR in time to use them on samples for this 
chapter. After spiking samples that had unspecific binding, with the ORF50 template I was 
able to get a perfect melt curve and single band on an agarose gel, suggesting the unspecific 
binding seen in samples was due to low expression of ORF50 in samples.  Therefore, this 
chapter contains only end point PCR results for ORF50 as although the primers gave an 
unspecific melt cure in RT-qPCR they gave a single band on a gel when doing end point PCR. 
Primers for PCR ORF50 (ORF50F: 5’- CATCTGAGGACGCGTTCATC- 3’ and ORF50R: 5’- 
CAGTGACACATGTTCCAT- 3’) generated a 100-bp product (Acc. No. AF105037.1), and ORF73 
(ORF73F: 5’ ACCATGCCAGGATCTATGYTATTGTGTGT- 3’ and ORF73R: 5’-
CTCCAAAGCATYTACTATTCAA- 3’) generated a 157-bp product (Acc. No. GQ169129.1). First 
PCR was carried out to check the validity of cDNA samples using the murine ribosomal 
protein L8 gene (acc no. AF091511), using forward primer 5’-
ACCAGAGCCGTTGTTGTTGTTGTGG-3’ and reverse 5’-AGTTCCTCTTTGCCTTGTACTTGTGG-3’. 
End point PCR was used to determine the presence of ORF73 and ORF50, the reaction 
mixture contained 5x PCR buffer, 10x dNTPS (2mM), Taq II Pol (0.8U/μl) and each primer at 
10μM each. Additionally, ORF73 was analysed by RT-qPCR using the same reaction mixture 
as for PCR, but with the addition of 10x SYBR green 1. PCR programme was as follows: 35 
cycles of 2 min at 95°C, 10s at 94°C, 20s at 60°C, 15s at 72°C, 10s at 75°C, followed by a melt 
curve analysis of 1 min at 94°C, 30s at 65°C and then 30s at 95°C. The detection limit for 
ORF73 qPCR was 1000 copies.   
ORF73 copy numbers below 1000 were only included in the analysis if a band was visible on 
a gel after end point PCR, however these quantities will be less accurate than those above 




3.3.5 Statistical analysis 
Four analyses were conducted, each examining different aspects of how current or previous 
H. polygyrus infection (presence or absence) or burden/FEC, or ivermectin treatment, could 
affect WMHV infection. For analyses 1 & 2 helminth burden refers to number of worms in 
the gut on dissection, for analyses 3 & 4 current and previous FEC refers to number of eggs 
per gram of faeces collected. Previous H. polygyrus refers to FEC/presence in the faeces on 
first capture, while current H. polygyrus refers to FEC /burden/presence (worms in the gut 
on dissection for analysis 1 and 2, and worms in faeces for analysis 3 and 4) the day they 
were sacrificed. Each analysis was conducted to address the following questions: 
1) Was there any association between current H. polygyrus infection or burden and WMHV 
infection among untreated animals from 2013-2016? 
2) Does current H. polygyrus infection or burden affect the probability that WMHV infected 
mice will have a latent or lytic infection or affect viral ORF73 quantity among untreated 
animals from 2013-2016? 
3) Is there any association between previous H. polygyrus infection or FEC, and WMHV 
infection among animals from 2014-2016? 
4) Does previous H. polygyrus infection or FEC affect the probability that WMHV infected 
mice will have latent or lytic infections or affect viral ORF73 quantity among animals from 
2014-2016? 
All statistical analysis was performed in R, v. 3.6.1 (R development core team 2011). Here 
each analysis is explained in more detail: 
1) Among untreated animals, is there an association between current H. polygyrus 
infection or burden and WMHV treatment? 
Using only untreated individuals from all years (2013-2016), I first analysed whether H. 
polygyrus infection was associated with the likelihood of WMHV infection (regardless of 
whether latent or lytic). I used a binomial GLM with WMHV infection (factor: yes or no), 
based on expression of any viral gene (ORF73 and/or ORF50) as the response variable and H. 
polygyrus (Hp) infection (factor: yes or no): 
48 
 
ORF73/ORF50 ~ Hp infection + eye lens mass * sex + year, 
 or H. polygyrus (Hp) burden (continuous): 
ORF73/ORF50 ~ Hp burden + eye lens mass * sex + year, 
 as the key predictor of interest. In each case I controlled for the following covariates: eye 
lens mass (continuous), host sex (factor, male or female) and year (Factor: 2013 -2016). In 
all cases, full models were created for each explanatory variable above, plus a sex*lens mass 
interaction, since previous work has suggested that older males are more likely to be 
WMHV-positive than any other demographic group (Knowles et al. 2012). Models were then 
simplified by backwards elimination of non-significant terms, initially with a cut-off at 
(p<0.07), starting with interaction terms, until a minimal model was reached with all terms 
p<0.05. 
 
2) Among untreated animals is current H. polygyrus infection or burden associated with 
the probability of WMHV infections being lytic/latent or orf73 copy numbers? 
To determine the effect of H. polygyrus infection or burden on the probability of WMHV 
infections being lytic/latent (using only untreated individuals from 2013-2016), an analysis 
was carried out using only WMHV positive individuals (those with either ORF73 and/or 
ORF50 expression). Among those animals, individuals that were positive for ORF50 
expression were assumed to harbour lytic infection; those without were assumed to 
harbour latent infection. Again, I used binomial GLM’s with lytic WMHV infection (factor: 
yes or no), based on expression of ORF50 as the response variable, and as the key predictors 
of interest either H. polygyrus infection (factor: yes or no): 
ORF50 ~ Hp infection + eye lens mass * sex + year, 
 or H. polygyrus burden (continuous):   
ORF50 ~ Hp burden + eye lens mass * sex + year, 
Next, to determine if H. polygyrus infection or burden affects the quantity of ORF73 gene 
expression (a proxy for viral load), an analysis was carried out using ORF73 RT-qPCR data 
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which had been normalised against the mouse L8 housekeeping gene. This assay had a 
detection limit of 1000 copies, therefore any quantities below this are less accurate, 
however all had bands of the correct size on an agarose gel, and so were included even if 
below the detection limit. I used Gaussian GLM’s with ORF73 (logged, continuous) as the 
explanatory variable and as the key predictor of interest either H. polygyrus infection 
(factor: yes or no): 
ORF73 ~ Hp infection + eye lens mass * sex + year+ ORF50 expression, 
 or H. polygyrus burden (continuous): 
ORF73 ~ Hp burden + eye lens mass * sex + year + ORF50 expression. 
Each model was tested for the effect of the covariates and interactions listed above, 
including ORF50 expression and simplified as above.  
3) Does previous ivermectin treatment (or current H. polygyrus infection), and previous 
H. polygyrus infection/burden, affect susceptibility to WMHV? 
This analysis uses only individuals from years where ivermectin treatments were given 
under a longitudinal study design (2014-2016) to determine if ivermectin 
treatment/previous H. polygyrus infection (presence/absence) is associated with WMHV 
infection. Crammers V test of association was used to determine whether current H. 
polygyrus infection (presence/absence) and ivermectin treatment were associated (v=0.73, 
p<0.001). Since current H. polygyrus treatment and ivermectin treatment are highly 
associated (those that were treated did not have current H. polygyrus infections), 
alternative versions of these models were explored. These involved either current H. 
polygyrus infection or ivermectin treatment being included as the key predictor of interest 
in the model, along with previous H. polygyrus infection, and models were compared using 
AIC. Since previous H. polygyrus infection status (determined from faecal sample collected 
at the time of sacrifice) was not associated by Crammer v test of association with either 
treatment (v=1.17, p=0.38) or current H. polygyrus infection (v=0.29, p=0.12) it could be 
included in both models. As assessed by AIC, having ivermectin treatment in the models 
(AIC: 33.64) provided a better description of the data than having current H. polygyrus in the 
models (AIC: 37.54).  Therefore, binomial GLM’s were used with WMHV infection (factor: 
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yes or no), based on expression of any viral gene (ORF73 and/or ORF50) as the response 
variable with ivermectin treatment (factor: yes or no) and previous H. polygyrus infection 
(factor: yes or no) as the key predictors of interest: 
ORF73/ORF50 ~ Previous Hp infection + Ivermectin treatment + eye lens mass * sex + year + 
ORF50 expression. 
To determine if current or previous H. polygyrus FEC is associated with WMHV infection, 
again I used binomial GLM’s with WMHV infection (factor: yes or no) as the response 
variable with current H. polygyrus FEC (continuous) and previous H. polygyrus FEC 
(continuous) as the key predictors of interest: 
ORF73/ORF50 ~ Previous Hp FEC + current Hp FEC + eye lens mass * sex + year + ORF50 
expression. 
Again current H. polygyrus FEC and previous H. polygyrus FEC were not correlated by 
Pearson test of correlation (r=-0.1, p=0.4) so could both be included in the model.  
Each model was tested for the effect of the covariates and interactions listed above, with 
the addition of ORF50 expression and simplified as above. 
4) Does ivermectin treatment (or current H. polygyrus infection), and previous H. 
polygyrus infection/FEC affect the probability of WMHV infections being lytic/latent 
or ORF73 copy numbers? 
Again, this analysis used only individuals from years where ivermectin treatments were 
given (2014-2016), but now restricted to only those animals with a detectable WMHV 
infection. As above, AIC values were used to determine if ivermectin treatment or current H. 
polygyrus infection (presence/absence) should be used in the models. The model containing 
treatment was better (AIC: 37.80) than the model containing current H. polygyrus infection 
(AIC: 37.94), so binomial GLM’s were used with lytic WMHV infection (factor: yes or no, 
based on ORF50 presence/absence), with ivermectin treatment (factor: yes or no) and 
previous H. polygyrus infection (factor: yes or no) as the key predictors of interest: 
ORF50 ~ Previous Hp infection + Ivermectin treatment + eye lens mass * sex + year.  
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To determine if current or previous H. polygyrus FEC is associated with lytic WMHV 
infection, again binomial GLM’s were used with lytic WMHV infection (factor: yes or no) as 
the response variable with current H. polygyrus FEC (continuous) and previous H. polygyrus 
FECFEC (continuous) as the key predictors of interest: 
ORF50 ~ Previous Hp FECFEC + current Hp FEC + eye lens mass * sex + year.  
Again current H. polygyrus FEC and previous H. polygyrus FEC were not correlated by 
Pearson test of correlation (r=-0.2, p=0.3), so could both be included in the model.  
AIC values were also used to determine whether current H. polygyrus infection or treatment 
should be included in the ORF73 expression (quantity) models. The AIC value for the model 
with current H. polygyrus infection was marginally better (AIC: 141.94) than the model 
containing ivermectin treatment (AIC: 141.98). As in question (2) I used Gaussian GLM’s with 
ORF73 (logged, continuous) as the explanatory variable with current H. polygyrus infection 
(factor: yes or no) and previous H. polygyrus infection (factor: yes or no): 
ORF73 ~ Previous Hp infection + current Hp infection + eye lens mass * sex + year + ORF50, 
and a second model with current H. polygyrus FEC (continuous) and previous H. polygyrus 
FEC (continuous): 
ORF73 ~ Previous Hp FEC + current Hp FEC + eye lens mass * sex + year ORF50, 
 as the key predictors of interest. Each model was tested for the effect of the covariates and 
interactions listed above, with the addition of ORF50 expression and simplified as above. 
 3.4 Results 
 A total of 61 spleen samples were analysed for expression of viral ORF73 (one of the main 
genes expressed during latent infection) and ORF50 (encodes the key lytic switch protein, 
Rta), from 2013 -2016. Across all years ORF73 expression was detected in 45.9% of samples, 
while ORF50 expression was detected in 24.6% of samples. Additionally, 63.9% of individuals 
had a H. polygyrus infection (Table 3.1). From this table we can see that there is the 
possibility of a 20% false negative rate as we have 3 samples that were ORF50 positive but 




 Table 3.1. Number of individuals with different combinations of ORF73, ORF50 and H. 









3.4.1 Among untreated animals is there an association between current H. polygyrus 
infection or burden and WMHV infection? 
There was no effect of current H. polygyrus infection on the likelihood of also having WMHV 
(regardless of active or latent) (X21=1.33, p=0.25; Table 2A). However, year (X23=16.57, 
p<0.001)  and a lens mass*sex interaction (X21=5.10, p=0.02) remained in the model (Table 
3.2A, Figure 3.2). There was also no effect of current H. polygyrus burden on the likelihood 
of having WMHV (X21=0.48, p=0.49; Table 2B), but year and a lens mass* sex interaction 
remained in the model as above (Table 3.2B).  
Table 3.2. Factors affecting susceptibility to WMHV in a wild wood mouse population. 
Model containing: A) H. polygyrus presence/absence and B) H. polygyrus burden (total 
worms in the gut on dissection). Models were simplified by backwards stepwise elimination. 








ORF50 ORF73 Negative  ORF73 Positive 
 Hp + Hp - Hp + Hp - 
Negative 15 15 13 3 
Positive 2 1 9 3 
A 
Variable 
df X2 p 
Lens mass*Sex  ¥ 1 5.1049 0.0239 
Lens mass  - - - 
Sex - - - 
Year  ¥ 3 16.5735 0.0009 
H. polygyrus infection 1 1.3273 0.2493 
B 
Variable 
df X2 p 
Lens mass*Sex   ¥ 1 5.1049 0.0239 
Lens mass  - - - 
Sex - - - 
Year  ¥ 3 16.5735 0.0009 
H. polygyrus burden 1 0.4813 0.4878 
¥ indicates terms retained in the final model (p<0.05) 
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Figure 3.2. The association between eye lens mass, for males and females and the 
probability of having a WMHV infection plotted for the year 2013 (n=32). 
 
 
3.4.2 Among untreated animals is current H. polygyrus infection or burden associated 
with the probability of WMHV infections being lytic, or ORF73 copy numbers? 
Among those with a WMHV infection there was no effect of H. polygyrus infection (X21=0.44, 
p=0.51; Table 3.3A) or H. polygyrus burden (X21=1.36, p=0.24; Table 3.3B) on the probability 
of having a lytic WMHV infection. Additionally, there was no effect of current H. polygyrus 
infection on ORF73 copy numbers (X21=1.65, p=0.20; Table 3.4A). However, there was an 
effect of current H. polygyrus burden on ORF73 copy numbers (X21=8.72, p=<0.01), with 





 Table 3.3. Factors affecting the probability of WMHV infected wild wood mice having an 
active infection. Model containing: A) H. polygyrus presence/absence and B) H. polygyrus 
burden (total worms in the gut on dissection). Models were simplified by backwards 
stepwise elimination. For variables not in the minimal model, statistics are those at the 










Table 3.4. Factors affecting viral ORF73 expression in WMHV infected wild wood mice. 
Model containing: A) H. polygyrus presence/absence and B) H. polygyrus burden (total 
worms in the gut on dissection). Models were simplified by backwards stepwise elimination. 












df X2 p 
Lens mass*Sex  1 0.3068 0.5797 
Lens mass  1 0.6037 0.4372 
Sex 1 0.0119 0.9131 
Year  3 5.5681 0.1346 
H. polygyrus infection 1 0.4404 0.5070 
B 
Variable 
df X2 P 
Lens mass*Sex  1 0.0488 0.8252 
Lens mass  1 0.0923 0.7613 
Sex 1 0.0033 0.9539 
Year  3 5.5681 0.1346 
H. polygyrus burden 1 1.3621 0.2432 
¥ indicates terms retained in the final model (p<0.05) 
A 
Variable 
df X2 p 
Lens mass*Sex  1 0.5125 0.4741 
Lens mass  1 3.0037 0.0831 
Sex 1 0.9562 0.3281 
Year  3 4.0593 0.2551 
H. polygyrus infection 1 1.6465 0.1994 
Orf50 expression 1 0.3336 0.5636 
B 
Variable 
df X2 P 
Lens mass*Sex  1 0.0012 0.9727 
Lens mass  1 0.0508 0.8217 
Sex 1 1.1793 0.2775 
Year  3 2.5084 0.4738 
H. polygyrus burden ¥ 1 8.7197 0.0031 
Orf50 expression 1 0.0728 0.7872 





Figure 3.3. The association between Heligmosomoides polygyrus infection burden and viral 
ORF73 expression (logged copy number) (±SEM) in wood mouse herpes virus (WMHV) 
infected wild wood mice. Increasing H. polygyrus burdens are associated with higher ORF73 
gene expression (n=64). 
 
3.4.3 Does previous deworming treatment or previous H. polygyrus infection/FEC affect 
susceptibility to WMHV? 
There was a significant negative association between deworming treatment and being 
infected with WMHV (X21= 7.37, p=0.007; Table 3.5A, Figure 3.4).  However, there was no 
association between previous H. polygyrus infection and WMHV infection (X21=1.28, p=0.26) 
(table 3.5a). Additionally, neither previous (X21=0.87, p=0.35) nor current (X21=0.001, 






Table 3.5. Factors affecting WMHV infection in wild wood mice. Model containing: A) 
previous H. polygyrus presence/absence and ivermectin treatment and B) current and 
previous H. polygyrus FEC (from feceal egg counts). Models were simplified by backwards 
stepwise elimination. For variables not in the minimal model, statistics are those at the 












Figure 3.4. The association between treated (Ivermectin + Pyrantel) (untreated (0), treated 
(1)) and wood mouse herpes virus infection (WMHV) in a wild wood mouse population (n= 
32). Mice given deworming treatments were less likely to have a WMHV infection. 
A 
Variable 
df X2 p 
Lens mass*Sex  1 1.2275 0.2679 
Lens mass  1 1.8914 0.1690 
Sex 1 1.7472 0.1862 
Year  3 0.3240 0.8504 
Previous H. polygyrus infection 1 1.2835 0.2573 
Ivermectin treatment  ¥ 1 7.3739 0.0066 
B 
Variable 
df X2 P 
Lens mass*Sex  ¥ 1 4.2121 0.0401 
Lens mass  1 - - 
Sex 1 - - 
Year  3 0.1290 0.9376 
Previous H. polygyrus  FEC   1 0.8672 0.3517 
Current H. polygyrus  FEC 1 0.0009 0.9767 
¥ indicates terms retained in the final model (p<0.05) 
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3.4.4 Does previous ivermectin treatment or previous H. polygyrus infection/FEC affect 
the probability of WMHV infections being lytic/latent, or ORF73 copy numbers? 
There was no association between ivermectin treatment (X21= 0.37, p=0.54) or previous H. 
polygyrus treatment (X21= 0.40, p=0.53) and the probability of having active WMHV 
infections (Table 6A). Additionally, there was no association between current H. polygyrus 
FEC (X21= 3.02, p=0.08) or previous H. polygyrus FEC (X21= 1.50, p=0.22) and the probability 
of having active WMHV infections (Table 3.6B).  
The amount of viral ORF73 expression was not associated with deworming treatment (X21= 
0.14, p=0.83) or previous H. polygyrus infection (X21= 3.31, p=0.07)  (Table 3.7A). 
Additionally, there was no association with current H. polygyrus infection (X21= 0.04, p=0.83) 
or previous H. polygyrus FEC (X21= 0.01, p=0.94) (Table 3.7B). 
Table 3.6. Factors affecting the probability of WMHV infected wild wood mice having an 
active infection. Model containing: A) previous H. polygyrus presence/absence and 
ivermectin treatment and B) previous H. polygyrus FEC (from feceal egg counts) and 
ivermectin treatment. Models were simplified by backwards stepwise elimination. For 
















df X2 p 
Lens mass*Sex  1 0.1558 0.6930 
Lens mass  1 1.7342 0.1879 
Sex 1 0.5961 0.4401 
Year  3 3.8227 0.1479 
Previous H. polygyrus infection 1 3.3128 0.0687 
Current H. polygyrus infection 1 0.1441 0.8336 
Orf50 expression 1 1.0886 0.2968 
B 
Variable 
df X2 P 
Lens mass*Sex  1 0.0187 0.8912 
Lens mass  1 1.7342 0.1879 
Sex 1 0.7275 0.3937 
Year  3 3.8227 0.1479 
Previous H. polygyrus  FEC   1 0.0052 0.9427 
Deworming treatment 1 0.0441 0.8337 
Orf50 expression 1 0.7296 0.3930 
¥ indicates terms retained in the final model (p<0.05) 
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Table 3.7. Factors affecting viral ORF73 expression in WMHV infected wild wood mice. 
Model containing: A) previous H. polygyrus presence/absence and current H. polygyrus 
presence/absence and B) previous H. polygyrus FEC (from feceal egg counts) and Deworming 
treatment. Models were simplified by backwards stepwise elimination. For variables not in 














3.5  Discussion  
In this study I used spleen samples collected from wild wood mice, plus data on their H. 
polygyrus treatment and, for some animals, prior anthelmintic treatment to determine if; 1) 
H. polygyrus infection is associated with susceptibility to WMHV, 2) H. polygyrus infection is 
associated with WMHV infections being lytic or affects control of WMHV gene expression 
(i.e. does it increase/decrease ORF73 gene expression), 3) previous H. polygyrus infection or 
ivermectin treatment is associated with susceptibility to WMHV, and 4) previous H. 
polygyrus infection or ivermectin treatment is associated with WMHV infections being lytic 
or affects control of WMHV gene expression? This study suggests that treatment with 
ivermectin (therefore reduced FECs) is associated with a decrease in susceptibility to WMHV 
infection, and that higher H. polygyrus burdens are associated with increased levels of 
ORF73 gene expression, a proxy for viral load of WMHV. Furthermore, older females (age 
based on lens mass) were more likely to have a WMHV infection than older males. However, 
A 
Variable 
df X2 p 
Lens mass*Sex  1 1.1458 0.2844 
Lens mass  1 0.4914 0.4833 
Sex 1 0.2924 0.5887 
Year  3 4.5624 0.1022 
Previous H. polygyrus infection 1 0.4027 0.5257 
Ivermectin treatment 1 0.3677 0.5442 
B 
Variable 
df X2 P 
Lens mass*Sex  1 2.7364 0.0981 
Lens mass  1 1.0512 0.3052 
Sex 1 0.3512 0.5534 
Year  3 4.1991 0.1225 
Previous H. polygyrus  FEC   1 1.5005 0.2206 
Current H. polygyrus  FEC 1 3.0186 0.0823 
¥ indicates terms retained in the final model (p<0.05) 
59 
 
H. polygyrus infection (current or previous) had no detectable effect on either the likelihood 
of an individual having WMHV infection, or on the likelihood of a WMHV-positive animal 
having a lytic infection.  
In contrast to the results found by Knowles et al. (2012), who found that WMHV infection 
probability was highest in reproductively active heavy male mice, this study found that older 
females were more likely to have a WMHV infection. However, I was unable to include 
reproductive status due to small sample sizes. While this could mean that older females in 
our system are more susceptible than males to WMHV; alternatively, it could be that older 
females are no more likely to become infected than males, however when they do become 
infected they are less able to suppress viral RNA expression in the spleen to below 
detectable levels.   
3.5.1. Reduced probability of WMHV in ivermectin treated wood mice  
The reduced likelihood of WMHV infection in individuals treated with ivermectin suggests 
that H. polygyrus and WMHV could be engaging in some sort of within-host interaction, 
whereby individuals infected with H. polygyrus are more likely to be infected with WMHV,  
and hence their removal by ivermectin treatment removes this interaction and reduces the 
likelihood of being infected with WMHV.  H. polygyrus is known to have suppressive effects 
on the host immune system with implications for susceptibility to, and progression of, 
infections by other microparasites. For example, Su et al. (2014) used laboratory mice co-
infected with H. polygyrus and Salmonella enterica serovar typhimurium, and found that 
mice with H. polygyrus– S. typhimurium co-infections had a higher mortality rate and more 
severe pathology than those with single S. typhimurium infections. One method of immune 
modulation includes the secretion of excretory-secretory (ES) products from adult worms 
(Hewitson et al. 2009). Additionally, H. polygyrus infection predominantly initiates a Th2 
immune response (Mohrs et al. 2005), which has been linked to the downregulation of the 
microparasite fighting Th1 arm of the immune response (Salgame et al. 2013). Therefore, 
immune perturbation caused by chronic helminth infection could be a confounding factor in 
increased susceptibility to WMHV. Our results support those found by Guivier et al. (2014) 
who studied wild vole populations and found a positive association between the nematode 
Heligmosomum mixtum and Puumala Hantavirus infections (PUUV), whereby those infected 
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with H. mixtum were more likely to become infected with PUUV. Moreover, Ezenwa et al. 
(2010) illustrated the importance of helminth infection in the facilitation of microparasitic 
infections. They found that helminth infection in wild free-ranging buffalo caused 
immunosuppression which facilitated the infection of buffalo with tuberculosis (TB); most 
notably, in populations without helminth infections TB was predicted to fail to invade the 
system (Ezenwa et al. 2010).  
It has previously been suggested that removal of helminths by deworming could potentially 
reverse the inhibitory effects of the Th2 response on the Th1 response (Bentwich et al. 
1995, Bentwich et al. 1999). Elias et al. (2001) hypothesized that reduced vaccine efficiency 
against TB in countries where helminth infections are common, is due to the strong Th2 bias 
caused by helminth infection. They found that Th1 responses (INF-γ) were down regulated 
in individuals with concurrent helminth infections, however this was shown to be reversed 
in individuals that received deworming treatments (Elias et al. 2001). Our data shows that 
individuals treated with ivermectin are less likely to have a detectable WMHV infection, 
which could potentially be due to a reversal of the inhibitory effects of the Th2 response. 
However, analysis of Th1/Th2 cytokines would be needed to determine if Th1 cytokines are 
down regulated in co-infected individuals, and if this is reversed in ivermectin treated 
individuals. Analysis of the cytokine responses of the animals in this study are presented in 
the next chapter. 
3.5.2. Higher H. polygyrus burdens are associated with higher ORF73 gene expression 
Additionally, our results suggest that H. polygyrus burden also affects the host’s ability to 
control WMHV, as higher H. polygyrus burdens were associated with higher ORF73 gene 
expression. Increased helminth burden has been known to exacerbate the negative effects 
of helminth infection (Goater and Ward 1992, Lowrie et al. 2004), for example in mice, 
increasing helminth burdens have been associated with increased host weight loss (Lowrie 
et al. 2004). Additionally, Goater and Ward (1992) found that toads with higher worm 
burdens were smaller in size, had higher mortality rates, and reduced dietary intake. All 
these consequences of increased helminth burden could potentially exacerbate the effects 




3.5.3. There is no association between H. polygyrus co-infection and lytic WMHV 
infections 
Since WMHV causes latent lifelong infections which can re-activate if the host is 
immunocompromised, we may expect to find that those co-infected with H. polygyrus are 
less able to keep latent WMHV infections under control, if the Th2 immune response caused 
by H. polygyrus is down regulating the Th1 immune response needed to control viral 
infections. However, I show that in our wild mouse populations H. polygyrus infection is not 
associated with individuals having a lytic WMHV infection. These results are in contrast to 
those found by Reese et al. (2014) who used laboratory mice models infected with H. bakeri 
and MHV-68. They found that H. bakeri initiated the Th2 immune response, resulting in the 
release of interleukin (IL) 4, which activates pathways resulting in the expression of ORF50 
and consequently re-activating MHV-68 from latency. However, it has recently been called 
into question the relevance of these highly artificial studies for real world wild animals 
(Beura et al. 2016a, Reese et al. 2016). Wild animals, over the course of their lives are faced 
with a diverse array of parasite infections, most of these will not be in isolation, or indeed 
be limited to the two species co-infections seen in laboratory co-infection studies. 
Additionally, wild animals will experience other stressors: social interactions, food 
limitation, other infections, adverse weather, and predation risk- all of which make the 
immune functions of wild mice more variable than those of laboratory strains (Abolins et al. 
2011). For example, Abolins et al. (2011) found that wild caught mice (Mus musculus), had 
greater immune function, more avid antigen-specific immune responses, and a greater 
overall activation of immune cells than laboratory-bred mice. Furthermore, laboratory 
studies often use unnatural combinations of host and parasites, and so their findings may be 
of limited relevance for combinations that have coevolved together over prolonged time 
periods. Taking these factors into account may explain why our results in wild populations 
differ from those in laboratory model studies. Our results highlight how important it is to 
conduct these experiments in wild populations and could explain why results seen in the 
laboratory cannot always be reproduced in the field. However, I had relatively low sample 
numbers which could also be a limiting factor when trying to detect these types of 
interactions, thus it may be that a larger set of samples would need to be analysed to fully 
rule out the interactions seen in laboratory mice. 
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3.6 Conclusion  
These results show that mice treated with the anthelmintic drugs ivermectin and pyrantel, 
were less likely to be infected with WMHV, while higher H. polygyrus burdens were 
associated with reduced ability to control WMHV infections, hinting at potential immune 
mediated interactions between H. polygyrus and WMHV in our wild mouse system. 
However, in contrast to previous laboratory studies I found no association between H. 
polygyrus infection or ivermectin treatment and lytic WMHV infections, highlighting the 




















4. Is helminth-viral co-infection associated 




At some point in their lives most animals, and many human populations will be co-infected 
with multiple parasite species. Co-infections involving helminths and microparasites are of 
importance as they are dealt with differently by the immune system, and these different 
arms of the immune system may be antagonistic to each other, such that the presence of 
one parasite may affect the ability of the host to mount an effective immune response 
against the other. Helminths tend to induce a Type 2 (Th2) immune response, whereas 
viruses (and other microparasites) induce a type 1 (Th1) immune response. Here, I use a 
wild wood mouse population, and RT-qPCR for some Th1 and Th2 cytokine genes, to 
determine if co-infection with H. polygyrus results in the downregulation of the anti-viral 
Th1 arm of the immune system. I found that in this wild wood mouse population mice with 
current or previous H. polygyrus co-infections had reduced Type 1 cytokine gene expression 
(Tnf-α, IL-6 and Tgf-β) compared to those with only WMHV infections. Additionally, there 
was no evidence of Th2/immunoregulatory cytokines being upregulated in response to H. 
polygyrus infection.  Overall, these results suggest that there could be a lag between 
upregulation of Th2 cytokines and the downregulation of Th1 cytokines which our trapping 
time scales were not able to capture. Additionally, it could be other immune 







4.2  Introduction 
 
Most animals, and indeed many human populations are co-infected with both helminth and 
microparasite species at some point in their lives (Petney and Andrews 1998, Cox 2001). 
These co-infections are of particular importance as they activate mutually exclusive arms of 
the immune system, and these arms may be antagonistic to each other, such that the 
presence of one parasite may alter the immune response towards another. Helminths tend 
to induce a Type 2 (Th2) immune response, whereas viruses (and other microparasites) 
induce a type 1 (Th1) immune response (Mosmann and Sad 1996). The Th2 immune 
response is characterised by the proliferation and activation of T-cells that secrete 
Interleukin (IL) 4, IL-5, IL-9, IL-10 and IL-13 (Anthony et al. 2007). These cytokines all play a 
role in mounting an effective immune response against helminth infections. In contrast, 
microparasites tend to induce a pro-inflammatory Th1 immune response which is essential 
for the control of viral infections via CD8+ cytotoxic T-cells and virus neutralising antibodies, 
and results in increased levels of IL-2, IL-23, tumor necrosis factor (TNF)-α, and interferon 
(IFN)- γ (Anthony et al. 2007, Alves et al. 2009, Moreau and Chauvin 2010). Recently, some 
Th1 responses have been split into a ‘new’ T-cell subset which is distinct from Th1 cells, 
called Th17 cells, which are crucial for controlling microparasitic infections (Milner et al. 
2008, Dienz et al. 2012). They are known to secrete IL-17 along with pro-inflammatory 
cytokines IL-6 and TNF-α (Kolls and Lindén 2004, Langrish et al. 2005, Anthony et al. 2007). 
TGF- β has been found to help in the differentiation of these Th17 cells, giving it an 
important role in the activation of the pro-inflammatory response (Veldhoen and Stockinger 
2006). 
 
Cytokines released during a Th2 immune response have their own important functions; IL-
13 plays a major role in the development of fibrosis (Chiaramonte et al. 1999, Cheever et al. 
2000), IL-5 regulates eosinophil production (De’Broski et al. 2000) which act as killer cells 
(Capron and Capron 1992) and as helper cells for protective antibody production (De’Broski 
et al. 2000), and IL-4 protects against a severe, lethal inflammatory condition in mice (Fallon 
et al. 2000), and is important for helminth expulsion (Urban et al. 2000), and IL-6 controls 
the differentiation of monocytes and macrophages, increases B-cell IgG production and 
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promoted the Th2 response via IL-4 (Velazquez-Salinas et al. 2019). Additionally, some Th2 
cytokines, such as IL-10, play a role in limiting damage to the host by its own immune 
system: by regulating the Th2 and Th1 responses during helminth infection, IL-10 can 
minimise immunopathology (Flores-Villanueva et al. 1996, Hoffmann et al. 2000). 
Interferons (IFNs) can initiate a diverse set of anti-microbial functions. IFN-γ is produced 
mainly by natural killer (NK) cells and T cells during infection with virus/bacteria/protozoa, 
and results in a number of downstream effects including inducing antimicrobial/autophagy 
response in macrophages, upregulation of MHC class I and II molecules, and activates T cell 
responses through enhancement of phagocytosis and antigen presentation (Newport et al. 
1996, Gutierrez et al. 2004, Schroder et al. 2004, Fabri et al. 2011, Rhein et al. 2015). For 
example, Rhein et al. (2015) found that mice given murine IFN-γ 24 hours before or after 
infection with mouse adapted Ebola virus were protected against lethal challenges with the 
virus, reduced morbidity and reduced viral titres in serum. The Th2 responses aimed at 
controlling helminth infections have the potential to downregulate Th1 cytokines such as 
INF-γ, IL-12 and TNF-α, which are essential for promoting effector mechanisms involved in 
fighting viral infections (Mosmann and Sad 1996). Hence, individuals co-infected with Th2- 
initiating parasites (such as helminths) may be more susceptible to, and less able to control, 
co-infecting microparasites such as viruses (Spiegel et al. 2003, Ezenwa et al. 2010). 
 
4.2.1 The effect of Helminth infection on co-infecting microparasites 
 
As an example of helminth-virus interactions, Reese et al. (2014) found that helminth 
infection, characterized by induction of the cytokine IL-4, caused on-going murine γ-
herpesvirus infection to become reactivated from latency in vivo. IL-4 promoted viral 
replication by binding to and acting on a viral promoter to induce expression of the viral 
latent-to-lytic switch gene (open reading frame 50 (ORF50)), and blocked the antiviral 
effects of INF-γ (Reese et al. 2014). Similarly, Actor et al. (1993) found that mice co-infected 
with Schistosoma mansoni and a recombinant vaccinia virus expressing the HIV-1 protein 
gp120, could take as much as 3 weeks longer to clear the virus, compared to mice only 
infected with the vaccinia virus. Additionally, when spleen cells taken from mice infected 
with only vaccinia virus were stimulated with gp120 they produced higher INF- γ and IL-2, 
but lower IL-4 responses than the mice infected with S. mansoni only. However, those 
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infected with both the vaccinia virus and S. mansoni produced lower INF- γ and IL-2 
responses when challenged with gp120 than the vaccinia virus alone, but produced no IL-4 
response above the non-specific response displayed by S. mansoni only infected mice (Actor 
et al. 1993). These results show that cytokines induced by helminth infections can affect a 
host’s ability to respond to co-infecting viruses by suppressing the anti-viral Th1 arm of the 
immune system. 
 
As suggested by the previous examples, most of our understanding of the immune response 
during co-infections has come from highly controlled laboratory settings involving 
laboratory mice kept in abnormally clean “specific pathogen free” (SPF) barrier facilities 
(Babayan et al. 2011, Beura et al. 2016b). Additionally, laboratory mice have limited genetic 
diversity, receive a constant supply of food and water and have far less experience with 
infectious disease than free-living animals would naturally acquire (Pedersen and Babayan 
2011, Maizels and Nussey 2013, Cadwell 2015). This is very different to what wild animals 
(and humans) experience. Wild animals have much more genetic diversity, variable amounts 
of food and water, diverse environmental conditions, and may be infected (or have been 
infected) with multiple pathogen species (Cox 2001, Ezenwa et al. 2010, Telfer et al. 2010). 
Hence, it is unsurprising that laboratory mice raised in SPF conditions have been found to 
have immune systems more closely related to that of neonatal humans than of adult 
humans (Beura et al. 2016b), whereas, ‘dirty’ pet store and wild mice had more 
differentiated memory T cells in lymphoid and non-lymphoid tissue, which more closely 
matches those of adult humans (Beura et al. 2016b). Moreover, animals in the wild are 
frequently infected with both Th1 stimulating micro-parasites and Th2 stimulating macro-
parasites, which can lead to immune driven within-host parasite interactions (Ezenwa and 
Jolles 2011), potentially influencing the abundance, distribution, and dynamics of each 
parasite species (Pedersen and Fenton 2007). Laboratory studies also often use unnatural 
host-parasite combinations, potentially resulting in differently with-in host-parasite 
interactions than would be seen in the natural host. Therefore, to fully understand the host 
immune response, how it drives co-infection dynamics and allow results to better capture 
the adult human response, we may need to move more towards ‘dirty’ or wild mice for 
immunological studies.  
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4.2.2 Deworming to control major microparasitic diseases 
Additionally, the possibility that helminth infection can exacerbate micro-parasitic infections 
has called into question whether mass deworming could be beneficial in controlling major 
viral, bacterial and protozoal diseases (Nacher 2006, Gerns et al. 2012). For example, Malla 
et al. (2006) found that individuals infected with the nematode Ascaris lumbricoides had 
lower levels of Th1 cytokines and higher levels of Th2 cytokines, compared to uninfected 
controls. Additionally, albendazole treatment of HIV-1 and A. lumbricoides co-infected 
individuals resulted in reduced IL-10 levels, compared to untreated individuals (Blish et al. 
2010).  Another study by Elias et al. (2001) found that when blood samples of people 
treated with albendazole, so reducing their worm burdens, were stimulated with Tuberculin 
purified protein derivative (PPD- which is used as a diagnostic aid in the detection of 
Mycobacterium tuberculosis infection) they showed an improvement in T-cell proliferation 
and increased INF- γ production. In contrast, helminth infection has been shown to have a 
protective effect against malaria infection, with co-infected children having lower 
Plasmodium falciparum parasite densities than those with only malaria infections (Briand et 
al. 2005, Lemaitre et al. 2014). These studies show that the effect of helminth removal on 
the immune response, and co-infecting micro-parasites can be hard to predict. We 
therefore need a suitable model system, which can easily be manipulated with deworming 
treatments, to fully understand the effect of helminth removal on the host immune 
response.  
 
4.2.3 Hypotheses  
 
The murine intestinal nematode, Heligmosomoides bakeri, triggers a highly polarized type 2 
immune response within the host (Gause et al. 2003). The type 2 immune response aimed 
at H. polygyrus infections is known to downregulate the type 1 immune response needed to 
control WMHV infections. This chapter explores whether H. polygyrus infection alters levels 
of type 1 cytokine expression which are aimed at controlling WMHV infections, under 
natural field conditions. Through semi-quantitative RT-qPCR for a number of type 1 and type 
2 cytokine genes from wild wood mouse spleens used in chapter 3, I will determine if H. 
polygyrus co-infection, ivermectin treatment and/or WMHV infection (latent or lytic) are 
68 
 
associated with increased, or decreased gene expression levels of type 1 or type 2 cytokines. 
Based on previous work, it is expected that H. polygyrus infection could increase the 
expression of type 2 cytokines (IL-5 and IL-10), and consequently reduce expression of type 
1 cytokines (Tnf-α, Inf-ƴ, IL-6 and Tgf- β) aimed at WMHV infection. Tgf- β expression has 
been shown to be important in the pro-inflammatory immune response, as it helps with the 
differentiation of the highly inflammatory Th17 cells. Additionally, it is expected that 
treatment with ivermectin could be associated with increased Th1 cytokine gene expression, 
and reduced Th2 cytokine gene expression.  
 
4.3  Methods  
For details on source of wild rodent spleen samples and RNA extraction refer to methods 
sections 3.3.1 – 3.3.3 in chapter 3. 
4.3.1    PCR for immune gene 
 
Relative RT-qPCR was used to compare Th1 and Th2 cytokine expression using the Pfaffl 
equation (Pfaffl 2001), using the murine ribosomal protein L8 gene as a reference gene (acc 
no. AF091511) forward primer 5’-ACCAGAGCCGTTGTTGTTGTTGTGG-3’ and reverse 5’-
AGTTCCTCTTTGCCTTGTACTTGTGG-3’. The Pfaffl equation allows relative quantification to be 
calculated between groups based on the relative expression of a target gene versus a 
reference gene, when target and reference genes have different primer efficiencies. For 
example, to determine if co-infected mice have reduced Th1 responses compared to those 
infected only with WMHV, or if ivermectin treated mice have increased Th1 cytokine gene 
expression compared to untreated mice. cDNA purified from mouse spleen samples was 
used to amplify the mouse genes associated with a Th1 or Th2 immune response (Table 
4.1)(Acc. No. GQ169129.1). Primer pairs that had previously been designed by the Pedersen 
group at the University of Edinburgh were tested in the same way as in chapter 3. I also 
tested primer pairs that had been designed for laboratory mice, however none gave a 
suitable melt curve. The efficiency of primer pairs was first checked by running a standard 
curve, to ensure all efficiencies were between 1.9 and 2.1. PCR reaction mixture contained 
5x PCR buffer, 10x dNTPS (2mM), 10x SYBR green 1, Taq II Pol (0.8U/μl) and each primer at 
10μM each. PCR programme was as follows: 2 min at 95°C, then 35 cycles of 10s at 94°C, 
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20s at 60°C, 15s at 72°C, 10s at 75°C, followed by a melt cure analysis of 1 min at 94°C, 30s 
at 65°C and then 30s at 95°C, run on a LightCycler480. 
Table 4.1. Primer pairs used for RT-qPCR 
Gene Primer pair Product length 
IL-5 IL5F: 5’ – GTGTAGCGAGGAGAGACGGAGGA- 3’  
IL5R: 5’ – CCCACTCTGTACCCATCACGGCA -3’ 
80bp 
IL-6 IL6F: 5’ – GCAAGAGACTTCCATCCAGTTGCC – 3’ 
IL6R: 5’ – AAGCCTCCGACTTGTGAAGTGGT – 3’ 
146bp 
Inf-γ InfgF: 5’ – TCTCCTGCTTCGGCCTAGCTCTG – 3’  
InfgR: 5’ – AGGCTTTCGATGAGTGTGCCGTG – 3’ 
117bp 
Tnf-α TnfaF: 5’ – GCACAGAAAGCATGATCCGCGAC – 3’  
TnfaR: 5’ – CCACGAGCAGGAACGAGAAGAGAC – 3’ 
120bp 
Tgf-β1 Tgfb1F: 5’ – GGTGGACCGCAACAACGCAATCT – 3’  




IL10F: 5’ – TTTAAGGGTTACTTGGGTTGC – 3’ 
IL10R: 5’ – TCAAATGCTCCTTGATTTCTG – 3’ 
109bp 
 
4.3.2      Statistical analysis 
All statistical analysis was performed in R, v. 3.6.1 (R development core team 2011).  
1) Does H. polygyrus co-infection downregulate the expression of cytokines aimed at 
WMHV infection?  
To determine if expression of each cytokine is associated with infection status among 
untreated mice from 2013-2016, I used Gaussian GLM’s with relative expression of each 
cytokine (square root transformed), as the response variable, and infection status (4-level 
factor: uninfected, co-infected, WMHV only, H. polygyrus only) as the explanatory variable 
of interest: 
Cytokine ~ Infection status + eye lens mass * sex + year 
The infection status variable used ‘current’ H. polygyrus infection, collected at the same 
time point as the cytokine data, determined by presence of worms in the gut on dissection. 
In each case I controlled for the following covariates: eye lens mass (continuous) as a proxy 
for host age (Clerc 2018; 2019), host sex (factor, male or female) and year (factor: 2013-
2016). Interactions were also included to test for age specific sex effects (eye lens mass * 
sex). In all cases, full models were created for each response variable above, and then 
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models were simplified by backwards elimination of non-significant terms initially with a cut 
off at (p<0.07), starting with interactions, to obtain a minimal model with all terms p<0.05. 
2) Do Th1 cytokine expression levels change depending on WMHV infection status (lytic 
or latent)?  
To determine if cytokine levels differ between WMHV infection stages (i.e. latent/lytic), only 
untreated mice with WMHV infections from 2013-2016 were included in this analysis. 
Gaussian GLM’s were used with relative expression of each cytokine (square root 
transformed), as the response variable, to determine if WMHV status (factor: infected 
latent, infected lytic, based on detectable levels of ORF73 and ORF50; see Chapter 3), and H. 
polygyrus co-infection (factor: co-infected, WMHV only) are associated with levels of 
cytokine expression (relative to L8) among WMHV infected mice: 
Cytokine ~ WMHV status + Hp co-infection + eye lens mass * sex + year. 
Again, the H. polygyrus co-infection variable uses current H. polygyrus infection determined 
by presence of worms in the gut on dissection. In each case I controlled for the same 
covariates and simplified as above. 
3) Does H. polygyrus co-infection or deworming treatment alter the expression of 
cytokines aimed at WMHV infection?  
For this analysis only mice from 2014-2016 were included, as in these years some mice were 
also given treatments. Crammers V test of association was used to determine whether 
current H. polygyrus treatment (presence/absence) and ivermectin treatment were 
associated (v=0.73, p<0.001).  Since current H. polygyrus infection status (determined by 
eggs in faecal samples at the time of sacrifice) and treatment (individuals were either given 
ivermectin and pyrantel or a control of water repeatedly over a period of ~2 weeks) are 
highly correlated only one can be included in the models. Hence 2 models were constructed 
for each cytokine, one containing current H. polygyrus infection status, and the other 
containing ivermectin treatment. These models used Gaussian GLM’s with relative 
expression of each cytokine (square root transformed), as the response variable, to 
determine if either current H. polygyrus infection (factor: yes or no): 
Cytokine ~ current Hp infection + eye lens mass * sex + year, 
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 or ivermectin treatment (factor: yes or no) and previous H. polygyrus infection (factor: yes 
or no): 
Cytokine ~ Ivermectin treatment + current Hp infection + eye lens mass * sex + year, 
 are associated with levels of cytokine expression (relative to L8). The two models were 
compared for each cytokine using AIC to determine which model best explained the data. 
Since previous H. polygyrus infection status (determined from faecal sample collected at the 
time of sacrifice) was not associated by Crammer v test of  association with either treatment 
(v=1.17, p=0.38) or current H. polygyrus infection (v=0.29, p=0.12) it could be included in 
both models.  
4) Do higher H. polygyrus FECs alter the expression of cytokines aimed at WMHV 
infection? 
Again, for this analysis only mice from 2014-2016 were included, as these years had data on 
current and previous H. polygyrus FECs. A set of Gaussian GLMs were constructed with 
relative expression of each cytokine (square root transformed), as the response variable, 
with current and previous H. polygyrus FEC (continuous) as the main explanatory variables 
of interest: 
Cytokine ~ current Hp FEC + previous Hp FEC + eye lens mass * sex + year. 
Current and previous H. polygyrus FEC were not correlated (r25=0.03, p=0.90) so could both 
be included in the model. In all models I controlled for the same covariates and simplified as 
above as above. 
 
4.4 Results 
A total of 61 spleen samples were collected from wild wood mice, some of which had been 
given deworming treatments and which had corresponding co-infection, and WMHV 




Table 4.2. Number of wild wood mice in each treatment group for ivermectin + pyrantel 
treated and untreated (2014-2016), and 2013 (all untreated).   
Treatment Treated (2014-2016) Untreated (2014-2016) Untreated (2013) 
WMHV only 5 0 2 
Co-infected 1 15 8 
Worms only 3 1 11 
Uninfected 3 0 12 
 
4.4.1 Does H. polygyrus co-infection downregulate the expression of cytokines aimed at 
WMHV infection?  
 
 Overall, only Tnf- α gene expression was found to be significantly associated with infection 
status (X23=11.01 , p= 0.012) (Table 4.3). Animals with WMHV-only infections had higher 
gene expression compared to co-infected, H. polygyrus only and uninfected animals (Figure 
4.1). This model also included significant effects of year (X23= 14.80, p= 0.002) and a lens 
mass * sex (X21=5.96, p= 0.015) interaction. Although not significant infection status (X23= 
4.45, p= 0.217) was the last term to drop out of the model for Inf-ƴ and, as for Tnf- α 
(another Th1 cytokine) expression was highest for WMHV only infected mice (Figure 4.2). 
 No other infection-related factors were found to be significant for any of the other 
cytokines (Table 4.3). However, there were significant differences among years for IL-6 (X23= 
12.62, p= 0.006), IL-10 (X23= 10.81, p= 0.013) and Tgf- β (X23= 42.07, p<0.0001 ) with the 









 Table 4.3. Factors affecting cytokine expression levels (relative to L8) in a wild wood mouse 
population. Models were simplified by backwards stepwise elimination. For variables not in 
the minimal model, statistics are those at the point that factor left the model. 
 
 
Figure 4.1. Association between Tnf-α gene expression and lens mass (mg), sex and 
infection status among untreated wild wood mice in 2013 (n=32). There were no females 
with only WMHV. Overall, there was a significant increase in Tnf-α gene expression in 
WMHV-only mice compared to the other infection categories. 
 
  A. IL-5 B. IL-6 C. IL-10 
Variable df X2       p X2 p X2      p 
Lens mass*Sex 1 2.0704 0.1502 0.0710 0.7898 0.0740 0.7857 
infection status 3 3.9545 0.2664 2.5613 0.4643 1.0022 0.8007 
Lens mass 1 0.6089 0.4352 0.1913 0.6619 0.1516 0.6970 
Sex 1 0.8336 0.3612 0.1246 0.7241 0.3416 0.5589 
Year 3 5.5854 0.1336 12.622 0.0055    ¥ 10.809 0.0128    ¥ 
  A. Tnf-α B. Inf-γ C. Tgf-β 
Variable df X2 p X2 p X2     p 
Lens mass*Sex   1 5.9582 0.0146   ¥ 3.0851 0.7901 5.8700 0.0154    ¥ 
infection status    3 11.005 0.0117   ¥ 4.4487 0.2169 0.6560 0.8836 
Lens mass 1 - - 0.1193 0.7298 - - 
Sex 1 - - 0.0108 0.9173 - - 
Year   3 14.800 0.0020   ¥ 4.4432 0.2174 42.0680 <0.0001  ¥ 












Figure 4.2. Association been Inf-ƴ gene expression and infection status among untreated 
wild wood mice (n=64). Infection status is not significant and is shown for illustrative 
purposes only. 
 
Figure 4.3. Association been Tgf- β gene expression, lens mass and sex among untreated 
wild wood mice for 2013 (n=32). Older females are more likely to have higher Tgf-β gene 
expression than males. 
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4.4.2 Do Th1 cytokine expression levels change depending on WMHV infection status (lytic 
or latent)?  
Overall, none of the cytokines showed significantly different levels of expression between 
lytic or latent WMHV infections (Table 4.4). However, there were significant differences 
among years for IL-6 (X23=9.24, p=0.03), IL-5 (X23=11.32, p=0.01), and IL-10 (X23=11.41, 
p=0.01). Additionally, Tgf-β had significant differences among years (X23=21.60, p<0.0001) 
plus a lens mass * sex interaction (X21=4.40, p=0.04), Inf-ƴ had only a significant lens mass * 
sex interaction (X21=6.67, p=0.01), and Tnf-α had significant differences among years 
(X23=15.37, p=0.002), infection status (X21=7.05, p=0.008) and a lens mass sex interaction 
(X23=11.34, p<0.001) (Table 4.4). 
 
Table 4.4.  Factors affecting cytokine expression levels in wild wood mice infected with 
WMHV. Models were simplified by backwards stepwise elimination. For variables not in the 
minimal model, statistics are those at the point they left the model. 
  A. IL-5 B. IL-6 C. IL-10 
Variable df X2       p X2 p X2      p 
Lens mass*Sex 1 2.9782 0.0844 2.2865 0.1305 3.1063 0.0780 
Treatment 1 1.5107 0.2190 0.5789 0.4468 1.0459 0.3065 
Lens mass 1 0.2607 0.6097 0.0205 0.8860 2.3438 0.1258 
Sex 1 1.6297 0.2017 0.0057 0.9400 0.5397 0.4625 
Year 3 11.323 0.0101   ¥ 9.2359 0.0263   ¥ 11.407 0.0097   ¥ 
WMHV infection status 1 2.6179 0.1057 0.0009 0.9767 3.4039 0.0650     
  D. Tnf-α E. Inf-γ F. Tgf-β 
Variable df X2 p X2 p X2     p 
Lens mass*Sex   1 11.341 0.0008  ¥ 6.6689 0.0098   ¥ 4.4001 0.0360   ¥ 
Treatment   1 7.0503 0.0079  ¥ 1.0868 0.2972 0.1529 0.6958 
Lens mass 1 - - - - - - 
Sex 1 - - - - - - 
Year   3 15.365 0.0015  ¥ 2.7799 0.4268 21.598 <0.0001   
¥ 
WMHV infection status 1 0.0043 0.9480 1.0565 0.3040 0.2388 0.6251 




4.4.3 Does H. polygyrus co-infection or deworming treatment alter the expression of 
cytokines aimed at WMHV infection?  
AIC values were used to determine whether treatment or current H. polygyrus infections 
should be in each model. The models containing treatment were better than models 
containing current H. polygyrus infection for Tnf-α, IL-6 and Tgf-β. However, models 
containing current H. polygyrus infection were better for IL-5, Inf-ƴ and IL-10 (Table 4.5). 
Table 4.5. AIC values for GLM’s containing either treatment or current H. polygyrus infection 
(Presence/absence). Numbers in bold indicate the model with the lowest AIC. 
 
 
Overall, neither treatment nor current H. polygyrus infection were significantly associated 
with any cytokines (Table 4.6). However previous H. polygyrus infection (presence/absence) 
(X21= 5.61, p= 0.02) and year (X22= 6.00, p=0.05) were significantly associated with levels of 
IL-6 gene expression; individuals with previous H. polygyrus infections had reduced IL-6 
expression (Table 4.6; Figure 4.4). Similarly, previous H. polygyrus infection (X21= 10.26, p= 
0.001) was associated with reduced expression of Tgf-β (Table 4.6; Figure 4). In addition, 
year (X22= 12.25, p= 0.002), and a lens mass * sex interaction (X21= 5.56, p= 0.02) were also 
significantly associated with Tgf-β expression- in males expression decreases with increasing 
lens mass, while in females expression increases with increasing lens mass (Table 4.6; Figure 
4.5). All other models had either no significant variables (Inf-ƴ), year (IL-5: X22= 7.51, p= 0.02; 
 Model AIC 
Cytokine Deworming treatment Current H. polygyrus 
Tnf-α 43.35 45.40 
IL-6 120.79 122.09 
Tgf-β 71.21 73.26 
IL-5 69.10 68.80 
Inf-ƴ 82.24 80.73 
IL-10 42.49 39.98 
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Figure 4.4. Relationship between IL-6 expression, and previous H. polygyrus infection status 
(presence(1)/absence(0)) and year in a wild wood mouse population (n=32). Wood mice 





















Table 4.6. Factors affecting cytokine expression levels in a wild wood mouse population, 
some of which have been given ivermectin treatments. Models were simplified by 
backwards stepwise elimination. For variables not in the minimal model, statistics are those 
at the point they left the model. 
 
 
Figure 4.5.  Relationship between Tgf-β gene expression (relative to L8), lens mass (proxy for 
age), previous H. polygyrus infection status (presence(1)/absence(0)) and year (2014) in a 
wild wood mouse population (n=15). 
 
  Tnf-α (AIC: 44.46) IL-6 (AIC: 125.74) Tgf-β (AIC: 82.79) 
Variable df X2       p X2 p X2      p 
Lens mass*Sex 1 0.1538 0.6949 0.3320 0.5645 5.5552 0.0184    ¥ 
Ivermectin treatment 1 2.3599 0.1245 2.3216 0.1276 2.1603 0.1416 
Lens mass 1 6.2846 0.0122   ¥ 2.1771 0.1401 - - 
Sex 1 0.0114 0.9151 0.0012 0.9722 - - 
Year 2 0.5889 0.7450 5.9950 0.0499    ¥ 12.245 0.0022    ¥ 
Previous H. polygyrus 1 0.0609 0.8052 5.6138 0.0178    ¥ 10.260 0.0014    ¥ 
  IL-5 (AIC: 67.53) Inf-γ (AIC: 83.45) IL-10 (AIC: 40.55) 
Variable df X2 p X2 p X2 p 
Lens mass*Sex 1 0.4307 0.5117 0.0117 0.9140 2.8108 0.0936 
Current H. polygyrus 1 0.4054 0.5243 1.4134 0.2345 1.5969 0.2063 
Lens mass 1 2.1523 0.1424 0.0970 0.7555 1.9439 0.1632 
Sex 1 0.4758 0.4903 1.6409 0.2002 0.4539 0.5005 
Year 2 7.5077 0.0234   ¥ 1.9781 0.3719 6.3620 0.0415 
Previous H. polygyrus 1 0.0165 0.8977 0.7418 0.1869 0.4982 0.4803 
¥ Variables in the minimal model (P < 0.05) 
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4.4.4 Do higher H. polygyrus FECs alter the expression of cytokines aimed at WMHV   
infection? 
Overall, neither current nor previous H. polygyrus FEC was associated with levels of any 
cytokine expression (Table 4.7). The only variables that remained in the models were year 
for Tgf-β (X22=8.82, p=0.01), IL-5 (X22=7.51, p=0.02). and IL-10 (X22=6.36, p=0.04), and lens 
mass for TNF-α (X21=6.28, p=0.01). 
 
Table 4.7. Factors affecting cytokine expression levels in a wild wood mouse population, 
some of which have been given ivermectin treatments. Models were simplified by 
backwards stepwise elimination. For variables not in the minimal model, statistics are those 









  Tnf-α IL-6 Tgf-β 
Variable df X2       p X2 p X2      p 
Lens mass*Sex 1 0.2393 0.6247 1.1957 0.2742 1.9636 0.1611 
Current H. Polygyrus  FEC 1 0.4598 0.4977 0.5676 0.4512 0.0747 0.7845 
Lens mass 1 6.2846 0.0122   ¥ 2.7051 0.1000 2.6581 0.1030 
Sex 1 0.0592 0.8078 0.1505 0.6981 1.5204 0.2146 
Year 2 0.9473 0.6227 5.7144 0.0574 8.8209 0.0122   ¥ 
Previous H. polygyrus  FEC 1 0.3581 0.5563 0.8828 0.3475 0.5730 0.4491 
  IL-10 Inf-ƴ IL-5 
Variable df X2       p X2 p X2      p 
Lens mass*Sex 1 2.4334 0.1188 0.0339 0.8538 0.2199 0.6391 
Current H. Polygyrus  FEC 1 0.0139 0.9061 0.2581 0.6115 2.6007 0.1068 
Lens mass 1 1.9439 0.1632 0.0623 0.8029 1.1581 0.2819 
Sex 1 0.6619 0.4159 0.6409 0.2002 0.6000 0.4386 
Year 2 6.3620 0.0415   ¥ 2.1710 0.3377 7.5077 0.0234    ¥ 
Previous H. polygyrus  FEC 1 1.6766 0.1954 0.0001 0.9943 0.1664 0.6834 




In this study spleen samples from wild wood mice, plus data on their H. polygyrus and 
WMHV infection status and, for some animals, prior anthelminthic treatment was used to 
answer the following questions: 1) Does H. polygyrus co-infection downregulate the 
expression of cytokines aimed at WMHV infection? 2) Do Th1 cytokine expression levels 
change depending on WMHV infection status (lytic or latent)? 3) Does H. polygyrus co-
infection or deworming treatment alter the expression of cytokines aimed at WMHV 
infection? 4) Do higher H. polygyrus FECs alter the expression of cytokines aimed at WMHV 
infection? This study suggests that expression of some Th1 cytokines are downregulated in 
H. polygyrus co-infected mice, compared to mice with WMHV only infections. In mice with 
current H. polygyrus infections both TNF-α and INF-ƴ (not statistically significant), showed 
reduced expression compared to WMHV only infected mice. Additionally, mice that had 
previous H. polygyrus infections had reduced type 1 immune responses, IL-6 and TGF-β, 
compared to mice with only WMHV infections. In contrast there was no association 
between treatment, WMHV status (latent or lytic), current H. polygyrus FECs or previous H. 
polygyrus FECs and expression of any cytokines.  
4.5.1. Reduced Th1 cytokine expression in co-infected wood mice 
One of the main findings of this study shows that animals with H. polygyrus co-infections 
have reduced Th1 cytokine expression compared to animals with only WMHV infections. 
Data from this chapter showed that Tnf-α expression was higher in mice with WMHV-only 
infections, however in mice with H. polygyrus co-infections expression was reduced to levels 
similar to those with H. polygyrus only infections, or uninfected mice. Although not 
statistically significant, Inf-ƴ also showed to be slightly higher in WMHV-only mice, again 
with expression levels falling in co-infected mice. These results suggest that co-infection 
with H. polygyrus can downmodulate these pro-inflammatory Th1 cytokines, which are 
essential for controlling virus infections. Other studies have found similar results, for 
example, infection of mice with the protozoan parasite Cryptosporidium parvum results in 
higher levels of INF-ƴ, however co-infection with Heligmosomoides bakeri (the laboratory 
species of the wild H. polygyrus found to infect wood mice) inhibits INF-ƴ secretion 
(Bednarska et al. 2008). Another study found that the larval stage of the helminth Ascaris 
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suum downregulated the immune response to Vaccinia virus (VACV), with reduced numbers 
of circulating CD4+ T-cells producing INF-ƴ in mice co-infected with both A. suum and VACV, 
compared to those only infected with VACV (Gazzinelli-Guimarães et al. 2017). The Th1 
cytokine TNF-α are known to be particularly important in controlling microparasitic 
infections and have been found in increased quantities in the spleens of MHV-68 infected 
mice (Sarawar et al. 1996). For instance, TNF-α plays a major role in the maturation of 
dendritic cells after challenge with adenovirus (Trevejo et al. 2001).  Furthermore, the 
cytokine IL-17 which is produced by Th-17 cells (Langrish et al. 2005) mediates tissue 
inflammation by inducing IL-6 and TNF-α, however infection with H. polygyrus has been 
found to suppress the production of IL-17 (Elliott et al. 2008). Hence, by suppressing IL-17 H. 
polygyrus also has the potential to initiate a reduction in the pro-inflammatory cytokines IL-
6 and TNF-α. 
4.5.2. No evidence of upregulated TH2 cytokine responses in co-infected wood mice 
Infection with H. polygyrus is known to modulate a variety of host immune responses. 
Specifically, the upregulation of Th2/immunoregulatory cytokine responses by H. polygyrus 
has been observed a number of cases (Bazzone et al. 2008, Reese et al. 2014). This 
upregulation of Th2 responses is thought to down-regulate Th1 responses, thus impairing 
the host’s ability to deal with co-infecting microparasites. However, I was unable to 
demonstrate the upregulation of any Th2 cytokines in response to H. polygyrus infection; 
even so, we still see a marked reduction in Th1 cytokine expression in mice with current or 
previous H. polygyrus co-infections. Hence, it could be that up-regulated levels of other Th2 
cytokines that were not measured in this study, such as IL-4 or IL-13, are responsible for the 
downregulation of Th1 cytokines shown. In particular, IL-4 has been shown to be 
upregulated in laboratory mice with H. polygyrus infections, and was particularly important 
in causing MHV-68 to re-active into an active infection (Reese et al. 2014). However, I was 
unable to measure IL-4 expression as I was unable to find IL-4 in the wood mouse genome. A 
second possibility is that any upregulation of Th2 cytokines were simply not visible in our 
data due to inadequate sampling time scales. For instance, Finney et al. (2007) found that H. 
polygyrus initiated a typical Th2 response early in infection, with high levels of Th2 cytokines 
14-21 days post infection, subsequently becoming downmodulated after 21 days. Hence, we 
82 
 
may not see a substantial increase in Th2 responses from any mice that became infected 
with H. polygyrus over 21 days prior to capture. 
I also found that in H. polygyrus co-infected mice expression of the Th17 pro-inflammatory 
cytokine TGF-β was downregulated compared to WMHV only infected mice. Conversely, H. 
polygyrus is known for inducing immunosuppression via T-reg cells and increased levels of 
TGF-β have been found in H. polygyrus infected mice (Finney et al. 2007, Bowron et al. 
2020). Furthermore, TGF-β signalling has been found to be critical for the survival of H. 
polygyrus in the host, indeed H. polygyrus itself produces Excretory-Secretory (HES) antigens 
which contain a functional TGF-β mimic (Grainger et al. 2010) since TGF-β can downregulate 
the Th2 protective response needed for the host to clear helminth infections (Wilson et al. 
2005). However, TGF-β is also known to be a driver of the highly pro-inflammatory Th17 cell 
subset which is very important in the anti-viral immune response (Eisenstein and Williams 
2009). 
4.5.3. Cytokine gene expression in mice with lytic and latent WMHV 
By comparing cytokine gene expression among mice with WMHV infections I could 
determine if expression of any cytokines differed between mice with lytic or latent 
infections, and if those with H. polygyrus co-infections had reduced Th1 cytokine gene 
expression. Surprisingly, I also found no difference in expression of any cytokines between 
lytic or latent WMHV infections, and the only cytokine we found to be associated with H. 
polygyrus co-infection was Tnf-α expression, which shows that co-infected mice have 
reduced levels of Tnf-α expression compared to mice with only WMHV. Additionally, there 
was no increase in any of the Th2 cytokines (IL-10 and IL-5) in mice with H. polygyrus co-
infections. It has previously been found that for H. bakeri infection to re-activate WMHV 
from latency there needs to be induction of the Th2 cytokine IL-4 and inhibition of Th1 
responses, specifically INF-ƴ (Reese et al. 2014). Our data show that mice with H. polygyrus 
co-infections do not have suppressed INF-ƴ expression which is significantly different 
compared to mice with only WMHV infections; hence, this may explain why in the previous 
chapter we don’t see mice with H. polygyrus co-infections being more likely to have lytic 





In conclusion, mice with current or previous H. polygyrus co-infections had reduced pro-
inflammatory/Type 1 cytokine gene expression (Tnf-α, IL-6 and Tgf-β) compared to those 
with only WMHV infections. TGF- β has long been considered an immunoregulatory 
cytokine, however it has been found that TGF- β helps in the differentiation of the highly 
pro-inflammatory Th17 cells. Additionally, there was no evidence of Th2 cytokines being 
upregulated in response to H. polygyrus infection. However, there was no association 
between ivermectin treatment, WMHV infection and current or previous H. polygyrus FEC 




















5. Does H. bakeri co-infection increase 




Most of our understanding of the immune response during co-infections has come from 
highly controlled laboratory settings involving laboratory mice kept in abnormally clean 
“specific pathogen free” (SPF) barrier facilities. These mice are often infected with unnatural 
host-parasite combinations, potentially causing different within-host interactions than if the 
natural host of the parasite were used. Hence, to fully understand the effect of co-infection 
on the host immune response it is necessary to moving more towards ‘dirty’ or wild animals  
with natural host-parasite combinations for these studies. Here I use controlled 
infection/co-infection experiments, with an outbred wild-derived, but now laboratory-
reared colony of wood mice, to investigate the within-host interactions between the 
helminth Heligmosomoides bakeri (the laboratory species which is similar to that found to 
naturally infect wild wood mice) and WMHV co-infection under both high and low quality 
nutritional provisioning. Overall, these results show that H. bakeri co-infection reduces the 
ability of the host to control WMHV in mice on lower quality diets, but not in mice on higher 
quality diets. Additionally, I found that being co-infected with H. bakeri was associated with 
mice having a longer period of lytic infection in the lungs, however during the early stages of 
WMHV infection, co-infection seems to enable the to host to suppress lytic virus in the lungs 
to lower levels. Furthermore, there was some evidence of co-infected mice having higher 











Most wild animal populations will be exposed to many different parasites and pathogens 
over the course of their lives, thus making co-infection with more than one species very 
common in nature (Petney and Andrews 1998, Cox 2001). Helminth infections are 
particularly important in co-infections since many parasitic worms can cause 
immunosuppression (Maizels et al. 2004, Maizels et al. 2012a, McSorley et al. 2013) and are 
incredibly common in most animal and human populations (Hotez et al. 2008). 
Consequently, lots of research has investigated the effects of helminth infection on the 
dynamics and transmission of co-infecting microparasites (viruses, bacteria etc). Several 
studies have shown that helminth co-infection can negatively impact the host’s ability to 
respond to microparasitic co-infections (Edwards et al. 2005, Ayash-Rashkovsky et al. 2007, 
Reese et al. 2014).  It has been hypothesised that these within-host interactions between 
helminths and pathogens are driven via the host immune system; specifically because 
helminth infection can skew the immune response towards a T-helper type 2 (Th2) 
phenotype, which along with the induction of immunoregulatory cytokines can 
downregulate the T-helper type 1 (Th1) anti-viral response (Mosmann and Sad 1996, Su et 
al. 2005, Anthony et al. 2007). (Mosmann and Sad 1996, Su et al. 2005, Anthony et al. 2007). 
However, it is also possible that within-host interactions between parasites and pathogens 
can occur through direct interactions, or indirectly through shared host resources (Pedersen 
and Fenton 2007). Given the ubiquity of helminth infection, it is crucial that we have a 
better understanding of how helminth infections alter the immune response to pathogens 
and how this impacts pathogen infection dynamics; as this will be important in the 
management of pathogenic infections of humans, livestock and wildlife. 
During infection with microparasites such as viruses, a Th1 pro-inflammatory response is 
induced resulting in the production of cytokines Interleukin (IL) 2, IL-23, tumor necrosis 
factor (TNF)-α, and IFN- γ (Anthony et al. 2007, Alves et al. 2009, Moreau and Chauvin 
2010). Additionally, Th-17 cells, a relatively newly discovered T-cell subset distinct from Th1 
cells are also crucial for controlling microparasitic infections by secreting IL-17, IL-6 and TNF- 
α (Kolls and Lindén 2004, Langrish et al. 2005, Anthony et al. 2007). These cytokines 
produced during a Th1 immune response can activate CD8+ cytotoxic T cells which kill virus-
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infected cells, induce neutralising IgG antibodies against virus particles and cause 
inflammation all these mechanisms are crucial for reducing viral loads and associated 
pathology. In contrast, during infection with macroparasites such as helminths, a Th2 
response is induced resulting in the release of cytokines IL-4, IL-5, IL-9, IL-10 and IL-13 which 
aid in mounting an effective immune response (i.e. clearing infection/reducing parasite 
burdens and reducing disease caused by infection)  (Anthony et al. 2007). These Th2 
cytokines enable helminth expulsion from the gut by inducing eosinophil differentiation, 
activating B cells (Chan et al. 1992, Anthony et al. 2007), and inducing alternatively activated 
macrophages (Weng et al. 2007). Some helminths can actively supress this Th2 pathway to 
improve their survival, and ability to infect and transmit offspring to new host. For example, 
helminths are strong inducers of regulatory T-cells (Treg) which secrete TGF-β and IL-10 
which can downregulate both Th1 and Th2 responses (Su et al. 2005, Hang et al. 2019). One 
of the most well-studied laboratory models of immunomodulatory helminth species is the 
murine intestinal nematode Heligmosomoides bakeri (Behnke and Harris 2010), a model of 
human hookworm infection (Monroy and Enriquez 1992, Maizels et al. 2012a). H. bakeri is 
known for modulating a wide variety of host immune responses, such as reducing antibody 
responses to influenza A infections (Chowaniec et al. 1972), exacerbating infection with 
plasmodia spp and increasing host mortality (Helmby 2009, Tetsutani et al. 2009). 
Additionally, H. polygyrus co-infection with Schistosoma mansoni was found to reduce 
schistosome egg-induced hepatic immunopathology which was associated with decreased 
levels of IL-17, INF-ƴ, TNF-a, IL-23 and IL-6, and increased levels of IL-4, IL-5, IL-10 and TGF- β 
(Bazzone et al. 2008), and re-activated murine gamma-herpes virus (MHV-68) from latency 
via induced IL-4 (Reese et al. 2014). Hence, it is clear that the immunomodulatory properties 
of H. bakeri leads to strong within-host interactions with microparasites; and as such it has 
become an important model organism in laboratory co-infection studies. 
5.2.1. The effect of nutrition on the host immune response 
In addition to being impacted by within-host parasite interactions, a host’s ability to mount 
an effective immune response can also be affected by its nutritional status. Hence, it is 
unsurprising that animals on lower quality diets have been found to be less able to cope 
with parasitic infections (i.e. they are less able to effectively clear infections and may have 
more sever disease outcomes) (Cypher and Frost 1999, Coop and Kyriazakis 2001, Ezenwa 
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2004). For example, kit foxes in California from residential areas, where anthropogenic food 
sources are available, were found to be heavier, in better condition and consequently had 
better stronger immune responses, than animals in a reserve, with less readily-available 
food sources (Cypher and Frost 1999). Also, Ezenwa (2004) found that wild bovids that were 
unable to maintain adequate nutrition during drought years, were less able to cope with 
gastrointestinal parasites, with reduced protein intake during dry periods being associated 
with reduced resistance to, and ability to recover from infection. Furthermore, energy 
deficits in laboratory mice have been shown to simultaneously suppress both Th1 (INF-ƴ) 
and Th2 (IL-4 and IL-5) responses and their effector functions (Koski et al. 1999). Examples 
of which include IL-4 being suppressed in the spleens of zinc deficient mice (Scott and Koski 
2000), and protein malnutrition being associated with increased survival of H. polygyrus, 
reduced levels the Th2 cytokine IL-4, but increased levels of the Th1 cytokine INF-g (Ing et al. 
2000). It is becoming clear that poor nutrition can have consequences for the host immune 
system, potentially reducing Th2 cytokine responses and upregulating Th1 pro-inflammatory 
responses. 
5.2.2. Comparing lab and wild animal models of infection 
Most studies on the immune response during co-infections have involved laboratory mice 
(Mus musculus) kept in clean, controlled “specific pathogen free” (SPF) barrier facilities 
(Babayan et al. 2011, Beura et al. 2016a). As a consequence, most laboratory co-infection 
studies have not investigated the impact of poor nutrition, since all animals are maintained 
on the same, high quality diets. These highly controlled experiments have eliminated as 
much experimental variation as possible; even so, the translation of findings from preclinical 
animal models to clinical efficacy and safety in humans has been notoriously unreliable, 
meaning that the majority of clinical trials do not result in approved human treatments (Hay 
et al. 2014, Harrison 2016, Pound and Ritskes-Hoitinga 2018). This is unsurprising since 
laboratory mice have limited genetic diversity, are not constantly exposed to different 
parasites as are wild animals (Pedersen and Babayan 2011, Maizels and Nussey 2013, 
Cadwell 2015), and have immune systems comparable to those of neonatal humans rather 
than of adult humans (Beura et al. 2016a). For example, the cellular immune systems of wild 
mice were found to be in a highly activated state compared to those of in-bred laboratory 
mice, despite this cells from wild mice had lower in vitro cytokine responses to pathogen-
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associated ligands compared to laboratory mice, potentially indicating the importance of 
maintaining immune homeostasis in the wild (Abolins et al. 2011). Furthermore, ‘dirty’ pet 
store and wild mice have been found to have higher numbers of differentiated memory T 
cells in lymphoid and non-lymphoid tissue, which more closely matches the immune 
systems of adult humans than genetically-deficient laboratory mice raised in SPF conditions 
(Beura et al. 2016a). Another reason why results from laboratory mouse models may not be 
reflected in natural populations is that many of these studies use unnatural host-parasite 
combinations, potentially causing different with-host interactions than if the natural host of 
the parasite were used. Thus, this suggests that to more closely model the immune 
response of humans and wild animals, we should move away from using inbred laboratory 
mice infected with unnatural parasite combinations and move more towards outbred or 
‘dirty’ animal models who are the natural host of the parasites, and may be subject to 
imperfect conditions (e.g. co-infection, lower quality diets). 
5.2.3. The wood mouse system as a natural model of co-infection  
The wood mouse (Apodemus sylvaticus) is a common wild mouse species living in 
woodlands in the UK and Europe (Knowles et al. 2013). Wood mice are commonly infected 
with both wood mouse herpes virus (WMHV) and the nematode H. polygyrus (sister species 
of the H. bakeri lab model), both of which are closely related to current laboratory mouse 
models of infection. Wood mouse herpes virus is a gamma-herpesvirus that is commonly 
found in mice and other murid rodents (Telfer et al. 2007), and its closely related laboratory 
species, MHV-68, has been well studied in laboratory mice. MHV-68 infection in laboratory 
mice usually starts with a lytic phase of infection (most viral genes are expressed, and the 
virus can replicate) in the lungs before moving to the spleen (Sunil-Chandra et al. 1992a, 
Flaño et al. 2005). Lytic virus replication in the lungs can be detected from 1 day post 
infection (dpi), with peak titres at 7 dpi and is usually cleared from the lungs by 10 dpi (Flaño 
et al. 2005). Furthermore, latent (non-replicating) virus has been found in the lungs of mice 
from as early as 3 dpi with levels of latent virus remaining high before declining to low 
stable levels by 30 dpi (Flaño et al. 2005). From the lungs the virus then spreads to the 
spleen, with infectious virus detectable at low levels from 3 dpi, with latent virus detectable 
from 6 dpi and peak latent infection is reached around 14 dpi before declining to low stable 
levels by day 90 days post infection (Sunil-Chandra et al. 1992a, Flaño et al. 2005). WMHV 
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then establishes a latent and lifelong infection, mainly in splenic B cells, but also in 
macrophages and dendritic cells (Flaño et al. 2000, Nash et al. 2001, Flaño et al. 2005) and 
lung epithelial cells (Stewart et al. 1998). The lifecycle of rodent gammaherpes viruses was 
investigated in laboratory mice, however Hughes et al. (2010b) studied the progression of 
lytic MHV-68 infection in the lungs and latent infection in the spleens of wood mice, and 
found that progression of MHV-68 in wood mice is similar to that in laboratory mice. 
Noticeably, the main differences were that infectious virus in the lungs could not be 
detected until day 7 and there were lower levels of latent virus in the spleen after 20 days 
post infection (Hughes et al. 2010b).  
 
During latent infection very few viral genes are expressed, however open reading frame 73 
(ORF73) is one of the few expressed throughout latency and ORF73 has been shown to be 
critical for establishing and maintaining viral infection in latently infected cells (Fowler et al. 
2003, Marques et al. 2003). This latent virus then has the molecular ability to reactivate into 
a lytic infection (Wu et al. 2000, Wu et al. 2001), controlled by the gene rta  (replication and 
transcription activator), primarily encoded by open reading frame 50 (ORF50) (Liu et al. 
2000, Wu et al. 2000, Wu et al. 2001). As mentioned previously, H. polygyrus is known to 
induce a highly polarized Th2 immune response in the host, and has the ability to suppress 
the host immune system via Treg cells (Maizels et al. 2012a), allowing for potential immune-
modulated interactions between WMHV and H. polygyrus. Taken together, this makes wood 
mice an excellent and tractable model to assess the interactions between helminths and 
viral pathogens in their natural host under a range of natural conditions (e.g. poor 
nutrition).  
5.2.4. Hypotheses 
In this study used controlled infection/co-infection experiments, with an outbred wild-
derived, but now laboratory reared colony of wood mice, to investigate the within-host 
interactions between H. bakeri (the laboratory strain of the species found to naturally infect 
wild wood mice) and WMHV co-infection under both high and low quality nutritional 
provisioning. Since H. bakeri is known to downregulate the Th1 immune response which 
would therefore increase host susceptibility to viral infection, I predict that mice infected 
with H. bakerii would have higher viral titres and a longer period of lytic infection; and that 
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this effect may be compounded in mice on a poorer quality diet. Next, I aimed to investigate 
the mechanistic basis for these within-host interactions, by exploring whether H. bakeri 
infection alters Th1 cytokine expression which are important for controlling WMHV 
infections, and if this relationship is affected by nutrition. Based on previous work, I 
expected that H. bakeri infection will lead to an increase in expression of type 2 cytokines 
(IL-5 and IL-10), and consequently a reduction in expression of type 1 cytokines (Tnf-α, Inf-ƴ, 
IL-6, and Tgf-β) compared to mice only infected with WMHV. Additionally, I hypothesised 
that WMHV-only infected mice have higher pro-inflammatory Th1 cytokine expression 
compared to co-infected mice. Hence, they could show higher expression levels of anti-
inflammatory cytokines, specifically IL-10 as this is an immunoregulatory and is produced in 
response to inflammation. It is also expected that mice on higher quality diets would be 
more able to mount an effective immune response, leading to a reduction in worm burdens, 
and lower viral titres of WMHV in both single and co-infected mice.  
This chapter aims to answer the following questions; 
1) Does co-infection with H. bakeri affect ORF50 or ORF73 expression in the spleen? 
2) Does co-infection with H. bakeri affect ORF50 or ORF73 expression in the lungs? 
3) Does H. bakeri co-infection downregulate the expression of Th1 cytokines in the 
spleen?  
4) Does H. bakeri co-infection downregulate the expression of cytokines aimed at 
WMHV infection in the lungs?  
 
5.3  Methods  
5.3.1. Source of virus stocks and Heligmosomoides bakeri  
Wood Mouse Herpes virus (WMHV) which was isolated from wild wood mice in Cheshire 
during 2002 and cultured from homogenized lung tissue was provided by Prof. James 
Stewart (Hughes et al. 2010a). It was recently tested to ensure that it was not contaminated 
with any other potential pathogens (IMPACT testing).  
The laboratory maintained helminth species H. bakeri provided by Dr. Amy Buck at the 
University of Edinburgh was used in this experiment; this species is closely related to the 
species found to infect wood mice in their natural habitat (Behnke and Harris 2010). 
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5.3.2. Wood mouse colony  
Wood mice (Apodemus sylvaticus) were maintained under standard laboratory conditions at 
the University of Edinburgh animal husbandry facilities. The wood mouse colony was 
originally derived from wild caught animals collected from a woodland in the Wirral, UK and 
have since been outbred to maintain as much genetic variability as possible. Wood mice 
were between 10-20 weeks old and a near equal ratio of males and females. All wood mice 
were co-housed in single sex groups of 6 animals and were individually identified by ear 
notching. 
 
5.3.3. Experimental design 
Our experimental design was composed of three infection groups, all of which were 
challenged with WMHV infection (see details below): 1) H. bakerii prior infection, 2) H. 
bakerii chronic infection, and 3) WMHV only (Figure 5.1). Each group had 20 age and sex-
matched wood mice, half of which were fed on a high-quality Transbreed diet, and the other 
half were fed on a standard-quality diet resulting in 6 experimental groups in total (3 
infection regimes x 2 diets). Fourteen days before the start of the experiment, 10 mice were 
randomly assigned to each of the 6 experimental groups, plus 4 mice randomly assigned to 
cages as transmission controls (sentinel mice to test for any within-cage transmission of 
either WMHV or H. bakeri). This led to a total of 64 wood mice, all of which were co-housed 
and fed their experimental diets for 2 weeks prior to any inoculations. The time schedule 
and details for each experimental group were as follows: 
Day -14: Mice were grouped, co-housed and fed with their experimental diets. 
Day 0: Mice from group 1 (H. bakeri prior infection) and group 2 (H. bakeri chronic infection) 
received 150 H. bakerii L3 infective stage larvae in 150μl of water via oral gavage. Group 3 
(WMHV only) and transmission controls, received an equivalent (150μl) dose of water via 
oral gavage.  
Day 14-16: All wood mice were transferred to clean cages for 4 hours to collect faecal 
samples to measure H. bakeri infection and egg shedding.  
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Day 21: All wood mice in group 2 (H. bakeri chronic) received a second dose of 150 H. 
bakerii L3 infective stage larvae in 150μl of water via oral gavage in an effort to maintain 
infection levels and generate chronic H. bakeri infections (Clerc et al. 2019b). Wood mice in 
group 1 (H. bakeri prior), received a weight adjusted dose (2μl/g) of a set of two 
anthelmintic drugs: Ivermectin and Pyrantel (9.4mg/kg Ivermectin and 100mg/kg Pyrantel) 
via oral gavage which have been shown to eliminate H. bakeri (Clerc et al. 2019a). The 
WMHV only group and transmission controls received 150μl of water via oral gavage. 
Day 28: All wood mice (except transmission controls) were intranasally inoculated with 
4x105 plaque forming units of WMHV (in 40μl PBS) under light anaesthetic following Hughes 
et al. (2010b). 
Day 35, 42 & 72: Two wood mice from each of the 6 experimental groups were culled and 
tissues harvested on each day (35, 42 and 72; see below), all transmission controls were 
culled at day 72. These time points correspond to 7 days (peak lytic infection in the lungs), 
14 days (peak latent infection in the spleen) and 35 days (persistent infection established in 







Figure 5.1. Experimental design. Wood mice were split into 3 groups (WMHV-only, H. bakeri 
chronic, H. bakeri prior) and fed their experimental diets for 14 days before being given their 
dose of H. bakeri larvae or water. On day 21 mice in the H. bakeri prior group were given a 
weight adjusted does of ivermectin, those in the H. bakeri chronic group were given a 
second dose of H. bakeri larvae and WMHV-only group were given water. On day 28 all mice 
were intranasally inoculated with 4x105 PFU WMHV. Mice were then culled on days 35, 42 
and 72. 
 
5.3.4. RNA extraction and cDNA synthesis 
I extracted RNA from both lung and spleen tissue that had been sorted in RNAlater at -80oC, 
using RNeasy® PowerLyzer® Tissue & cells kit (Qiagen) according to instructions, including 
on column DNase 1 treatment. Next, I measured optical density of each RNA sample to 
determine RNA concentration before running an agarose gel to ensure there was no DNA 
contamination. cDNA was reverse transcribed from RNA by first heating 2μg total RNA in the 
presence of random primers, dNTP’s and RNase free water (total volume of 13μl) to 65 
degrees, before snap cooling on ice and adding first strand synthesis buffer plus 0.1M DTT, 
then heating to 42oC before adding 1μl RTase (SuperScript II) and incubating at room 
temperature. The mixture was then incubated at 42oC for 2 hours, then inactivated at 70oC. 
Samples were stored at -20oC until needed. 
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5.3.5. Real-time quantitative RT-PCR analysis 
Quantification of viral ORF50 (as a measure of lytic WMHV infection) and ORF73 (as a 
measure of both active and latent infection) gene expression in spleen and lung samples 
was performed using a LightCycler480 for method see section 4.3. Additionally, a 100bp 
portion of the WMHV gene ORF50 was amplified using the forward primer 5’-
CATCCGAGGACGCGTTCATA-3’ and reverse 5’-GTGGAACACACATCACTGTC-3’ (acc. no. 
GQ169129.1).  
For details on RT-qPCR for cytokine gene expression refer to Methods section 4.2.1. 
All RT-qPCR reactions were carried out in duplicates and all samples used in the analysis had 
duplicate ct values that were within 0.5 sd of each other. 
5.3.6. Statistical analyses 
All statistical analysis was performed in R, v. 3.1.5 (R development core team 2011).  
For all analyses the two helminth infection groups (prior H. bakeri and chronic H. bakeri) 
were combined into one ‘co-infected’ variable since preliminary analyses suggested that 
having them separate did not provide any additional insight in either the spleen (see 
Supplementary Material; Figure 1: Table 1) or the lungs (see Supplementary Material; Figure 
2: Table 2), so they were combined for simplicity. Since chronic H. bakeri and prior H. bakeri 
were combined in the first analysis (the effect of infection group and diet on WMHV gene 
expression) they were also combined for all subsequent cytokine analyses. 
Worm FEC was not used in the analyse since very few mice were shedding H. bakeri eggs 
(26% of mice were shedding eggs), hence there were some groups in which all mice were 
not shedding eggs making the analysis meaningless. 
Analyses were conducted to address the following questions; 
1) Does co-infection with H. bakeri affect ORF50 or ORF73 expression in the spleen? 
To determine if WMHV infection (detectable ORF73 expression; represented as factor: yes 
or no) was associated with infection group (factor: WMHV only, H. bakeri-co-infected) or 
diet (factor: standard quality, high quality) I ran a binomial GLM: 
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WMHV infection ~ time point * (diet *Infection group + Sex).  
Next, I ran a second binomial GLM to determine if, among those with detectable infections 
(detectable ORF73 expression), having a lytic WMHV infection (detectable ORF50 
expression) was associated with infection group or diet: 
ORF50 ~ time point * (diet *Infection group + Sex). 
 In all models I controlled for the following variables: sex (factor: female, male) and time 
point (days since WMHV infection; factor: 7, 14 and 35). Interactions were also included to 
test for time specific sex effects (days since infection* sex), and a three-way interaction to 
test for time and diet specific infection group effects (days since infection *diet* infection 
group). In all cases, full models were created for each response variable above, and then 
models were simplified by backwards elimination of non-significant terms initially with a cut 
off at (p<0.07), starting with interactions, to obtain a minimal model with all terms p<0.05. 
To determine if H. bakeri co-infection was associated with higher levels of ORF50 (WMHV 
lytic infection) or ORF73 (WMHV infection) in the spleen; I only included wood mice with 
detectable levels of ORF50 or ORF73 expression (>0). I modelled this using two gaussian 
GLM’s to determine if expression of (i) ORF50 or (ii) ORF73 (continuous, log transformed) 
was associated with infection group (factor: WMHV only,  co-infected) or diet (factor: 
standard quality, high quality): 
(i) ORF50 quantity spleen ~ time point * (diet *Infection group + Sex) 
(ii) ORF73 quantity spleen ~ time point * (diet *Infection group + Sex) 
In each model, as described above I included covariates, relevant interactions, and model 
simplification. 
2) Does co-infection with H. bakeri affect ORF50 or ORF73 expression in the lungs? 
To determine if H. bakeri co-infection was associated with (i) detectable WMHV infection 
(detectable ORF73 expression), or (ii) lytic WMHV infection (detectable ORF50 expression) 
in the lungs, I conducted a similar set of analyses as above, but using data from lung 
samples: 
(i) ORF50 quantity lungs ~ time point * (diet *Infection group + Sex) 
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(ii) ORF73 quantity lungs ~ time point * (diet *Infection group + Sex) 
 
3) Does H. bakeri co-infection downregulate the expression of Th1 cytokines in the 
spleen?  
To determine if H. bakeri infection affects cytokine gene expression, I modelled the level of 
expression for each cytokine separately (Th1: TNF-α, INF-ƴ , TGF-β,  and IL-6; Th2: IL-5, IL-10) 
at each time point (days since WMHV infection) as the response variables. All models were 
Gaussian GLM’s with relative expression of each cytokine (square root transformed), as the 
response variable, and infection group (factor: WMHV only, co-infected) and diet (factor: 
standard quality, high quality) as the main explanatory variables of interest: 
Cytokine expression in spleen ~ diet *Infection group * Sex 
All models controlled for sex (factor: female, male), and included a three-way interaction to 
test for sex and diet specific co-infection effects (sex*diet* infection group). All models were 
simplified as above. Adjusted P-values for terms in the minimal model (q-values) were 
calculated based on the 'Graphically Sharpened' false discovery rate method (Pike 2011). 
4) Does H. bakeri co-infection downregulate the expression of cytokines aimed at 
WMHV infection in the lungs?  
To determine if H. bakeri infection affects cytokine gene expression in the lungs, I conducted 
a similar set of analyses as above, but using cytokine levels of gene expression from lung 
samples: 
Cytokine expression in lungs ~ diet *Infection group * Sex. 
 Adjusted P-values for terms in the minimal model (q-values) were calculated based on the 






5.4  Results 
 
5.4.1 Does co-infection with H. bakeri affect ORF50 or ORF73 expression in the spleen? 
 
There was a diet-specific infection group effect (diet* infection group interaction) 
(x21=5.589, p=0.018; Table 5.1a, Figure 5.2a) on the probability of having a detectable 
WMHV infection (ORF73 expression) in the spleens. H. bakeri co-infection was associated 
with increased probability of mice having a detectable WMHV infection at days 7 and 35 
post infection when on lower-quality standard diets, compared to WMHV-only mice on the 
same diet. All mice across both diets had detectable infections in their spleens at day 14 
post infection and there was no effect of co-infection among mice on high-quality diets. 
Additionally, there was a significant main effect of sex on the probability of having 
detectable infection across both diets and infection groups (x21=5.473, p=0.019), suggesting 
that females were less able than males to suppress ORF73 below detectable levels in the 
spleen (Figure 5.2a). There was also a significant time point*diet interaction (x22=6.720, 
p=0.018) (Table 5.1a, Figure 5.2a). However, in mice that had detectable ORF73 expression 
there was no association between co-infection and ORF73 quantity (x21=0.087, p=0.768; 
Table 5.1b); the only variable that remained in the model was time point (x22=32.933, 
p<0.001), showing that expression levels were lowest 7 days post infection, which increased 
at 14 days post infection, before decreasing again by day 35 (Table 5.1b, Figure 5.2b).    
In contrast, helminth co-infection was not associated with the probability of having an active 
WMHV infection (detectable ORF50 expression) in the spleen (x21=0.01, p=0.91; Table 5.1c). 
Again, the probability of having detectable ORF50 expression varied significantly across time 
points (x22=18.40, p<0.0001); around 35% of mice had detectable ORF50 expression 7 days 
post-infection, rising to all mice having detectable expression at 14 days post infection, 
declining to about 75% of mice at 35 days post-infection (Table 5.1c, Figure 5.2c). Again, 
infection group was not associated with expression levels of ORF50 (x21=1.452, p=0.228; 
Table 5.1b). However, time point (x22=31.907, p<0.001) and sex (x21=4.029, p=0.0447) 
remained in the model, with the highest ORF50 expression 14 days after WMHV infection, 
and females having higher expression of ORF50 than males over all time points (Table 5.1d, 






Figure 5.2. Association between a) probability having a detectable WMHV infection (detectable 
ORF73), diet, sex and infection group, b) ORF73 quantity and days since WMHV infection, c) 
probability of lytic infection (detectable ORF50 expression) and days since WMHV infection, and d) 
ORF50 quantity, sex and days since WMHV infection in laboratory bread wood mice; (n=60). Co-
infection with H. bakeri is associated with reduced ability to suppress ORF73 below detectable levels 




Table 5.1.  Factors affecting WMHV gene expression levels in the spleens of laboratory bred 
wood mice infected with WMHV. Models were simplified by backwards stepwise 
elimination. For variables not in the minimal model, statistics are those at the point they left 
the model. The variable ‘time’ refers to the number of days since WMHV infection. 
 
 
     
5.4.2 Does co-infection with H. bakeri affect ORF50 or ORF73 expression in the lungs? 
 
Similar to data from the spleen, there was a significant diet specific effect of infection group  
on the probability of having a detectable WMHV infection (detectable ORF73 expression) 
(x21=6.031, p=0.014; Table 4a, Figure 5.3a). Once again, co-infected animals on lower-quality 
diets were more likely to have detectable WMHV infections at days 7 and 35 post infection 
compared to those with only-WMHV infections on the same diet. Again, all mice across both 
diets had detectable infections in the lungs at day 14 post infection and there was no 
association between H. bakeri co-infection and the probability of having detectable 
infections in those on high quality diets. Additionally, there was a significant overall main 
effect of sex (x21=20.56, p<0.001), and time point (x22=23.60, p<0.001) on the probability of 
  A. ORF73 p/a (AIC: 52.86) B. ORF73 quantity (AIC:208.59) 
Variable df X2 p X2 p 
Time*Diet*  infection 
group 
1 0.0000 1.0000 1.6971 0.1927 
Time*   infection group 2 2.7203 0.1871 0.7083 0.7018 
Time*Diet 2 6.7201 0.0181  ¥ 0.9464 0.6230 
Time*Sex 2 2.8237 0.2437 1.6337 0.2012 
Diet*  infection group 1 5.5894 0.0181  ¥ 0.0606 0.8055 
Diet 1 - - 0.6510 0.4197 
Sex  1 5.4734 0.0193  ¥ 0.1165 0.7328 
infection group 1 - - 0.0870 0.7680 
Time     2 - - 32.933 <0.0001  ¥ 
  C. ORF50 p/a (AIC: 57.37) D. ORF50 quantity  (AIC: 167.12) 
Variable df X2 p X2 p 
Time*Diet*  infection 
group 
1 3.7798 0.1511 1.6186 0.2033 
Time*   infection group 2 0.4833 0.7853 0.3108 0.5772 
Time*Diet      2 1.7122 0.4248 0.5130 0.7738 
Time*Sex 2 0.0594 0.9707 0.1398 0.5656 
Diet*  infection group   1 0.1786 0.6726 0.0667 0.7962 
Diet 1 0.9102 0.3401 0.1540 0.2828 
Sex      1 1.1368 0.2863 4.0290 0.0447  ¥ 
infection group 1 0.0138 0.9063 1.4520 0.2283 
Time 2 18.395 0.0001  ¥ 31.907 <0.0001  ¥ 
¥ Variables in the minimal model (P < 0.05) 
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having a detectable infection (Table 5.2a, Figure 5.3a). In particular, as with the analyses 
from the spleens, females tended to have higher probabilities overall of having a detectable 
WMHV infection. Additionally, among those with detectable infections infection group  was 
not associated with ORF73 quantity (x21= 0.040, p=0.842), only time point remained in the 
model (x22=12.044, p=0.002) (Table 5.2b, Figure 5.3b). 
 
In contrast to data from the spleen, in the lungs there was a significant association between 
infection group  (x21=5.66, p=0.02) and time point (x22=28.57, p<0.0001) and the probability 
of having detectable ORF50 expression (Table 5.2c, Figure 5.3c). At day 35 co-infected mice 
were more likely to have detectable ORF50 expression compared to those with only WMHV 
infections. However, in those with detectable ORF50, H. bakeri co-infection was associated 
with lower levels of ORF50 expression (x21=7.867, p=0.005). Again, time point remained in 
the model, showing that levels of ORF50 expression varied with days post WMHV infection 
























Table 5.2. Factors affecting WMHV gene expression levels in the lungs of laboratory bred 
wood mice infected with WMHV. Models were simplified by backwards stepwise 
elimination. For variables not in the minimal model, statistics are those at the point they left 
the model. The variable ‘time’ refers to the number of days since WMHV infection. 
 
  A. ORF73 p/a (AIC: 38.32) B. ORF73 quantity (AIC: 157.56) 
Variable df X2 p X2 p 
Time*Diet* infection group 1 0.0000 1.0000 1.3563 0.0575 
Time*   infection group 2 4.8917 0.0867 4.7232 0.0943 
Time*Diet 2 0.0000 1.0000 3.1497 0.2070 
Time*Sex 2 4.4987 0.1055 2.0039 0.3672 
Diet*  infection group 1 6.0309 0.0141  ¥ 1.7421 0.1869 
Diet 1 - - 0.0773 0.7810 
Sex  1 20.555 <0.0001 ¥ 2.0923 0.1480 
infection group 1 - - 0.0400 0.8415 
Time     2 23.597 <0.0001 ¥ 12.044 0.0024  ¥ 
  C. ORF50 p/a (AIC: 42.82) D. ORF50 quantity  (AIC: 130.36) 
Variable df X2 p X2 p 
Time*Diet*  infection 
group 
1 0.0000 1.0000 0.2286 0.6326 
Time*   infection group 2 0.0000 1.0000 0.8586 0.3541 
Time*Diet      2 0.0000 1.0000 2.3050 0.3158 
Time*Sex 2 0.0000 1.0000 0.6654 0.7170 
Diet*  infection group   1 0.0000 1.0000 1.1328 0.2872 
Diet 1 0.6438 0.4223 0.2693 0.6038 
Sex      1 0.1165 0.7328 0.4508 0.5020 
infection group 1 5.6612 0.0173  ¥ 7.8666 0.0050   ¥ 
Time 2 28.568 <0.0001  ¥ 18.569 <0.0001  ¥ 
¥ Variables in the minimal model (P < 0.05) 
102 
 
Figure 5.3. Association between a) probability of detectable WMHV infection (detectable 
ORF73 expression), sex, diet, infection group and days since WMHV infection, b) ORF73 
quantity and days since WMHV infection, c) probability of detectable ORF50, infection group  
and days since WMHV infection and d) ORF50 quantity, infection group and days since 
WMHV infection in the lungs of laboratory bred wood mice; (n=60). H. bakeri co-infections 
were associated with reduced ability to suppress ORF73 (in mice on standard quality diets) 
and ORF50 (at day 35 post WMHV infection) expression below detectable levels. 
Additionaly, in those with detetable ORF50, co-infected mice at days 7 and 14 had higher 
ORF50 quantites compared to WMHV-only mice, there were no WMHV-only mice with 




5.4.3 Does H. bakeri co-infection downregulate the expression of cytokines aimed at WMHV 
infection in the spleen?  
 
Type 1 cytokines in the spleen  
Inf-ƴ gene expression was significantly affected by an infection group *diet*sex interaction 
at day 14 (x21=4.08, q=0.049; Table 5.3b; Figure 5.4a) and an infection group *sex (x21=6.12, 
q=0.032) and diet*sex (x21=3.87, q=0.049) interaction at day 35 (Table 5.3c; Figure 5b). At 
day 14 there was an effect of co-infection in males on lower quality standard quality diets; 
they had lower Inf-ƴ expression compared to WMHV-only males on the same diet, but there 
was no effect of co-infection on Inf-ƴ expression for high quality males or females on both 
diets (Figure 5.4a). Additionally, in males with WMHV-only infections and co-infected 
females, lower quality diets increased Inf -ƴ expression compared to those on higher quality 
diets. At day 35, co-infected females on both diets had higher Inf -ƴ expression than WMHV-
only mice (Figure 5b). In contrast, at day 7 there was no association between Inf -ƴ 
expression and infection group  (x21=1.08, p=0.18; Table 5.3a). 
Tnf-α gene expression was significantly associated with infection group  in animals on 
standard quality diets at day 14 (x21=13.04, q=0.004; Table 5.3e, Figure 5.4c). Co-infected 
animals on standard quality diets had reduced Tnf-α gene expression compared to WMHV-
only infected animals. Additionally, across both co-infected and WMHV-only infected those 
on standard quality diets had increased Tnf-α expression compared to those on high quality 
diets, and there was no association between infection group and Tnf-α expression in 
animals on high quality diets. Furthermore, there was no association between Tnf-α gene 
expression and infection group  at day 7 (x21=0.09, p=0.76; Table 5.3d) or day 35 (x21=0.03, 
p=0.86; Table 5.3f); however, there was a significant effect of diet on day 7 (x21=5.11, 
q=0.033; Table 5.3d). Animals on standard quality diets had higher Tnf-α gene expression 
compared to those on high quality diets.  
Finally, Tgf-β expression had a significant diet*infection group infection group  interaction 
(x21=5.21, 0.033), sex*infection group  interaction (x21=6.02, 0.032), and a diet*sex 
interaction (x21=4.93, q=0.033) at day 14 (Table 5.3h, Figure 5.4d). Co-infected males on 
both diets had lower TGF-β expression compared to those with only-WMHV infections, 
whereas there was no effect of co-infection in females. Additionally, WMHV-only males and 
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all females had higher Tgf-β expression when on lower-quality standard diets compared to 
those on higher-quality diets. Furthermore, there was no significant association between 
infection group  and Tgf-β expression at day 7 (x21=0.10, p=0.76; Table 5.3g) or day 35 
(x21=0.04, p=0.85; Table 5.3g). However, both diet (x21=10.11, q=0.012) and sex (x21=3.91, 
q=0.049) remained in the model at day 7 (Table 5.3i), with animals on standard quality diets 
having higher expression than those on high quality diets. 
Additionally, IL-6 expression was significantly associated with infection group at day 7 
(x21=4.49, q=0.040), and there was a significant diet*sex interaction (x21=5.78, q=0.032) 
(Table 5.3J, Figure 5.4d). Animals with co-infections had higher IL-6 expression compared to 
WMHV-only infected animals, and females on lower quality standard diets had higher 
expression than females on high quality diets. Conversely, there was no association 
between IL-6 expression and infection group  at day 14 (x21=1.68, p=0.19; Table 5.3K) or day 



















Figure 5.4. Association between a) INF-ƴ gene expression, sex, diet and infection group  at 
day 7, b) INF-ƴ gene expression, sex, diet and infection group at day 14 , c) TNF-α gene 
expression, diet and infection group  at day 14 d) TGF-β expression diet and infection group 
at day 14, e) IL-6 gene expression, diet, sex and infection group at day 7 in the spleen of 
laboratory bred wood mice (n=20). There is a very mixed response to co-infection, however 
the standard lower-quality diets increase Th1 expression compared to higher-quality diets, 
sometimes giving co-infected animals a boost of Th1 expression. 
c d e
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Infection Status Infection Status 
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Table 5.3. Factors affecting Th1 cytokine expression levels in the spleens of laboratory bred 
wood mice. Models were simplified by backwards stepwise elimination. For variables not in 
the minimal model, statistics are those at the point that factor left the model. Q values 




 A.  Inf-ƴ day 7 B.  Inf-ƴ day 14 C.  Inf-ƴ day 35 
variable df X2 p q X2 p q X2 p q 
infection group 
*Diet*Sex 
1 0.0438 0.8342 - 4.0765 0.0435 ¥ 0.0485 2.0297 0.1543 - 
Diet*Sex 1 2.7882 0.0950 - - - - 3.8722 0.0491 ¥ 0.0491 
infection group *Diet 1 0.0918 0.7619 - - - - 0.1205 0.7285 - 
infection group *Sex 1 0.0672 0.7955 - - - - 6.1227 0.0134 ¥ 0.0317 
Diet  1 1.7346 0.1878 - - - - - - - 
Sex 1 0.2444 0.6210 - - - - - - - 
infection group 1 1.8028 0.1794 - - - - - - - 
 D.   Tnf-α day 7 E.   Tnf-α day 14 F.   Tnf-α  day 35 
Variable df X2 p q X2 p q X2 p q 
infection group 
*Diet*Sex 
1 0.5713 0.4497 - 0.0050 0.9437 - 0.4654 0.4951 - 
Diet*Sex 1 0.0149 0.9028 - 0.5102 0.4750 - 0.0416 0.8383 - 
infection group *Diet 1 2.5067 0.1134 - 13.038 0.0003 ¥ 0.0044 0.0002 0.9886 - 
infection group *Sex 1 0.6843 0.4081 - 0.8563 0.3548 - 0.6786 0.4101 - 
Diet  1 5.1124 0.0238 ¥ 0.0333 - - - 0.2956 0.5866 - 
Sex 1 0.2175 0.6410 - 0.0311 0.0817 - 1.6524 0.1986 - 
infection group 1 0.0944 0.7587 - - - - 0.0324 0.8571 - 
 G. Tgf-β day 7 H. Tgf-β day 14 I Tgf-β day 35 
Variable df X2 p  X2 p  X2 p  
infection group 
*Diet*Sex 
1 1.4227 0.2330 - 3.5007 0.0613 - 0.7660 0.3815 - 
Diet*Sex 1 3.7074 0.0542 - 4.9275 0.0264 ¥ 0.0333 0.3598 0.5486 - 
infection group *Diet 1 0.1255 0.7232 - 5.2058 0.0225 ¥ 0.0333 0.1100 0.7402 - 
infection group *Sex 1 0.5703 0.4502 - 6.0152 0.0142 ¥ 0.0317 0.2827 0.5949 - 
Diet  1 10.110 0.0015 ¥ 0.0116 - - - 1.1385 0.2860 - 
Sex 1 3.9050 0.0481 ¥ 0.0491 - - - 0.0924 0.7611 - 
infection group 1 0.0950 0.7580 - - - - 0.0372 0.8470 - 
 J. IL-6 day 7 K.  IL-6 day 14 L.  IL-6 day 35 
Variable df X2 p q X2 p q X2 p q 
infection group 
*Diet*Sex 
1 0.0131 0.9090 - 0.3934 0.5305 - 0.5988 0.4390 - 
Diet*Sex 1 5.7842 0.0162 ¥ 0.0319 0.0747 0.7846 - 2.6240 0.1053 - 
infection group *Diet 1 1.4358 0.2308 - 0.7837 0.3760 - 0.9863 0.3207 - 
infection group *Sex 1 0.3227 0.5699 - 0.3736 0.5411 - 3.8058 0.0511 - 
Diet  1 - - - 1.7107 0.1909 - 0.7558 0.3847 - 
Sex 1 - - - 0.8908 0.3453 - 0.0213 0.8841 - 
infection group 1 4.4899 0.0341 ¥ 0.0396 1.6809 0.1948 - 0.0012 0.9724 - 
¥ Variables in the minimal model (P < 0.05) 
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Type 2/immunoregulatory cytokines in the spleen 
There was no significant association between infection group  and IL-10 at any time point 
(Day 7: x21=0.52, p=0.47, Table 5.4a; Day 14: x21=0.29, p=0.59, Table 5.4b; Day 35: x21=0.24, 
p=0.62, Table 5.4c). However, there was a significant diet*sex interaction at day 7 (x21=7.68, 
q=0.023; Table 5.4a), showing that females on standard diets had higher IL-10 expression 
than females on high quality diets, and diet had no effect on IL-10 expression in males.  
In contrast to IL10, IL-5 had a significant infection group *diet*sex interaction at day 7 
(x21=3.89, q=0.049; Table 5.4d, Figure 5.5a), day 14 (x21=9.23, q=0.012; Table 5.4e, Figure 
5.5b) and day 35 (x21=6.29, q=0.031; Table 5.4f, Figure 5.5c). At day 7 co-infected females on 
standard diets had higher IL-5 expression than WMHV-only infected females on the same 
diet, whereas there was no effect of infection group  on females on standard quality diets 
and mice on high quality diets. At day 14 co-infected females on standard diets and co-
infected males on high quality diets had higher IL-5 expression compared to mice with 
WMHV-only infections, and there was no effect of co-infection on females on high quality 
diets and males on standard diets. At day 35 co-infected females on standard diets had 
higher IL-5 compared to WMHV-only females on the same diet, in contrast co-infected 
males on standard quality diets had higher IL5 expression compared to those WMHV-only 
infections. Additionally, WMHV-only males at day 7 and 14 and co-infected females at day 7, 
14 and 35 on lower-quality standard diets had increased IL-5 expression compared to those 








Table 5.4. Factors affecting Th2/immunoregulatory cytokine expression levels in the spleens of 
laboratory bred wood mice. Models were simplified by backwards stepwise elimination. For 
variables not in the minimal model, statistics are those at the point that factor left the model. Q 












 A. IL-10 day 7 B. IL-10 day 14 C. IL-10 day 35 
variable df X2 p q X2 p q X2 p q 
infection group 
*Diet*Sex 
1 1.4409 0.2300 - 0.8508 0.3563 - 0.3864 0.5342 - 
Diet*Sex 1 7.6757 0.0056 ¥ 0.0232 3.2426 0.0718 - 3.1997 0.0737 - 
infection group *Diet 1 2.6658 0.1025 - 0.2673 0.6052 - 0.4457 0.5044 - 
infection group *Sex 1 0.3642 0.5462 - 0.8259 0.3635 - 1.1496 0.2836 - 
Diet  1 - - - 1.4368 0.2307 - 0.0008 0.9772 - 
Sex 1 - - - 1.3212 0.2504 - 0.1512 0.6974 - 
infection group 1 0.5167 0.4722 - 0.2886 0.5912 - 0.2429 0.6221 - 
 D. IL-5 day 7 E. IL-5 day 14 F. IL-5 day 35 
Variable df X2 p  X2 p  X2 p  
infection group 
*Diet*Sex 
1 3.8867 0.0487 ¥ 0.0491 9.2333 0.0024 ¥ 0.0139 6.2892 0.0122 ¥ 0.0317 
Diet*Sex 1 - - - - - - - - - 
infection group *Diet 1 - - - - - - - - - 
infection group *Sex 1 - - - - - - - - - 
Diet  1 - - - - - - - - - 
Sex 1 - - - - - - - - - 




Figure 5.5. Association between a) IL-5 expression, diet and infection group  at day 7, b) IL-5 
expression, diet and infection group at day 14, c) IL-5 expression, diet and infection group at day 35; 
(n=20). Overall a mixed response to co-infection, although there seems to be more of a trend 
showing an increase in Th2 expression in co-infected mice compared to WMHV-only infected mice 
mainly in mice on lower-quality standard diets.  
 
5.5.4 Does H. bakeri co-infection downregulate the expression of cytokines aimed at WMHV 
infection in the lungs? 
Type 1 cytokines in the lung 
There was no association between infection group and Inf-ƴ at day 7 (x21=1.53, p=0.22; 
Table 5.5a) or day 35 (x21=0.002, p=0.96; Table 5.5c). However, at day 14 an infection group 
*diet interaction remained in the model (x21=5.44, q=0.032; Table 5.5b, Figure 5.6a). Co-







WMHV infection on the same diet. There was no effect of co-infection on Inf -ƴ expression 
in mice on standard quality diets. 
For Tnf-α, there was no association between infection group  and Tnf -α expression at day 7 
(x21=0.28, p=0.60; Table 5.5d), day 14 (x21=0.35, p=0.55; Table 5.5e) or day 35 (x21=0.001, 
p=0.38; Table 5.5f). However, there was a significant main effect of diet at day 7 (x21=10.00, 
q=0.012; Table 5.5d), day 14 (x21=5.46, q=0.032; Table 5.5e) and day 35 (x21=4.78, q=0.035; 
Table 5f), with animals on standard quality diets having higher Tnf -α compared to those on 
high quality diets across all time points.  
There was no significant association between infection group  and Tgf- β at day 7 
(x21=0.0001, p=0.98; Table 5.5g), day 14 (x21=1.42, p=0.23; Table 5.5h), or day 35 (x21=0.04, 
p=0.83; Table 5i). However, there was a significant effect of sex at day 7 (x21=5.56, q=0.032; 
Table 5.5g) and diet at day 35 (x21=5.09, q=0.033; Table 5.5i), with higher Tgf -β expression 
in those on standard quality diets compared to high quality diets.   
For IL-6, there was a significant infection group *diet*sex interaction at day 7 (x21=30.43, 
q=0.003; Table 5.5J, Figure 5.6b), day 14 (x21=6.41, q=0.032; Table 5.5K, Figure 5.6c) and day 
35 (x21=5.43, q=0.032; Table 5.5L, Figure 5.6d). At day 7, co-infected females on standard 
quality diets and males on high quality diets had reduced IL-6 expression, whereas co-
infected males on standard quality diets had increased IL-6, and co-infection had no effect 
on females on high quality diets. At day 14, IL-6 expression was increased in co-infected 
standard quality females but decreased in co-infected males on high quality diets, and there 
was no effect of co-infection for males on standard quality diets or for females on high 
quality diets. Lastly, at day 35, co-infection was only associated with IL-6 expression in those 
on standard quality diets, with co-infected males had lower IL-6 expression while co-






Table 5.5. Factors affecting Th1 cytokine expression levels in the lungs of laboratory bred wood mice. Models were simplified by 
backwards stepwise elimination. For variables not in the minimal model, statistics are those at the point that factor left the model. Q 
values indicate FDR-adjusted P-values (see Methods). 
 
 
 A.  Inf-ƴ day 7 B.  Inf-ƴ day 14 C.  Inf-ƴ day 35 
variable df X2 p q X2 p q X2 p q 
infection group 
*Diet*Sex 
1 1.5275 0.2165 - 0.0135 0.9074 - 0.0020 0.9642 - 
Diet*Sex 1 0.1527 0.6959 - 1.8778 0.1706 - 2.7539 0.0970 - 
infection group *Diet 1 1.0732 0.3002 - 5.4366 0.0197 ¥ 0.0319 0.0041 0.9488 - 
infection group *Sex 1 0.6264 0.4287 - 0.7571 0.3843 - 0.0081 0.9285 - 
Diet  1 2.8805 0.0897 - - - - 0.5049 0.4774 - 
Sex 1 1.7688 0.0850 - 0.2070 0.6491 - 1.2428 0.2649 - 
infection group 1 0.1586 0.6904 - - - - 2.1469 0.1429 - 
 D.  Tnf-α day 7 E.   Tnf-α day 14 F.   Tnf-α day 35 
Variable df X2 p q X2 p q X2 p q 
infection group 
*Diet*Sex 
1 0.1574 0.6915 - 0.3848 0.5350 - 2.2972 0.1296 - 
Diet*Sex 1 2.1897 0.1389 - 0.0033 0.9539 - 3.0575 0.0803 - 
infection group *Diet 1 0.0290 0.8648 - 3.5315 0.0602 - 3.4403 0.0636 - 
infection group *Sex 1 2.3913 0.1220 - 0.2760 0.5994 - 0.0623 0.8029 - 
Diet  1 9.9998 0.0016 ¥ 0.0116 5.4618 0.0194 ¥ 0.0319 4.7834 0.0287 ¥ 0.0347 
Sex 1 2.3028 0.1291 - 0.8259 0.3635 - 0.6453 0.4218 - 
infection group 1 0.2816 0.5956 - 0.3527 0.5526 - 0.0008 0.9768 - 
 G.  Tgf-β day 7 H.  Tgf-β day 14 I.  Tgf-β day 35 
Variable df X2 p q X2 p q X2 p q 
infection group 
*Diet*Sex 
1 1.4977 0.2210 - 2.1345 0.1440 - 0.8000 0.3711 - 
Diet*Sex 1 0.2803 0.5965 - 0.7841 0.3759 - 0.9275 0.3355 - 
infection group *Diet 1 0.8130 0.3672 - 2.1267 0.1448 - 1.2917 0.2557 - 
infection group *Sex 1 0.1103 0.7398 - 0.0014 0.9702 - 1.5527 0.2127 - 
Diet  1 3.2024 0.0735 - 1.3344 0.2480 - 5.0876 0.0241 ¥ 0.0333 
Sex 1 5.5574 0.0184 ¥ 0.0319 1.1645 0.2805 - 0.2920 0.5889 - 
infection group 1 0.0008 0.9771 - 1.4163 0.2340 - 0.0449 0.8322 - 
 
 J. IL-6 day 7 K.  IL-6 day 14 L.  IL-6 day 35 
Variable df X2 p q X2 p q X2 p q 
infection group  
infection group 
*Diet*Sex 
1 30.4290 <0.0001 
¥ 
0.0029 6.4144 0.0113 ¥ 0.0317 5.4338 0.0198 ¥ 0.0319 
Diet*Sex 1 - - - - - - - - - 
infection group *Diet 1 - - - - - - - - - 
infection group *Sex 1 - - - - - - - - - 
Diet  1 - - - - - - - - - 
Sex 1 - - - - - - - - - 
infection group 1 - - - - - - - - - 





Figure 5.6. a) infection group , diet and Inf-ƴ expression at day 14 b) infection group , diet, 
sex and IL-6 expression at day 7, c) infection group , diet, sex and IL-6 expression at day 14, 
d) infection group , diet, sex and IL-6 expression at day 35 in the lungs of laboratory bred 









Infection Status Infection Status 
Infection Status Infection Status 
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Type 2/immunoregulatory cytokines in lung 
At day 7, IL-10 had a significant diet*sex*infection group  interaction (x21=6.05, q=0.032; 
Table 5.6a, Figure 5.7a). Co-infected males on standard quality diets had increased IL-10 
expression compared to WMHV-only infected mice, however this could be overcome by a 
higher quality diet with co-infected males on high quality diets having lower IL-10 
expression than those on standard quality diets. Additionally, co-infection had no effect on 
expression in all females or males on high quality diets. At day 14, there was a significant 
infection group *diet interaction (x21=6.26, q=0.023; Table 5.6b, Figure 5.7b), showing that 
co-infected animals on high quality diets had lower IL-10 expression compared to WMHV-
only infected mice on the same diet. Additionally, among those with co-infections higher 
quality diets reduced IL-10 expression compared to those on lower quality standard diets, 
and there was no effect of co-infection in mice on standard quality diets. Additionally, there 
was no association between IL-10 and infection group  at day 35 (x21=1.57, p=0.21; Table 
5.7c).  
For IL-5 infection group  was not significantly associated with expression at day 7 (x21=1.08, 
p=0.30; Table 5.6g) or day 35 (x21=1.52, p=0.22; Table 5.6i) with only diet remaining in the 
model at day 7 (x21=5.06, 0.033; Table 5.6g). At day 7 animals on standard quality diets had 
higher IL-5 expression compared to those on high quality diets. Conversely, there was a 
significant infection group *diet*Sex interaction at day 14 (x21=7.86, 0.023; Table 5.6h, 
Figure 5.7c). Co-infected females on standard quality diets and co-infected males on high 
quality diets had higher IL-5 expression compared to those with WMHV-only infections, and 
that there was no effect of co-infection on males on standard quality diets and females on 









Table 5.6. Factors affecting type 2/immunoregulatory cytokine expression levels in the lungs 
of laboratory bred wood mice. Models were simplified by backwards stepwise elimination. 
For variables not in the minimal model, statistics are those at the point that factor left the 




 A. IL-10 day 7 B. IL-10 day 14 C. IL-10 day 35 
variable d
f 
X2 p q X2 p q X2 p q 
infection group 
*Diet*Sex 
1 6.0518 0.0139 ¥ 0.0317 0.9567 0.3280 - 0.3948 0.5298 - 
Diet*Sex 1 - - - 1.1922 0.2749 - 1.5173 0.2180 - 
infection group *Diet 1 - - - 6.2602 0.0124 ¥ 0.0317 1.0697 0.3010 - 
infection group *Sex 1 - - - 2.0324 0.1540 - 0.9096 0.3402 - 
Diet  1 - - - - - - 3.0322 0.816 - 
Sex 1 - - - 1.6225 0.2028 - 0.1646 0.6849 - 
infection group 1 - - - - - - 1.5724 0.2099 - 
 D. IL-5 day 7 E. IL-5 day 14 F. IL-5  day 35 
Variable X
2 
p X2 q X2 p q X2 p q 
infection group 
*Diet*Sex 
1 1.2967 0.2548 - 7.8610 0.0051 ¥ 0.0232 1.6491 0.1991 - 
Diet*Sex 1 0.0158 0.9001 - - - - 1.9284 0.1649 - 
infection group *Diet 1 0.1037 0.7474 - - - - 2.1227 0.1451 - 
infection group *Sex 1 0.4459 0.5043 - - - - 0.6103 0.4347 - 
Diet  1 5.0606 0.0245 ¥ 0.0333 - - - 3.5809 0.0585 - 
Sex 1 0.7178 0.3969 - - - - 0.2504 0.6168 - 
infection group 1 1.0783 0.2991 - - - - 1.5235 0.2171 - 





Figure 5.7. Association between a) treatment, sex, diet and IL-10 expression at day 7, b) 
treatment, diet and IL-10 expression at day 14, c) treatment, sex, diet and IL-5 expression at 












Overall, most of the effects of co-infection seen in mice on the lower quality standard diet 
were not observed in mice on the higher quality diets (figure 5.9). There is more of an effect 
of co-infection on cytokine expression in females on standard quality diets compared to 
females on high quality diets. However, in both males and females there is no clear 
increase/decrease in Th1 or Th2 expression in mice on either diet, even so there is more of a 
tendency for Th1 and Th2 expression to be decreased in males, while females on standard 




Figure 5.9. The effect of H. bakeri co-infection on cytokine gene expression in the spleens and lungs of laboratory bred wood mice compared to WMHV-only 
infected mice, for male and females on high quality or lower quality standard diets. Line thickness indicates effect size. Red arrows  indicate that co-infection 
reduces expression compared to WMHV-only infected mice. Green arrows indicate that co-infection increases cytokine gene expression compared to WMHV-






5.5.1.   Effect of co-infection on the probability of having a detectable WMHV infection 
 
I found that co-infection with H. bakeri had the same effect on the probability of having a 
detectable WMHV infection in both the lungs and the spleen. Only mice on lower quality 
standard diets were affected by H. bakeri co-infection, with co-infected mice less able to 
suppress WMHV infection below detectable levels at 7 and 35 dpi, compared to WMHV-only 
mice. These results suggest that H. bakeri co-infection reduces the host’s ability to control 
WMHV infections, but that mice on high quality diets are able to over-come the suppressive 
effects of H. bakeri co-infection. This is not supprising since nutrition is essential for 
maintaining a correctly functoning immune system and since mice in the wild are unlikely to 
be reciving such a high quality diet, the lower quality standard diet is most likely to be 
indicatve of what we would expect to see in wild populations . Previous studies have found 
that co-infected mice are less able to control co-infecting viral infections. For example, mice 
infected with a recombinant vaccinia virus expressing HIV-1, took three weeks longer to 
clear the virus when co-infected with Schistosoma mansoni, compared to when infecting 
alone (Actor et al. 1993). Another study by Edwards et al. (2005) found that the liver of mice 
co-infected with S. mansoni and lymphocytic choriomeningitis virus (LCMV) was more 
susceptible to virus replication, compared to those only infected with LCMV. Additionally, 
previous studies have shown that nutrition can impact a host’s ability to respond to 
infections (Cypher and Frost 1999, Coop and Kyriazakis 2001, Ezenwa 2004). For example, 
kit foxes from residential areas in California who therefore had access anthropogenic food 
sources, were found to be heavier and in better condition than animals in a reserve, and 
consequently had better immune status (Cypher and Frost 1999).  
 
5.5.2. Effect of co-infection on WMHV lytic gene (ORF50) expression 
To further determine the effects of co-infection on WMHV I analysed the expression of the 
latent-to-lytic switch gene, ORF50. I found that co-infection only affects ORF50 expression in 
the lungs and not in the spleen, which is of particuar importance since the lungs are the 
main site of lytic viral replication (Flaño et al. 2005, Hughes et al. 2010b). I found co-infected 
mice were more likely to still have detectable ORF50 expression in the lungs at 35 dpi on 
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both diets, whereas WMHV-only mice were able to clear lytic virus infection by 35 days post 
infection. This suggests that co-infected mice are less able to control viral replication, and so 
have lytic infections for longer than WMHV-only mice, potentially due to H. bakeri infection 
inducing a Th2 response within the host causing the anti-viral Th1 arm of the immune 
system to be downregulated. Indeed, Reese et al. (2014) found that helminth infection, 
characterized by induction of the cytokine IL-4, caused on-going murine γ-herpesvirus 
infection to become reactivated from latency in vivo. IL-4 promoted viral replication by 
binding to and acting on a viral promoter to induce expression of the viral latent-to-lytic 
switch gene (ORF50), and blocked the antiviral effects of INF-γ (Reese et al. 2014). These 
results could have consequences for WMHV infection dynamics since WMHV is only 
transmittable to others in the lytic stage of infection, meaning those with co-infections 
could be able to trasnmit the virus for longer periods of time compared to those with 
WMHV-only infections.  
 
In contrast to results from previous chapters (chapters 2 and 3), and indeed to considerable 
evidence that helminth co-infection reduces the ability of the host to deal with co-infecting 
viral infections (Reese et al. 2014, Dietze et al. 2016), I found that among mice with 
detectable ORF50 expression, co-infected mice had lower expression of ORF50 levels at 7 
and 14 dpi compared to WMHV-only infected mice. Hence, although co-infected mice were 
more likely to have lytic infections, those active infections had lower levels of ORF50 gene 
expression. This is a supprising result, because if co-infection with H. bakeri makes the host 
more susceptible to WMHV, It would be expected that expression levels of ORF50 would be 
higher in co-infected mice. For instance, helminth-HIV co-infection was associated with 
higher plasma HIV viral loads comared to inviduals without helminth co-infections (Mulu et 
al. 2013). However, our results suggest the opposite, in that during the lytic infection stage 
in the lungs (7 and 14 dpi) helminth co-infection seems to have a protective effect by 
reducing ORF50 expression levels compared to WMHV-only mice. This relationship then 
switches by 35 dpi, whereby only mice with co-infections had any detectable ORF50 
expression and those with WMHV-only infections were able to clear lytic viral infection. A 
somewhat similar result was found recetly by Lin et al. (2019), who found that mice 
previously infected with H. polygyrus (mice were infected and then drug-cured 2 weeks 
later) were more likely to survive after challenge with the bacteria, Listeria monocytogenes, 
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compared to those only infected with L. monocytogenes. Additonally they found that H. 
polygyrus co-infetced mice had reduced bacterial burdens compared to mice only L. 
monocytogenes infections. There have also been other studies which show helminth 
infection offering protection. For example, McFarlane et al. (2017) found that mice co-
infected with H. polygyrus and respiratory syncytial virus (RSV) had reduced viral loads 
compared to mice with just RSV, and H. polygyrus infections coincided with the upregulated 
expression of type 1 INF in the gut and lungs. However, the mechanisms underlying these 
different effects of helminth-microparasite co-infections are poorly understood and could 
be specific for different infection models and different parasite combinations (Lin et al. 
2019). Taken together these results suggest that H. bakeri co-infection could be having an 
affect on the host immune system, therefore allowing for the within-host interactions seen 
in our laboratoy bred wood mice. 
 
5.5.3. Course of WMHV infection 
As expected the course of WMHV infection was different between the lungs and the spleen. 
At 7 dpi in the in lungs there was a high probability of mice having a detectable infection 
(detectable ORF73 expression) and of these mice with detectable infections all had lytic 
infections (detectable ORF50 expression). Furthermore, by 14 dpi all mice had lytic 
infections and high expression levels, and by 35 dpi the probability of having a detectable 
infection declined as did expression levels of both genes. Whereas in the spleen, the 
probability of a detectable infection was low at 7 dpi as were expression levels of both 
genes. However, both detectable expression and expression levels peaked at day 14, 
corresponding with peak latent infection in the spleen, and by 35 dpi the probability of 
having a detectable infection had declined but remained higher compared to the lungs. This 
is similar to the patterns of infection previously found by Hughes et al. (2010b) for MHV-68 
in wood mice and laboratory mice. 
 
5.5.4. Effect of co-infection on type 1 cytokine gene expression 
To determine the mechanism of interaction between WMHV and H. bakerii, I used RT-qPCR 
to quantify expression of several cytokine genes important for controlling both WMHV (type 
1) and H. bakeri (type 2) infections (Figure 8) . Overall, the effect of co-infection on type 1 
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cytokine gene expression in the spleen was fairly mixed, mostly there was no effect of co-
infection on type 1 expression, however co-infection could also increase (day 7 IL-6 and day 
35 females INF-ƴ) or decrease (day 14 males Inf-ƴ) gene expression of type 1 cytokines in 
the spleen. However, the effect of diet was relatively clear, mice on low quality standard 
diets increased the expression of type 1 cytokines compared to high quality diets, and had 
increased type 1 expression in mice with co-infections (Inf-ƴ day 7 females, IL-6 day 7 
females and Tnf-α) compared to co-infected mice on higher quality diets. In the lungs, the 
effect of co-infection and diet on type 1 cytokine expression is very mixed but tends to 
reduce (Inf-ƴ day 14 on high quality, IL-6 day 7 males on high quality and females on 
standard quality, IL-6 day 14 and 35 males standard quality) rather than increase (IL-6 day 
14 males on standard quality, IL-6 day 14 and 35 females on standard quality) type 1 
cytokine gene expression.  
Additionally, at day 14 co-infection decreased the expression of the pro-inflammatory Th17 
cytokine, Tgf-β in the spleen of male mice compared to WMHV-only infected males, and 
mice on lower quality standard diets tended to have higher expression of Tgf-β compared to 
mice on high quality diets, however this effect of diet was removed in co-infected males. 
Indeed, there was elevated type 1 responses in mice on lower quality diets compared to 
those on high quality diets, since Tgf-β is produced by Th17 cells and is important in 
inflammatory responses I would be expected that Tgf-β would also be increased.  
As with the spleen, I found that lower quality standard quality diets can sometimes 
overcome the suppressive effects of co-infection by increasing Th1 expression in co-infected 
mice compared to co-infected mice on higher quality diets. Although many studies have 
found that the Th2 responses aimed at helminth infection can downregulate the Th1 
response needed to control co-infecting microparasites (Actor et al. 1993, Spiegel et al. 
2003, Babu et al. 2009, Osborne et al. 2014, Gazzinelli-Guimarães et al. 2017), others have 
shown that helminth co-infection has no effect on Th1 responses (Dietze et al. 2016, Ahmed 
et al. 2017). Specifically, Dietze et al. (2016) found that mice co-infected with Friend virus 
(FV) and the helminth Litomosoides sigmodontis had increased viral loads compared to mice 
with only FV infections, however Th1 cytokine responses were not affected by co-infection. 
Instead Increased viral loads were associated with reduced titres of neutralizing virus-
specific antibodies (Dietze et al. 2016). These results, showing that helminth co-infection 
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can affect some virus specific immune responses while leaving Th1 cytokine responses 
unaffected, could explain why co-infected mice on standard quality diets are less able to 
suppress WMHV gene expression below detectable levels, and why all co-infected mice 
have lytic infections for longer than mice with WMHV-only infections, but there is hardly 
any suppression of Th1 cytokines. This suggests that these effects of co-infection could be 
mediated by the downregulation of other immune responses separate from Th1 cytokine 
expression.  
 
5.5.5. Effect of co-infection on type 2 cytokine gene expression 
Co-infection increased the expression type 2 cytokines (IL-5) in females on lower quality 
standard diets across all time points, while those on higher quality diets did not show any 
difference in expression between co-infected and WMHV-only infected mice. Males showed 
more of a mixed response, with co-infected males on high quality diets at 14 dpi showing 
increased expression and standard quality males at 35 dpi showing reduced expression. 
These results suggest that (particularly in females) higher quality diets can remove the effect 
of co-infection on IL-5 expression and can reduce expression in co-infected mice compared 
to co-infected mice on lower quality standard diets. In the lungs co-infection increases IL-5 
at day 14 (high quality males and standard quality females) and mice on standard quality 
diets tend to have higher expression compared to mice on higher quality diets. These results 
suggest that lower quality diets are associated with higher levels of Th2 cytokines and are 
more likely to see co-infection increase Th2 cytokine gene expression. These results could 
partly explain why co-infection only reduces the ability of mice to suppress WMHV infection 
below detectable levels in mice on lower quality diets.  
In the lungs I found that lower quality standard diets tended to increase IL-10 expression 
compared to those on high quality diets, giving co-infected mice a boost of IL-10 expression. 
The evidence indicates that co-infected mice have reduced expression of immunoregulatory 
cytokines compared to mice with WMHV-only infections, and that lower quality diets can 
increase expression of these cytokines. This effect of diet could be explained by the 





Overall, I show that H. bakeri co-infection reduces the ability of the host to control WMHV in 
mice on lower quality diets. Interestingly, those on high quality diets showed no association 
between co-infection and ability to control WMHV infection suggesting that higher quality 
diets can overcome the negative effects of co-infection. Additionally, I found that being co-
infected with H. bakeri was associated with mice having a longer period of lytic infection in 
the lungs, however during the early stages of WMHV infection, co-infection seems to enable 
to host to suppress lytic virus in the lungs to lower levels.  
I expected that, since H. bakeri co-infection overall has a suppressive effect on the host’s 
ability to control WMHV, I would see the downregulation of type 1 cytokine expression and 
upregulation of type 2 cytokine expression in co-infected mice. There was some evidence of 
co-infected mice having higher type 2 (IL-5) expression, however I found the type 1 
response to co-infection was very mixed. This suggests that other mechanisms other than 

















6.  Final discussion  
6.1 Effect of co-infection on susceptibility to WMHV in a wild wood mouse population 
One of the key aims of this thesis was to establish whether co-infection with H. polygyrus 
reduces the host’s ability to deal with co-infecting WMHV, and if deworming treatments 
could change this outcome. Throughout this thesis, I found numerous occasions where H. 
polygyrus co-infection seems to hinder the host’s ability to effectively deal with WMHV. In 
chapter 2, I found that among mice given prior deworming treatments, those with higher H. 
polygyrus FECs when treated were associated with an increased probability of having a 
WMHV infection 2-3 weeks later. It has previously been noted that FECs quickly return to 
pre-treatment levels in this system (Knowles et al. 2013, Clerc 2017).  Hence, giving short-
lived deworming treatments and having worm burdens bounce back as the effects of 
deworming wear off, has a detrimental effect on the host’s ability to control WMHV. In fact, 
in this system deworming treatment (potentially due to its short-lived effects on H. 
polygyrus FECs) was not beneficial to the host in terms of reducing susceptibility to WMHV. 
In contrast, in chapter 3 there was evidence that mice given effective deworming 
treatments (~70% of treated mice were not infected with H. polygyrus when sacrificed and 
had a mean H. polygyrus FEC of 1 (compared to 19 for untreated mice)) were less likely to 
have a WMHV infection ~2 weeks after treatment (chapter 3). Furthermore, in chapter 2, 
the detrimental effect of helminth reinfection on the host’s ability to control WMHV is 
exacerbated by higher H. polygyrus FECs, hinting that the suppressive effects of H. polygyrus 
are FEC dependent. Furthermore, I found that higher H. polygyrus burdens were associated 
with higher ORF73 gene expression, providing further evidence that effect of H. polygyrus 
can be burden dependent (chapter 3).  
These findings that helminth co-infection can reduce the host’s ability to respond to 
microparasitic infections has been demonstrated for many unnaturally clean SPF (Specific 
Pathogen Free) laboratory studies (Actor et al. 1993, Edwards et al. 2005, Su et al. 2014), 
but few have shown this in free living naturally infected animals. However, these few wild 
studies have found results similar to ours, in that helminth co-infection can increase 
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susceptibility to microparasites, and subsequent disease severity. For example, wild voles 
infected with Heligmosomum mixtum were more likely to become infected with Puumala 
Hantavirus infections (PUUV) (Guivier et al. 2014); wild boars co-infected with bovine 
tuberculosis (bTB) and a nematode species (Metastrongylus spp.) had an increased infection 
severity compared to those only infected with bTB (Risco et al. 2014), and African buffalo 
infected with helminths had an increased probability of becoming infected with tuberculosis 
(Ezenwa et al. 2010). To further explore the effects of helminth co-infection on WMHV, I 
also investigated whether co-infected mice are more likely to have a lytic (active, and 
transmissible) WMHV infection. It has been shown using H. polygyrus and MHV-68 in 
laboratory mice, which are not the natural host for these parasites, that H. polygyrus co-
infection is able to reactivate MHV-68 from latency (Reese et al. 2014). In contrast to this I 
found in our wild wood mouse system that neither H. polygyrus co-infection nor ivermectin 
treatment was associated with having a lytic WMHV infection. These differing results could 
potentially show the importance of using natural host-parasite combinations, and of using 
‘dirty’ mice with natural immune systems; laboratory mice raised in SPF conditions have 
been found to have immune systems more closely related to those of neonatal humans than 
adult humans (Beura et al. 2016a). Alternatively, it could be that our trapping timescales 
were not ideal to catch any effect of helminth co-infection on lytic virus gene expression, for 
example any effects could potentially only have been detectable before or after the final 
capture, or occur between successive trapping events. Furthermore, since I only analysed 
spleen samples from the natural population in chapter 3, and most lytic virus replication 
happens in the lungs, I would have missed any potential interactions that would only have 
been detectable in the lungs. Consequently, any further studies could use mice sacrificed at 
different time points post treatment and include analysis of lung samples, thus potentially 
capturing any interactions that happen in the lungs and spleen more or less than two weeks 
after treatment. 
The results from chapters 2 and 3 could have implications for deworming programmes in 
locations where concurrent infection with multiple parasite species is common. With 
evidence mounting that helminth infections can have an impact on co-infecting 
microparasites, it has been questioned whether the severity of, and susceptibility to, 
infection with microparasites could be altered using anti-helminthic drugs (Nacher 2006). 
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Helminth infections can cause a considerable amount of disease burden in human 
populations in developing countries (Brooker 2010). Consequently, there have been calls for 
mass deworming to be introduced into control measures against major viral, bacterial or 
protozoal diseases (Molyneux et al. 2005, Hotez 2009). Our results suggest that deworming 
can reduce susceptibility to microparasitic infections, however any benefits could be quickly 
reversed if treatment is not long-lasting meaning worm burdens quickly return to pre-
treatment levels. Additionally, our results highlight how treatment effects can differ even 
among the same host-parasite systems. In chapter 2, treatment had no beneficial effects on 
susceptibility to WMHV, however mice who had received treatment and had high H. 
polygyrus FECs were more susceptible to WMHV than their untreated counterparts. 
Conversely, in chapter 3 (where the study was carried out in a different population of mice 
from Falkirk, rather than Liverpool) I found that treatment was associated with reduced 
susceptibility to WMHV infection. This difference is likely to be due to study design, mice 
from Falkirk were treated with both ivermectin and Pytantel, whereas mice in Liverpool 
were treated less frequently and only with ivermectin. This is especially important as some 
studies have found that the anti-inflammatory effects of helminth infections can protect 
against immunopathology caused by microparasitic infections, and therefore be beneficial 
to the host (Bazzone et al. 2008). 
6.2 Effects of co-infection on the host immune response 
In terms of the mechanisms driving these co-infection interactions, helminths are widely 
known to have suppressive effects on the host immune system, causing immune-mediated 
within-host interactions during co-infection with microparasites such as viruses, bacteria or 
protozoa (Maizels et al. 2004, Elliott et al. 2007, Maizels et al. 2012a). These suppressive 
effects are most often attributed to the macroparasite fighting Th2 arm of the host immune 
system’s  ability to down regulate the microparasite fighting Th1 immune response.  For 
example, Actor et al. (1993) infected mice that had previously been infected with 
Schistosoma mansoni, with a recombinant vaccinia virus expressing the HIV-1 protein gp120 
and found that co-infected mice could take as much as 3 weeks longer to clear the virus. 
Furthermore, stimulated spleen cells from co-infected mice produced lower Th1 responses 
(INF- γ and IL-2) when challenged with gp120 than the vaccinia virus alone (Actor et al. 
1993). Additionally, H. polygyrus co-infection initiated the reactivation of MHV-68 in 
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laboratory mice via induced Th2 responses (IL-4) and suppression of Th1 responses (INF-ƴ) 
(Reese et al. 2014). Hence, I hypothesised that the main drivers of H. polygyrus-WMHV 
interactions were immune mediated, via suppression of the Th1 response by the helminth 
induced Th2 response. I found that type 1 expression was lower in mice with current (TNF-α 
and INF-ƴ (albeit not statistically significant)) and previous (IL-6) H. polygyrus infections 
(chapter 4). However, type 2 expression was not higher in mice infected with H. polygyrus 
and TGF-β expression was higher in WMHV-only mice (chapter 4). While these results agree 
with the hypothesis that type 1 responses will be downregulated in co-infected mice, 
surprisingly I found that type 2 cytokine gene expression was not upregulated under 
helminth infection, compared to WMHV-only infected mice. This could be an artifact of 
sampling time scales, with our sampling missing the period when type 2 cytokines are 
upregulated. An alternative hypothesis could be that other immune mechanisms, or 
suppression directly caused by H. polygyrus, could be responsible for the downregulation of 
Th1 responses seen in co-infected mice. In fact, H. polygyrus is well known for excreting 
proteins which mimic the effects of TGF-β and can aid in the survival of H. polygyrus by 
downregulating the immune response (Johnston et al. 2017, Smyth et al. 2018).     
6.3 Effect of H. bakeri co-infection on WMHV in laboratory bred wood mice 
To better understand how co-infection effects WMHV and host Th1/Th2 responses I used an 
outbred colony of previously wild wood mice in controlled laboratory conditions (chapter 5). 
This allowed us to collect samples from specific time points post infection and eliminate 
other potential factors which could affect host immunity. Importantly, our ‘wild-like’ system 
has an advantage over inbred SPF-raised mice in other laboratory studies, since it is a wild-
caught outbred colony and wood mice are the natural hosts of both WMHV and H. 
polygyrus meaning it is more likely to accurately capture the host-parasite interactions we 
would see in the wild. I was also able to give mice a standard quality and high quality diet to 
determine the effect of host nutritional status on co-infection effects. I found that mice on 
the lower quality diets were less able to control WMHV infection in the lungs and spleen 
than those on high quality diets, and co-infected mice on both diets were less able to 
suppress lytic virus in the lungs at day 35 post infection than single-infected mice. These 
results in the laboratory agree with my results from wood mice in the wild, in that co-
infected mice are less able to control WMHV infections, and there is no effect of co-
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infection on lytic virus in the spleen. Thus, this backs up the argument for analysing lung 
samples from wild wood mice to allow detection of any effects on lytic WMHV. It was also 
found that in the early stages of infection in the lungs (day 7 and 14 post infection), co-
infected mice had lower quantities of ORF50 expression (the marker for lytic WMHV 
infection) suggesting that H. bakeri could be having a protective effect in the lungs during 
the early stages of infection. Helminths having protective effects (i.e. the host is better able 
to control microparasitic infection) has already been demonstrated in other studies 
(McFarlane et al. 2017, Lin et al. 2019). However, to fully understand the effects of co-
infection on lytic WMHV it would be beneficial to perform plaque assays for lytic virus on 
lung tissues to determine accurate viral loads.  
6.4 Effect of H. bakeri co-infection on host immune repose in laboratory bred wood mice 
To further explore how helminth co-infection effects WMHV in our out-bred wood mouse 
colony, and how that compares to what we see in the wild, I analysed gene expression for 
several type 1, type 2 and immunoregulatory cytokines. I found that overall, there was no 
effect of co-infection on the expression of type 1 cytokines between co-infected and WMHV 
only infected mice. This is surprising since in the wild there was a decrease in type 1 
expression in co-infected mice. Again, in contrast to what is seen in the wild this data 
suggests that the overall trend was for Th2 cytokine expression to be increased in co-
infected mice. 
6.5 Effect of deworming on co-infecting WMHV 
I also found that co-infection effects were the same regardless of whether the mouse was 
given deworming treatments or not. One hypothesis for this could be that mice given 
deworming treatments had the same response to those not given treatments because in the 
lab environment mice are quickly able to clear H. bakeri infections, even after multiple 
doses. Indeed, in our system very few untreated mice had worms in the gut on dissection 
suggesting that they had cleared their infections without the need for deworming 
treatments. Alternatively, it could be that in this system any previous infection with H. 
bakeri has a lasting effect on the host immune system, regardless of whether the infection is 
cleared or not. These results differ somewhat from the results found in wild wood mice, 
where results suggested that effective treatment can reduce susceptibility to WMHV. 
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Explaining these differences requires an understanding of the differences between 
experiments in wild systems and those in laboratories. Wild animals will have a diverse 
history of previous infection whereas mice in the laboratory are immunologically naïve. 
Additionally, mice in the wild will experience many different stressors such as food shortage, 
adverse weather and predation which are not possible to replicate in the laboratory 
environment. Furthermore, mating behaviours in wild mice such as scent marking, male on 
male fighting and pregnancy could all affect susceptibility to microparasitic diseases. Indeed, 
I found in chapter 2 that heavier male mice were more at risk of WMHV infection, which 
agrees with results found by . All these results, taken together, show how variable the 
effects of deworming treatments can be even within the same host-parasite system. The 
benefits of deworming treatments for controlling microparasitic diseases are debated, 
mainly due to conflicting results on the outcomes of deworming co-infected individuals. For 
example, some studies show reduced HIV viremia (Mulu et al. 2013), and increased CD4+ cell 
count (Blish et al. 2010) in anthelminthic treated individuals. Additionally, Wolday et al. 
(2002) studied the effect of anthelminthic treatment on HIV viral load in individuals co-
infected with helminths and HIV in Ethiopia. They found that six weeks after treatment 
there was a significant change in HIV viral loads between treated and non-treated 
individuals- with treated individuals having lower viral loads. However, Modjarrad et al. 
(2005) found that there was no association between the treatment of helminth infections 
and reduced HIV viral load in adults in Zambia. Additionally, there is also evidence that 
interactions between helminths and microparasites can be negative (infection with one 
parasite infers resistance to another) (Pedersen and Fenton 2007). Hence, the outcome of 
treatment can be variable and any other potential factors such as nutritional status, 
behaviour (scent marking, male on male fighting etc) or adverse weather conditions should 
also be taken into account when assessing if deworming could be beneficial for controlling 
microparasitic diseases, particularly if evidence for or against comes from laboratory based 
studies. 
6.6 Diet effects on WMHV-H. bakeri co-infection dynamics 
The results from chapter 5 also suggest that high-quality diets can overcome many of the 
effects of co-infection. Previous studies have shown that nutrition can impact a host’s ability 
to respond to infections (Cypher and Frost 1999, Coop and Kyriazakis 2001, Ezenwa 2004). 
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For example, kit foxes from residential areas in California who therefore had access to 
anthropogenic food sources, were found to be heavier and in better condition than animals 
in a reserve, and consequently had better immune status (Cypher and Frost 1999). In fact, 
our results show that increased nutrition could be better at overcoming the impact of 
helminth infection on the host’s ability to respond to microparasitic co-infections than 
deworming. This could be particularly important when considering integrated control 
programmes for poor people in developing countries where helminth co-infections are 
common and can cause a considerable disease burden in human populations (Brooker 
2010). The effects of nutritional status on the host immune response have been well 
studied. For example, energy deficits in laboratory mice have been shown to simultaneously 
suppress both Th1 and Th2 responses and their effector functions (Koski et al. 1999), and IL-
4 was suppressed in the spleens of zinc deficient mice (Scott and Koski 2000). Whereas, 
protein malnutrition was associated with increased the survival of H. polygyrus, reduced 
levels the Th2 cytokine IL-4 and increased levels of the Th1 cytokine INF-g (Ing et al. 2000). 
There was a somewhat mixed response of Th2 cytokine gene expression to diet. Even so, 
there was a trend (especially in females) for mice on lower quality diets to have higher levels 
of IL-5 compared to mice on higher quality diets, and co-infection only increased IL-5 
expression in mice on lower quality diets . Additionally, those on lower quality diets also had 
higher expression of the Th2/immunoregulatory cytokines (IL-10) and Type 1 cytokines (Tgf-
β and, IL-6, Inf-ƴ) compared to mice on higher quality diets. These differences in immune 
response between the two diets could explain differing effects of co-infection between the 
diets. To further understand the effects of nutrition on co-infection interactions it would be 
beneficial to further study the effect of increased nutrition on co-infection dynamics in the 
wild, since there was some evidence that deworming can sometimes reduce susceptibility to 
microparasitic infections in wild wood mouse populations. 
6.7  Final conclusion 
Overall, H. polygyrus co-infection was found to hinder the host ability to deal with WMHV 
infections in the wild and in the laboratory. In the wild co-infection increased susceptibility 
to WMHV infection, higher H. polygyrus burdens were associated with increased ORF73 
gene expression. Likewise, in the laboratory co-infection increased susceptibility to infection 
and was associated with higher expression of ORF73 (a proxy for viral load), and co-infected 
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mice were more likely to have longer lytic WMHV infections than singly infected mice. 
Despite this evidence that H. polygyrus infection can have a detrimental effect on the host’s 
ability to deal with co-infecting WMHV, the effects of deworming treatments were variable. 
In the wild effective deworming treatment was associated with reduced susceptibility to 
WMHV infection, but short-lived deworming treatments (resulting in subsequent H. 
polygyrus re-infection) were associated with an increase in susceptibility to WMHV 
infection. Additionally, in the lab there was no effect of deworming treatments on 
susceptibility to infection or duration of lytic WMHV infections. These differing effects of 
deworming treatments between the wild and laboratory are most likely because animals in 
the lab can clear H. bakeri infections without treatment, thus most untreated mice had no 
H. bakeri infection upon sacrifice. Additionally, once infections were cleared there were no 
opportunities for reinfection as would be the case for wild wood mice. The effect of co-
infection on Th1 and Th2 cytokine responses was somewhat mixed. In the wild co-infection 
was associated with reduced Th1 response but no effect on Th2 cytokine expression. 
Conversely, there was no association between co-infection and reduced Th1 responses in 
the lab, but there was a trend towards increased Th2/immunoregulatory responses in co-
infected mice compared to WMHV-only infected mice. However, this study only measured 
the gene expression of cytokines and there will be varying levels of correlation between 
RNA and protein expression for each of the cytokine we measured. To get a better insight 
into how co-infection affects the immune response further work would need to be done on 
levels of Th1 and Th2 immune cells.   
Taken together, these results show that co-infection with H. polygyrus has the potential to 
reduce the host ability to deal with co-infecting WMHV, and that effective deworming 
treatments have the potential to reverse this effect. Furthermore, these results show how 
complex within-host co-infection interactions can be and why it is particularly important to 
study these interactions in the natural host, since results can vary between the lab and the 
field even with the same, natural, host-parasite combinations. They also highlight that whilst 
the host immune response can play an important role in determining the outcomes of co-
infections, other factors such as host nutritional status can also plays a critical role, which 
could potentially have implications if mass deworming was used to control major 
microparasitic infections. I also provided additional support to moving away from artificially 
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clean SPF laboratory studies, and instead using wild or ‘dirty’ lab animals, whose immune 
systems are challenged by co-infections and/or poor nutrition, and who are the natural 
hosts for the parasites. Thus, providing a more natural model of infection, with the hope 
that these results will more accurately capture what is seen in wild animal and human 
populations, thus enabling more successful treatment programmes. 
 
7. Supplementary material 
 
Table 7.1. Factors affecting WMHV gene expression levels in the spleen of laboratory bred 
wood mice infected with WMHV. Models were simplified by backwards stepwise 
elimination. For variables not in the minimal model, statistics are those at the point they left 
the model. The variable ‘time’ refers to the number of days since WMHV infection. infection 
group  includes chronic H. bakeri, prior H. bakeri and WMHV-only 
 
  A. ORF73 p/a (AIC: 60.76) B. ORF73 quantity (AIC:206.37) 
Variable df X2 p X2 p 
Time*Diet*  infection 
group 
1 0.0000 1.0000 6.6648 0.0834 
Time*   infection group 2 4.7583 0.3130 0.3102 0.5408 
Time*Diet 2 6.7004      0.0351   ¥ 0.4851 0.7846 
Time*Sex 2 3.0825 0.2141 0.9748 0.6142 
Diet*  infection group 1 6.2325      0.0443   ¥ 0.6230 0.7324 
Diet 1 - - 0.6510 0.4197 
Sex  1 5.8280      0.0158   ¥ 0.1463 0.7021 
infection group 1 - - 0.8160 0.6649 
Time     2 - - 32.933    <0.0001   ¥ 
  C. ORF50 p/a (AIC: 71.62) D. ORF50 quantity  (AIC: 174.83) 
Variable df X2 p X2 p 
Time*Diet*  infection 
group  infection group 
1 0.0000 1.0000 1.9701 0.3734 
Time*   infection group 2 1.3861 0.8466 1.5428 0.9724 
Time*Diet      2 1.4017 0.4962 1.0391 0.5948 
Time*Sex 2 0.8320 0.6597 1.1142 0.5729 
Diet*  infection group   1 3.9330 0.1400 0.2341 0.8896 
Diet 1 1.4260 0.2325 0.0110 0.3146 
Sex      1 2.5730 0.1087 4.0290     0.0447  ¥ 
infection group 1 1.4680 0.4800 1.6360 0.4413 
Time 2 29.212   <0.0001  ¥ 31.907   <0.0001  ¥ 





Figure 6.1. probability WMHV infection (detectable ORF73 expression) diet, sex and 
infection group , and days since WMHV infection in the spleens of laboratory bread wood 
mice. 
Table 7.2. Factors affecting WMHV gene expression levels in the lungs of laboratory bred wood mice 
infected with WMHV. Models were simplified by backwards stepwise elimination. For variables not 
in the minimal model, statistics are those at the point they left the model. The variable ‘time’ refers 
to the number of days since WMHV infection. infection group  includes chronic H. bakeri, prior H. 
bakeri and WMHV-only 
  A. ORF73 p/a (AIC: 50.32) B. ORF73 quantity (AIC:159.14) 
Variable df X2 p X2 p 
Time*Diet*  infection group 1 0.0000 1.0000 6.4377 0.1688 
Time*   infection group 2 6.0309      0.0490   ¥ 7.2185 0.1248 
Time*Diet 2 4.4987 0.1055 3.5257 0.1716 
Time*Sex 2 0.0000 1.0000 2.5528 0.2790 
Diet*  infection group 1 4.8917 0.2986 2.1581 0.3399 
Diet 1 - - 0.0983 0.7539 
Sex  1 20.555   <0.0001  ¥ 2.0923 0.1480 
infection group 1 - - 1.5303 0.4653 
Time     2 23.5974   <0.0001  ¥ 12.044     0.0024  ¥ 
  C. ORF50 p/a (AIC: 57.99) D. ORF50 quantity  (AIC: 117.06) 
Variable df X2 p X2 p 
Time*Diet*  infection group 1 0.0000 1.0000 9.4829 0.0235  ¥ 
Time*   infection group 2 0.0000 1.0000 - - 
Time*Diet      2 0.0000 1.0000 - - 
Time*Sex 2 0.0000 1.0000 6.0410 0.0488  ¥ 
Diet*  infection group 1 1.5140 0.4692 - - 
Diet 1 0.0000 1.0000 - - 
Sex      1 4.5570     0.0328  ¥ - - 
infection group 1 6.3890 0.0410 - - 
Time 2 51.663   <0.0001  ¥ - - 




Figure 6.2. As sociation between a) probability of WMHV infection (detectable ORF73 
expression) diet, sex and infection group , b) probability having an active WMHV infection 
(detectable ORF50), sex and infection group , c) predicted ORF50 quantity, diet, sex and 
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